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1.1 The importance of structural biology
“It has not escaped our notice that the specific pairing we have pos-
tulated immediately suggests a possible copying mechanism for the ge-
netic material.” With this seemingly unassuming conclusion Watson and
Crick (1953) have charmed many in the paper describing the double-
helix structure of DNA. A model that elegantly explained X-ray diffrac-
tion experiments on DNA fibres by Franklin and Gosling (1953). The
discovery of the DNA double helix laid the foundation for a molecular
understanding of heredity. While the relation between structure and
function of a macromolecule may not always be so apparent, more often
than not, a three dimensional atomic model gives valuable insight into
the molecular basis for its biological activity. Only a few years after the
discovery of the structure of DNA, Kendrew et al. (1958) published the
first X-ray structure of a protein: myoglobin, an iron containing protein
related to haemoglobin.
Both discoveries set off a research effort to unravel the molecular
structure of life and improve understanding of the molecular defects
in human disease at an atomic level, an endeavour that has resulted in
more than eighty-thousand crystal structures of protein and nucleic acid




1.1.1 The molecular basis of life
Life is characterized by a number of innate unique qualities that set it
apart from ordinary, lifeless matter. The self-organisation of well de-
fined structural components into systems of enormous organisational
complexity is the most ubiquitous property of life and required to per-
form many of the functions that are also considered to be essential traits
of living systems, such as the ability to interact with the environment,
transform energy, metabolize matter, and reproduce (Palade 1964). At
the heart of these processes are proteins whose function is determined
by their molecular structure and composition.
The genes needed to produce all proteins are stored on either the
strand of what is without question the best known structure of a bio-
logical molecule: the DNA double helix. The amino acid sequence of
a protein is encoded in a gene using a simple cypher consisting of a
triplet of the bases adenine (A), thymine (T), cytosine (C), and guanine
(G) (e.g. Lodish et al. 2000). The highly specific pairing of the A/T
and G/C base-pairs, not only ensures that each strand can be reliably
copied from the other, but also allows a gene to be converted into an
RNA intermediate by a process called transcription. In the last stage
of protein expression, each triplet in the RNA sequence is translated to
the one of the twenty-one amino acids that can occur in a protein until a
triplet signalling the end of the protein is encountered (e.g. Lodish et al.
2000).
The human genome is composed of roughly three billion base-pairs
distributed over twenty-two chromosomes common to both men and
women plus the two sex chromosomes. The DNA content of a single
human cell is about two meters stretched end-to-end (Lander et al. 2001;
Watson and Crick 1953). To some extent the length of this molecule
may be reduced by introducing additional coils into the double helix
causing the molecule to kink and fold up on itself (Champoux 2001). This
however is not enough to confine the DNA to the small volume of the cell
or cellular nucleus. Thus, most organisms express proteins that pack the
DNA into a compact structure called chromatin by wrapping the DNA,
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introducing bends, or looping the DNA by intra-strand forming bridges
(Luijsterburg et al. 2008).
An important functional aspect of DNA packing is in the control
of gene activity; usually local unpacking is associated with increased
expression of the genes in that region and vice versa (Li et al. 2005;
Luijsterburg et al. 2008). In addition to the role in gene activity, chro-
matin organisation has an important function in promoting the genomic
stability, which is critical to survival and proliferation of an organism
(Duboule et al. 2007; Oberdoerffer and Sinclair 2007). One example is
the involvement of chromatin organisation and mobility in DNA damage
repair. DNA lesions, caused by, for instance, UV- or ionizing radiation
can have detrimental effects on the cell by blocking the transcription of
the DNA into RNA, hindering DNA-replication or introducing muta-
tions in the genetic code. While chromatin mobility was considered of
little functional relevance, and chromatin packing often regarded as an
obstacle to DNA repair, both are now recognized to have an active role
in the repair of DNA lesions (Duboule et al. 2007; Groth et al. 2007;
Misteli and Soutoglou 2009; Soria et al. 2012).
Homologous recombination, one of the processes involved in main-
taining genomic integrity, sometimes inadvertently causes duplication of
whole stretches of DNA. The genes duplicated through recombination or
other mechanisms, can be passed on to an organism’s offspring and may
diverge in function over time (Näsvall et al. 2012; Ohno 1970). In Chap-
ter 4 the crystal structure of the Sso10a2 protein is presented, a member
of three highly homologous DNA binding proteins that have co-evolved
in Sulfolobus solfataricus. Even though the structure of Sso10a2 is very
similar to that of Sso10a, there are a number of striking differences.
Chapter 4 speculates about the different functional role of Sso10a2 by
comparing the structure with the homologous structure of Sso10a.
1.1.2 Protein structure and human disease
As well as unravelling the molecular basis of life’s processes, knowledge of
protein structure is important to understanding disease processes caused
5
1. Introduction
by molecular defects in proteins. Normal cellular activity is disrupted
when a protein that performs an essential function is not active or not
expressed, which in some cases can lead to serious disease.
The same processes that cause gene duplication can result in deletion
of a gene and consequently reduce or completely abolish the expression
of the encoded proteins. Various other types of mutation can affect
protein activity either by disrupting the global fold, often the result
of a frameshift or nonsense mutation, or by missense mutations that
result in the substitution of a different amino acid. Especially when
located in the hydrophobic core, an amino acid substitution can have a
dramatic effect on the stability and global fold of a protein (Dill 1990;
Eriksson et al. 1992; Sharp 1991), whereas localized changes in structure
often have the greatest effect near the catalytic centre of an enzyme or
in interaction sites (Schaefer and Rost 2012). Several diseases, such as
familial Alzheimer’s and autosomal recessive Parkinson’s disease, are
associated with mutations that decrease protein stability (Stefl et al.
2013; Wang and Moult 2001; Yue et al. 2005).
While the substitution of an amino acid does not always lead to ap-
preciable changes in the protein’s structure, the altered chemistry can
have a marked influence on the activity of the protein. A well known
example of such a mutation is the substitution of glutamic acid at posi-
tion 6 by valine in haemoglobin that causes Sickle-cell disease in people
homozygous for the mutation (Ingram 1958; Neel 1949). Under low oxy-
gen conditions, a hydrophobic patch is exposed on the haemoglobin sur-
face that binds the valine at position 6 resulting in the polymerization
of haemoglobin into rod-like structures. The sickle shape and reduced
flexibility of the red blood cells, induced by the fibrous haemoglobin pre-
cipitates, causes blockage of capillaries. Consequently, the symptoms of
sickle cell disease are mostly a direct result of restriction of blood flow
to organs and tissues.
Sometimes small molecule drugs can mitigate the effect of inactive or
malfunctioning proteins by targeting other parts of the disease causing
pathway. While difficult to achieve with a small molecule, restoration of
6
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the biological function of an inactive protein can sometimes be accom-
plished by simply substituting it with an active equivalent. For instance,
hereditary angioedema (HAE), a condition which is accompanied by
life-threatening swelling in the upper airways, may be treated by substi-
tuting endogenous inactive or absent C1 inhibitor (C1INH) though in-
travenous injection of Ruconest®, a recombinant C1INH (Plosker 2012;
Varga and Farkas 2011; Zuraw et al. 2010). Chapter 5 reports the out-
come of a high-throughput crystallization screen of three forms of recom-
binant human C1 inhibitor (rhC1INH) in over one thousand different
conditions. Several high quality crystals were obtained and preliminary
evidence suggests that these crystals may contain rhC1INH in a confor-
mation that is currently unknown. Knowledge of both active and latent
(Beinrohr et al. 2007) forms of C1INH will give insight into the molecular
mechanisms underpinning C1INH’s activity, and could provide a molec-
ular explanation for HAE and other diseases associated with molecular
defects in C1INH.
1.2 An introduction to X-ray structure
solution
Nowadays, a structural biologist has access to an entire arsenal of tech-
nologies for biophysical characterisation of a protein, including powerful
methods like nuclear magnetic resonance spectroscopy (NMR) and high
resolution cryo-electron microscopy. Nonetheless, X-ray crystallography
remains the method of choice for determining the structure of a protein
at atomic resolution. In order to do so, however, one has to accom-
plish the often difficult task of expressing, purifying and crystallizing
the molecule of interest. Even if a crystal is obtained and diffracts,
confounding factors such as high mosaicity, twinning, non-isomorphism
or a weak (anomalous) signal may make structure solution difficult or
impossible. New algorithms that intelligently handle these situations in
conjunction with the integration of individual programs into software
suites have enabled the crystallographer to rapidly try different struc-
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ture solution strategies and obtain a three dimensional model from even
the most challenging diffraction data.
1.2.1 The basics of diffraction and the phase problem
The behaviour of X-ray photons can be understood in terms of properties
associated with waves, as well as particle-like properties. When an X-
ray photon interacts with an electron bound to an atomic nucleus it can
scatter elastically. This means the energy of the photon, and thus its
wavelength, is conserved and only the direction of the photon is changed.
Alternatively, X-ray scattering can be thought of as the interaction of
electromagnetic waves with the electrons in a solid material. Irradiation
of the solid with an X-ray beam causes the electrons to oscillate with the
same period as the incoming beam. The accelerated electrons emit their
own electromagnetic field with the same phase and wavelength as the
incident X-rays that propagates radially outward from every scatterer.
The resultant field composed of contributions of individual scatterers is
called the scattered wave.
Due to the periodic structure of a crystalline solid, diffraction of X-
rays by a crystal can be described as scattering of electromagnetic waves
by a series of equidistant planes, denoted by three integers h, k and `,
known as Miller indices (Miller 1839). As illustrated in Section 1.2.1 the
incident X-ray beam hitting the surface of an (hk`) plane at angle θ is
partially scattered at the same angle θ away from the plane. The non-
scattered radiation is transmitted deeper into the solid until it interacts
with the electrons in the second plane, where the process repeats. The
X-rays reflected off a given (hk`) plane will travel different path lengths
through the solid. Constructive interference of the scattered waves only
occurs at certain angles θ for which the path lengths are equal to an
integer number n times the wavelength λ. This relationship, shown in
Equation 1.1 was derived by William Lawrence Bragg and is known as
Bragg’s law (Bragg 1913).
nλ = 2d sin(θ) (1.1)
8




Figure 1.1: Bragg diffraction. At the given angle of incidence θ the X-
rays scattered off the parallel (hkℓ) planes separated by a distance d are
shifted in phase such that they interfere constructively and give rise to
a detectable reflection. For most other values of θ the reflected waves
are out of phase and do not interfere constructively.
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The distance between successive identical planes in the crystal is
denoted by d. It is immediately apparent from the reformulation of
Bragg’s law shown in Equation 1.2 that the maximum resolution at
which a crystal can be sampled, that is the minimum distance dmin be-
tween (hk`) planes, is determined by θmax, the maximum angle to which
the crystal still diffracts. Theoretically the maximum resolution would
be obtained when θmax = 12π, but due to decreasing atomic scattering








In a diffraction experiment the angle of the primary X-ray beam
with respect to the crystal planes is changed by rotating the crystal.
Whilst rotating, the position and intensity of the diffracted waves are
recorded on an X-ray detector. The result is a regular arrangement of
spots of varying intensity, known as reflections (see Section 1.2.1). Each
reflection can be assigned a set of indices (hk`) associated with the
direction of the set of reflecting parallel planes in the crystal. The type
and number of scattering atoms in the (hk`) planes, or more precisely
the associated electrons, determine the magnitude of the corresponding
(hk`) reflection. The squared structure factor amplitude is proportional
to the intensity value of a reflection |Fhk`|2 ∝ Ihk`.





The structure factor is a complex number, as shown in Equation 1.3,
and can be obtained by a simple summation over all N atoms j in the
unit cell with positional coordinates xj , yj and zj . The atomic scattering
factor fj depends on the element and the diffraction angle for reflection
(hk`). Equation 1.3 shows that if the atomic coordinates are known, the
structure factor amplitudes Fhk` and phase αhk` can easily be obtained.
However, in X-ray crystallography one tries to solve the inverse problem,
that is determining the electron density ρ(x, y, z) in the unit cell. Note
10
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Figure 1.2: Diffraction image from the data set used to solve the Sso10a2
structure presented in Chapter 4. Each dot represents a reflection that
is assigned an (hk`) index. The structure factor amplitude |Fhk`| is
calculated from the intensity value Ihk` of each reflection. Most X-rays
pass through the crystal without being scattered, which shows up as a
large high intensity circle in the centre of the image. The further away
from the centre the reflections are, the higher the resolution of the data
set. Some of the reflections are obscured by the large ring around 2.2Å,
a problem that results from scattering by the ice that can accumulate
on the crystal.
that the structure factors are a reciprocal space quantity as the Miller in-
dices are actually derived from the fractional numbers 1/h, 1/k and 1/`
denoting the intersections of the associated lattice planes with the unit
cell axes. By applying a Fourier transform to Equation 1.3 the recip-









As mentioned earlier the structure factor amplitudes are propor-
tional to the square root of the intensity |Fhk`|2 ∝ Ihk`. However,
the phase αhk` in Equation 1.4 cannot be measured experimentally and
methods are needed to estimate the phase. This is known as the phase
problem in crystallography.
1.2.2 Solving the phase problem
Below, three methods to solve the phase problem in X-ray crystallogra-
phy are discussed: Direct methods refer to mathematical methods that
try to estimate the phases of the Fourier transform of the scattering den-
sity from the corresponding structure factor amplitudes alone. Another
increasingly popular method in macromolecular X-ray crystallography
is molecular replacement, which makes use of a similar structure to the
structure one is trying to solve to obtain the initial phase estimates. The
third family of methods exploit the scattering by one or more heavy
atoms in the crystal to obtain the phases. These effects consider ad-
ditional information from crystals containing a heavy atom that can
be measured experimentally and are hence referred to as experimental
phasing methods.
Direct methods
Direct methods encompass a broad range of mathematical relations be-
tween phases based on knowing the (normalized) structure factor am-
plitudes that stem from the fact that the electron density of the correct
model must be greater than zero and that the structure is composed of
discrete atoms (e.g. Giacovazzo 2008). An important concept in direct
methods is that of structure invariants, which are linear combinations of
phases that do not depend on the choice of origin and whose value de-
pends solely on the crystal structure and may in principle be estimated
from the structure factor amplitudes (e.g. Giacovazzo 2008). Currently,
the vast majority of X-ray structures of small molecules are solved by
direct methods. Based on the experience with solving a large number of
such structures, Sheldrick (1990) concluded that direct methods rarely
12
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lead to a solution unless at least half of the theoretically measurable
reflections in a 1.1 to 1.2Å range are observed. This empirical rule,
which has come to be known as “Sheldrick’s rule”, was given a struc-
tural basis for proteins by Morris and Bricogne (2003) who argue that
the rule has its origin in bonding distances typical of such molecules and
the occurrence of families of inter-atomic distances that differ by 1.1 to
1.2Å. Resolutions above 1.2Å however are seldom attained in macro-
molecular X-ray crystallography. Moreover, the application of classical
direct methods is limited to structures of several hundred non-hydrogen
atoms. The advent of dual space iteration methods as implemented
in SnB (Rappleye et al. 2002) and SHELXD (Schneider and Sheldrick
2002) allows larger structures up to a few thousand non-hydrogen atoms
to be solved (Usón and Sheldrick 1999) and is enhanced by the presence
of intrinsic metal ions or other heavy atoms (Weeks and Miller 1999).
Nonetheless direct methods are of limited practical use in protein crys-
tallography, with the exception of the determination of the heavy-atom
substructure in experimental phasing methods, discussed in more de-
tail in Section 1.3.1. Perhaps the combination of direct methods with
other phase improvement procedures may relax the resolution restraints
somewhat and allow larger structures to be phased in the future.
Molecular replacement
Molecular replacement (MR) leverages the abundance of structural in-
formation present in the PDB to solve a new structure. An initial elec-
tron density map is obtained by combination of the structure factor
amplitudes of the unknown structure with the phase information of one
or more known structures that are believed to have a similar fold. As a
rule of thumb MR has a good chance of being successful if the unknown
structure has more than 25% sequence identity with the MR search
model and their Cα atoms have a root-mean-square deviation smaller
than 2.0Å (Giorgetti et al. 2005; Taylor 2010).
The principal problem in molecular replacement is finding the cor-
rect orientation and position of the search model in the unit cell of the
13
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new structure. Instead of exploring six-dimensional space for the cor-
rect solution, many programs split this problem into finding the right
rotation and translation separately. Classically, these search methods
employ the Patterson function shown in Equation 1.5.




|Fhk`|2cos(2π(hu+ kv + `w)) (1.5)
Generating a Patterson map does not require knowledge of the
phases and can simply be calculated from the squared structure fac-
tor amplitudes, which are proportional to the intensities. The peaks in
a Patterson map correspond to interatomic vectors, that is for a crystal
with N atoms in the unit cell the map has N(N − 1) maxima. This
high-density of peaks and the partial overlap due to thermal vibration
of the atoms makes it impossible to generate distance restraints for all
atoms in case of larger structures like proteins. However the correla-
tion of a Patterson map of the experimental data with Patterson maps
of a MR search model in different orientations can be used to find the
correct rotation (Crowther 1972; Rossmann 1990). Similarly, Patterson-
based methods can be used to find the appropriate translation of the
origin and using the self-rotation function non-crystallographic symme-
try (NCS) can be identified. The phases calculated from the correctly
oriented MR search model are used to generate an initial electron density
map for the new structure. These phases can be subsequently improved
by model building iterated with refinement.
The MR approach is so powerful that to date nearly two-thirds of
the structures deposited in the PDB have been solved1 by MR. As the
size of the PDB continues to grow so will the probability that a given
new structure can be solved by MR.
Experimental phasing methods
The use of heavy-atom derivatives was amongst the first methods em-
ployed to solve the phase problem in protein crystallography (Kendrew
1Molecular replacement was the structure determination method for 51 151 of the
82 022 entries in the PDB as of August 10th 2013.
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et al. 1958; Perutz 1956). The method relies on the intensity differ-
ences between the native protein crystal and an isomorphous heavy-atom
derivative to obtain the correct phase of the native protein structure.
Heavy atoms, such as lanthanides, (transition) metals, can be in-
troduced into a protein crystal by soaking it in a solution containing
a heavy atom salt. Frequently these heavy-atoms bind on well defined
places in the protein. For instance Hg2+ ions bind the cysteine thiol
groups and uranyl salts like UO2NO3 preferentially bind between the
carboxyl groups of glutamic acid and aspartate. Other examples in-
clude Pb and PtCl2–4 -ions that bind cysteine and histidine, respectively
(e.g. Rould 1997).
The use of heavy atom solutions, however, carries one major practical
downside. Many of substances containing heavy atoms are highly toxic,
which in combination with the tendency of many of these compounds to
accumulate in the human body, poses a health risk to exposed workers.
Noble gases, such as Xe, are non-hazardous heavy atoms that can be
introduced into the crystal in a high-pressure environment. Note, that
there is no guarantee that an heavy atom can even be introduced in the
crystal. In fact often crystals are seen to disintegrate in the heavy atom
soaking solution. When the effect on the crystal packing is more subtle,
poor diffraction compared to the native crystal can be the result.
The intensity differences arising from incorporation of a heavy atom
are relatively easy to determine, considering a single Hg atom in a 1000
atom protein can give a fractional change in intensity of as much as 25%
(Crick and Magdoff 1956; Taylor 2010).
Defining the structure factor obtained from both heavy atoms and
protein as the derivative structure factor FPH and assuming it is a vec-
tor sum of the native FP and the heavy atom FH structure factor, an
initial estimate of the heavy atom structure factor amplitude may be
obtained with the following approximation: |FH | ' |FPH |− |FP |. Using
this estimate and the interatomic distance restraints that can readily be
obtained from the large heavy atom peaks in the Patterson map, the po-
sitions of the heavy atoms can be calculated. Alternatively, the locations
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of the heavy atoms in the unit cell may be obtained by direct methods
(see Section 1.3.1). Once the heavy atom substructure is known the
heavy atom coordinates and other parameters such as thermal B-factors
and occupancy can be refined to give a more accurate estimate of the
heavy atom structure factor FH and consequently the phase of FP .
In an error-free, idealized experiment, obtaining the native protein
phase is a simple geometric problem that is solved by applying the cosine
rule shown in Equation 1.6, which leads to two possible solutions for αP
that are distributed symmetrically about the heavy atom phase as is
illustrated by the Harker construction shown in Figure 1.3.
αP = αH ± arccos
F 2PH − F 2P − F 2H
2FPFH
(1.6)
Isomorphism of the heavy atom derivative is a critical condition to
the success of phase determination by isomorphous replacement that
may not be met. A seemingly small change in unit cell dimensions, ori-
entation of the protein in the unit cell, or other form of non-isomorphism
result in intensity differences that interfere or completely mask the
signal from the heavy atom(s) alone (Crick and Magdoff 1956). Non-
isomorphism can be caused by the soaking process itself, that, in many
cases causes shrinkage of the crystal by dehydration due to the difference
in osmotic concentration between the mother liquor and the heavy atom
solution. Furthermore. soaking can induce reorientation and changes in
conformation of the protein, as well as exchange of salt-ions other than
the heavy atoms.
In anomalous scattering wavelength dependent differences in scatter-
ing behaviour of certain atoms in the protein are used to obtain initial
phase estimates. In a classical description of scattering X-ray photons
are assumed to only change direction. In other words, the structure
factor amplitude |Fhk`| is taken to only depend on the positions and
not on the scattering behaviour of individual atoms. This is the basis
for Friedel’s law, which states that |Fhk`| = |F−h−k−`|. However, the
assumption that photons only change direction when scattered is an
oversimplified model. While a high-energy X-ray photon may be scat-
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Figure 1.3: The Harker construction for a single isomorphous replace-
ment (SIR) experiment. The circles indicate possible values for the
phase. In the idealized case there are two possible choices for the phase,
found where the circles intersect. However, in reality one needs to ac-
count for errors in the measurements and in the atomic parameters and
the possible phase is smeared out.
tered normally when interacting with the electron cloud surrounding the
atomic nucleus it may also be absorbed and promote an electron from an
inner shell. The absorbed photon can be re-emitted at a lower energy,
known as fluorescence; immediately re-emitted at the same energy; or
retarded compared to the normally scattered photon. The latter can be
modelled by the addition of an imaginary component to the photon’s
phase represented by the if” term in Equation 1.7.
f(θ, λ) = f0(θ) + f ′(λ) + if ′′(λ) (1.7)
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The scattering behaviour of individual atoms is given by the atomic
scattering factor f shown in Equation 1.7. In the simplified description
the wavelength dependent contributions f ′ and f ′′ can be ignored and
the scattering factor only depends on the Bragg angle θ and Friedel’s
law holds.
The anomalous scattering effect is most noticeable and easy to mea-
sure close the absorption edge(s) where the absorption term f ′′ becomes
large and consequently the difference between |Fhk`| and |F−h−k−`| are
heightened. Note that the term “anomalous scattering” can be consid-
ered a misnomer as the resonance effects on the atomic scattering factor
are always present, but are generally to small to be accurately measured.
As illustrated in Figure 1.4 the anomalous, or Bijvoet difference is sim-
ilar to the isomorphous difference and can be used in the same way to
locate the anomalous substructure and recover the native protein phase.
The sulphur SAD phasing method only requires the sulphur atoms
present in almost any protein to obtain initial phase estimates and solve
the structure. The crambin structure, solved in 1981 by Hendrickson and
Teeter, was one of the first structures to be determined by the sulphur
SAD phasing method. However, to date relatively few structures have
been solved by using the anomalous differences from the sulphur atoms
alone (Doutch et al. 2012; Ramagopal et al. 2003). There are several
reasons for this apparent lack in progress. Typically synchrotron radi-
ation sources are operated at a wavelength well away from the sulphur
K-edge at 5.0155Å. Even though modern quantum area detectors are
substantially more sensitive than older detectors such as film and image
plates, the Bijvoet difference is usually very small and the anomalous
signal may be lost in detector noise, requiring long exposure times. On
the other hand the small Bijvoet differences can easily be overwhelmed
by the effects of radiation damage or overexposure (Dauter 2010). Data
collection strategy programs like BEST (Bourenkov and Popov 2006),
that estimate different measures of data quality from the first images of
a diffraction experiment, may be helpful in optimizing collection of SAD
data set.
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Figure 1.4: The Harker construction single-wavelength anomalous
diffraction (SAD) experiment. In the presence of an anomalous scat-
terer Friedel’s law breaks down. The f ′′ term is advanced 90° in phase,
which gives rise to the Bijvoet difference ∆F± = |FPH(+)| − |FPH(−)|.
If the measurement errors are ignored, the phase choices are given by
the intersections of the phase circles.
Nowadays high-efficiency selenomethionine labelling protocols are
available for bacterial, yeast, insect and mammalian cell expression sys-
tems (Barton et al. 2006). The major advantage of selenium over sulphur
in SAD and multiple-wavelength anomalous diffraction (MAD) phasing
is that the selenium absorption edge (0.9795Å) is within 1.5 to 2.5Å
the typical range at a tunable macromolecular beamline (Doutch et al.
2012). Note that approximately 80% of all proteins have a methionine
content of 1% or more (Strub et al. 2003), the percentage required for
a successful MAD experiment (Hendrickson and Ogata 1997).
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An idealized error-free SIR or SAD experiment would both result in
two possible choices for the phase, only one of which is correct. This
phase ambiguity cannot be resolved without introducing additional in-
formation. An earlier procedure to address the phase ambiguity is the re-
solved anomalous phasing approach, as used by Hendrickson and Teeter
(1981) to solve the crambin structure, which uses the combined probabil-
ity resulting from the partial structure and from anomalous scattering,
unless the latter gives rise to a strong unimodal phase probability dis-
tribution. An alternative approach to choose the right set of phases is
based on direct methods and employs the relations between large nor-
malized structure factors to refine the initial phase estimates (Fan et al.
1990; Hauptmann 1982, 1996). Finally, the iterative single-wavelength
anomalous scattering method introduced byWang (1985) starts from the
average phase and enhances meaningful features in the macromolecular
crystal through iterative real-space smoothing of the electron density
in the solvent region, much like ordinary solvent flattening in density
modification (DM).
Another difficulty associated with phase determination by the SIR
or SAD is that the initial phase estimates are often simply too inaccu-
rate to generate an electron density map with interpretable features, or
even one that could be improved by density modification. This inac-
curacy has its origin in the experimental errors in the measurement of
the structure factor amplitudes, errors due to scaling, non-isomorphism,
errors in heavy atom parameters or even that the isomorphous and/or
anomalous signal is not strong enough.
To account for these effects and define a phase probability Blow and
Crick (1959) introduced the concept of lack of closure ε as graphically
illustrated in the with the Argand diagram in Figure 1.5. Simply put ε
is the difference between derivative structure factor amplitude FPH(calc),
calculated from the assumed values of structure factor amplitudes for
the native protein and heavy atom contributions, and the measured
FPH(obs).
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Figure 1.5: The lack of closure ε between the calculated derivative struc-
ture factor amplitude FPH(calc) and the observed FPH(obs) illustrated for
a SIR experiment.
ε = |FPH(obs)| − |FPH(calc)| = |FPH(obs)| − ||FP |eiαP + |FH |eiαH || (1.8)
In the case of a SIR experiment the phase probability distribution is
obtained as shown in Equation 1.9. This assumes the measurement er-
rors are contained in the derivative structure factor amplitude FPH(calc)
and follow a Gaussian distribution (Blow and Crick 1959). The lack of
closure variance E2 is given by Equation 1.10.
P (αP ) ∝ e−ε
2/2E2 (1.9)
E2 = 〈(FPH(obs) − FPH(calc))2〉 (1.10)
Collecting additional data, in the form of MAD data or several
heavy-atom data set, is often worthwhile. As illustrated in Figure 1.6
for a MIR experiment, the combination of several heavy-atom data sets
breaks the phase ambiguity by restricting the phase angle and sharp-



















Figure 1.6: The Harker construction for a multiple isomorphous replace-
ment (MIR) experiment. The additional heavy atom derivative restricts
the phase from two in the case of SIR to a single choice.
anomalous differences from a heavy-atom derivative are used in a single
isomorphous replacement with anomalous scattering (SIRAS) experi-
ment to the same effect (Figure 1.7). However, the relative ease with
which selenomethionine may be incorporated in the protein and the
availability of macromolecular crystallography beamlines with tunable
wavelength at many of the major synchrotrons has made collection of
MAD data routine. More than 50% of the experimentally phased struc-
tures deposited to the PDB in 2006 were determined by MAD (Barton
et al. 2006) from selenomethionines or natively present metal atoms.
MAD phasing makes use of the wavelength dependence of the dispersive
f ′ and absorption f ′′ effect of the atomic scattering factor (see Equa-
tion 1.7), to provide distinct sets of possible phases. Similar to MIR
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Figure 1.7: The Harker construction for a SIRAS experiment. The
phase choices are restricted from two options for SAD to one choice by
the combination isomorphous replacement and anomalous data.
the phase circles in a MAD Harker diagram have only one intersection.
The added benefit of MAD is that the data can be collected on a single
crystal.
1.3 Automation in X-ray structure solution
The growing need for automation in the structure solution process is fed
by two trends in X-ray crystallography. Easy access to synchrotron radi-
ation sources and the availability of commercial crystallization reagents,
consumables and equipment have made protein X-ray crystallography
available to an ever expanding audience of life scientists. Bundling
and integration of individual software tools into graphical user interface
(GUI) driven user friendly software suites, like CCP4 (Winn et al. 2011)
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or Phenix (Adams et al. 2010), that use sensible default settings and a
high degree of automation allow non-crystallographers to solve a crys-
tal structure. Secondly, X-ray crystallography technology has matured
to a stage where it is being deployed in structural genomics consortia
across the world for high-throughput structure determination. The large
number of diffraction experiments performed by such consortia call for
automation of data processing to enable efficient evaluation of candidate
data sets for structure solution.
Many research groups involved in development of software for macro-
molecular crystallography are attempting to provide fully automated
programs for structure solutions by integrating MR strategies, pipelines
for structure solution from experimentally obtained phase estimates,
and increasingly combinations of both. Structure solution from phase
estimates obtained from an anomalous scattering or isomorphous re-
placement experiment always follows the same basic separation of steps
shown in Figure 1.8 even though the programs used may differ.
1.3.1 Substructure detection
Solving a structure by experimental phasing rests on the ability to suc-
cessfully detect the anomalous substructure. Without it, calculation of
substructure phases is impossible. Even if the phases recovered from the
substructure cannot be extended to the full model automatically, it is
clear that if substructure detection is successful there is some anomalous
signal that may be exploited to provide better phase estimates, by for
instance combination with phase information from MR or DM.
The Patterson function has an important application in MR as dis-
cussed in Section 1.2.2. However, it is also used to locate heavy atoms in
anomalous scattering and isomorphous replacement experiments. Con-
sidering the height of a peak in a Patterson map is determined by the
number electrons in an atom, atoms with a higher atomic number are
relatively easy to detect. The substructure may be readily calculated
from the distances vectors of the heavy atoms. The program Solve
(Terwilliger and Berendzen 1999) implements Patterson based routines
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Model building & refinement
Figure 1.8: Typical steps in the (automated) solution of a macromolec-
ular crystal structure by experimental phase determination. In contrast
to phasing by molecular replacement the initial phase estimates are re-
covered from the anomalous scattering component, or the isomorphous
difference between a native- and heavy atom derivative data set.
for determining the substructure for MAD and MIR.
Direct methods, first popularized by Hauptmann and Karle (1953)
for phasing of small molecule X-ray crystal structures ab initio, have
also found application in the determination of the heavy-atom substruc-
ture in macromolecular crystallography. The introduction of dual-space
iteration, also known as ‘Shake-and-Bake’, by Miller et al. (1993) was a
major advance in this area. First, starting phases are calculated from
a set of atoms, that may either be randomly placed or whose position
is constrained by for example agreement with the Patterson function.
In the ‘shaking’ half of the method the starting phases are refined in
reciprocal space either through minimisation of the minimal function
(Debaerdemaeker and Woolfson 1983; Miller et al. 1993) or by using
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the tangent formula (Karle and Hauptmann 1956). The map obtained
by combination of the improved phases with the normalized structure
factors is searched for the highest peaks that could be possible atoms.
Several different approaches exist for the real space, or ‘baking’ part
of the ‘Shake-and-Bake’ routine (Usón and Sheldrick 1999). The pro-
gram SnB implements the dual-space iteration algorithm in its purest
form, though most substructure detection programs, such as SHELXD,
HySS (Grosse-Kunstleve and Adams 2003) and SIR2011 (Burla et al.
2012) employ a hybrid approach combining ‘Shake-and-Bake’ type pro-
cedures, other direct methods inspired approaches, as well as Patterson
based procedures. A noteworthy exception is the program Crunch2
(de Graaff et al. 2001), which takes a different approach to ‘Shake-and-
Bake’ that is based on Karle–Hauptman determinants (van der Plas et
al. 1998).
1.3.2 Substructure phasing
Obtaining accurate initial experimental phases estimates is an important
aspect of automated structure solution pipeline. Advanced maximum-
likelihood methods offer substantially better models of an anomalous
scattering or isomorphous replacement experiment and associated errors.
The univariate Gaussian phase probability defined by Blow and Crick
(1959) was an important conceptual advance in thinking about phase
estimation and modelling errors. Many researchers expanded on the
lack of closure work using more advanced probabilistic models based
on the maximum-likelihood formalism. The first step in this direction
was taken by Otwinowski et al. (1991) who, in Mlphare (Collaborative
Computational Project Number 4 1994; Otwinowski et al. 1991), applied
the phase probability as a weight in heavy-atom refinement as well as
during the structure factor calculation. In contrast to many others at
that time who used only one phase for each reflection to estimate the
heavy-atom parameters.
The maximum-likelihood based approach chosen in the program
Sharp (Bricogne et al. 2003) numerically integrates over all possible
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phases and the “true” structure factor amplitude which, for example,
is not measured in a SAD or MAD experiment. While the program
refines errors, scale and atomic parameters simultaneously with a Gaus-
sian error in the isomorphic and anomalous terms, it does not consider
correlations between data sets and errors. In contrast, the program Bp3
(Pannu and Read 2004) directly considers the correlations between data
sets and correlated errors for a SAD experiment, which has shown to be
better over other approaches.
1.3.3 Density modification
The experimentally phased electron density map may initially be of
insufficient quality to allow automatic tracing of a three dimensional
atomic model. DM aims to improve phase estimates with an itera-
tive procedure that cycles between real space incorporation of chemical
knowledge and combination of the real space modified phases or phase
distributions with the experimentally obtained phase probabilities in
reciprocal space.
Figure 1.9 illustrates DM in its most traditional form, starting with
the generation of the electron density map by Fourier summation of the
structure factors calculated with the centroid phases from the experi-
mentally obtained phase probabilities (see Equation 1.4). Three proce-
dures frequently used to modify the resulting electron density map are
solvent flattening (Leslie 1987; Wang 1985), NCS averaging (Muirhead
et al. 1967) and histogram matching (Zhang et al. 1997).
Solvent flattening (Leslie 1987; Wang 1985) is one of the earlier den-
sity modification procedures and relies on the disorder of the solvent
in a protein crystal. In theory the disordered solvent molecules do not
give rise to constructive interference in the diffraction experiment and
hence the electron density in the protein crystal solvent channels should
be featureless and flat. However, at the start of DM the experimental
phase estimates are not very accurate and the initial electron density
map is noisy. This may make it difficult to distinguish the boundary be-










α = f(αmod, αex)
Figure 1.9: Steps in traditional density modification. Structure fac-
tor amplitudes, phases and electron density are indicated with |F |, α
and ρ(x), respectively. The updated phase probabilities are obtained
by multiplication of the original phase probabilities with the modified
phases weighted according to the agreement between original and mod-
ified structure factor magnitudes.
the electron density to distinguish solvent and protein, the solvent mask
may be defined by looking at local variance throughout the unit cell.
Indeed, the featureless solvent region will have a low variance compared
to the regions with protein. In the flattening stage, the electron den-
sity in the solvent region is set to the average solvent density, effectively
removing the noise not associated with any structural information.
In cases where there are several copies of a molecule or domain in the
asymmetric unit, the multiple redundant samples of highly similar elec-
tron density may be combined to improve the signal-to-noise ratio. The
usefulness of non-crystallographic symmetry (NCS) averaging in gener-
ating improved electron density maps has long been known (Muirhead
et al. 1967). By comparison, histogram matching (Zhang et al. 1997) has
been described only recently. The premiss in histogram matching is that
the electron density values for a well phased map follow characteristic
distributions as opposed to the electron density values of a randomly
phased map that follow a normal distribution. By non-linear rescaling
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of the electron density the histogram is made to look more like that of
a well phased map. This suppresses negative electron density and tends
to sharpen electron density peaks (Cowtan 2010).
Note that the application of scaling and masking functions in real
space is equivalent to combining, in reciprocal space, many structure
factors through a convolution. This is an intrinsic property of the re-
lation between reciprocal and direct space by Fourier transformation.
Consequently, the random error component of the structure factors will
average out, whereas the true values of the structure factors will add up
systematically.
After modification of the electron density map the modified struc-
ture factors, obtained by inverse Fourier transform, need to be com-
bined with the experimental phase probabilities. Because there is no
explicit modified phase probability distribution, one is generated by es-
timating the errors in the density-modified phases from the agreement
from the between the observed and modified structure factor magni-
tudes. In the final stage of a DM cycle the probability distribution
of modified phases and original experimental phases are multiplied to
give an updated distribution. In the popular σA (Lunin and Urzhumt-
sev 1984; Read 1986) algorithm, the original experimentally determined
phases, represented by Hendrickson-Lattman coefficients (Hendrickson
and Lattman 1970), are combined with the density-modified structure
factors through a heuristic weighting scheme (Read 1997).
There are two major problems associated with the traditional DM
approach. All information about the phase probabilities is discarded
by using only the centroid phases when calculating the electron density
map. Furthermore, when multiplying probabilities care must be taken
to ensure that the those probabilities are independent so as to avoid
introducing bias. Yet, clearly the modified phase probabilities ultimately
depends on the experimental phase probabilities through the DM cycle,




Several methods have been developed to reduce the correlation be-
tween the original and density-modified structure factors. Some of
the earlier approaches include the reflection omit method (Cowtan and
Main 1996), solvent flipping (Abrahams and Leslie 1996) and the γ-
correction (Abrahams 1997) method. The γ parameter is an estimate
of the contribution of the initial experimental structure factor to the
density-modified structure factor in solvent flattening. By subtracting
this contribution from the density-modified structure factor the correla-
tion with the initial structure factor is suppressed. The γ-perturbation
method (Cowtan 1999) is a generalization of this method for any type
of density modification. Recently, Skubák and Pannu (2011) introduced
the β correction parameter, a novel cross-validation method aiming to
reduce bias in maximum-likelihood phase combination functions.
The statistical density modification techniques pioneered by Ter-
williger (2004); Terwilliger and Berendzen (1999) and Cowtan (2000)
are a different approach to reduce bias in DM. Rather than using a sin-
gle modified map to express the a priori knowledge incorporated in the
electron density map, statistical DM expresses the newly introduced in-
formation in terms of probability distributions, which are subsequently
carried forward into reciprocal space illustrated in Figure 1.10. Since
the density-modified phase probabilities are no longer estimated from
the agreement between the observed and density-modified structure fac-
tor magnitudes, the link between the experimental and density-modified
phase information is weakened.
Maximum likelihood allows for a rational incorporation of other
sources of information. The use of maximum-likelihood in the phase-
combination scheme described by Pannu et al. (1998) allows for incor-
poration of experimentally determined phase information in the form of
Hendrickson-Lattman coefficients. The method has been shown to out-
perform the σA phase combination traditionally used in classical density
modification (Cowtan 2010).
It is clear that the problem of a poor electron density map can be
partially mitigated by using prior knowledge about the expected distri-
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|F |, P (αex)









P (α) = P (αmod)× P (αex)
Figure 1.10: Steps in statistical density modification. Structure factor
amplitudes and phases are indicated with |F | and α, respectively. The a
priori information inferred from the electron density, ρ(x) is expressed
as probability distributions, P (ρ(x)). These are carried forward into
reciprocal space, P (αmod) and multiplied with the experimental phase
probabilities, P (αex) to obtain the updated phase probabilities, P (α).
bution of electron density and typical arrangement of a protein crys-
tal and combining this density-modified phases with the experimental
phases. Current methods assume that these sources of information are
independent, yet it is clear that they are not, which results in model bias
and escalated figures of merit. Chapter 3 describes a DM scheme based
on a novel multivariate equation that does not assume independence of
initial and density-modified phases. Large scale testing of the new DM
method convincingly shows that this procedure generates dramatically
improved electron density maps, allowing many more macromolecular
structures to be traced without manual intervention from the user.
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1.3.4 Automated model building and refinement
Once the diffraction data is collected, manual model building and refine-
ment of a protein structure are the single most time consuming tasks in
solving a protein structure. Automatic chain tracing has made the over-
all process of building a structural model of a protein substantially more
efficient, which has benefited both high-throughput structure solution
and structure solution in a non-automated setting. The computer pro-
grams ARP/wARP (Langer et al. 2008), Resolve (Terwilliger 2000,
2002), Buccaneer (Cowtan 2006) and SHELXE (Sheldrick 2002) are
designed to build protein structures into electron density maps without
user intervention. Although the implementation between the different
programs differs, the basic premise is the same. Often the only input
required is the amino acid sequence and a file with the structure fac-
tor amplitudes and phases. In the first step towards model building
the electron density map is populated with a number of seed atoms.
Subsequently, the Cα atom seeds are connected into chain fragments
and individual amino acids or short peptides are docked into the frag-
ments. The final stage often includes connecting the fragments into
chains, building loops and resolving clashes.
To date the ARP/wARP program is the most comprehensive solu-
tion available, including high-level decision maker driven iterative pro-
tein model building, fast building of the secondary structure of a pro-
tein, tracing of flexible loops in alternate conformations, fully automated
placement of ligands, and locating ordered water molecules (Langer et
al. 2008). The program initially required high resolution data (Perrakis
et al. 1999), but later developments (Morris et al. 2002, 2003) have re-
laxed the resolution requirements and the recent inclusion of a secondary
structure recognition routine allows partial model building down to 4.5Å
(Langer et al. 2008).
The Buccaneer program combines a novel oriented electron-
density likelihood target function for positioning Cα atoms with a several
existing routines. By using the same likelihood function in different ways
throughout the chain-tracing procedure has resulted in a program that
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is relatively simple and very suitable for incorporation into automation
pipelines (Cowtan 2006). The method is reasonably fast and performs
well on data of moderate to low resolution (Cowtan 2006).
The program Resolve carries out model building in somewhat dif-
ferent, highly hierarchical fashion. Firstly, α-helices and β-sheets are
located and fitted, followed by extension of these secondary structure
elements with tripeptides, computed from a set of refined protein struc-
tures. In the final stage individual fragments are connected into chains
(Terwilliger 2002). In addition to performing model building Resolve
includes a likelihood-based density modification procedure, that yields
better phase improvement than conventional procedures such as solvent
flattening and histogram matching (Terwilliger 2000).
To improve a partial model and obtain the best electron density map,
model building is often iterated with reciprocal space refinement. Ref-
mac (Murshudov et al. 2011) is a popular refinement program that uses
different likelihood-based functions to best fit the experimental condi-
tions and the availability of prior information, for instance the presence
experimental phase information in the form of a SAD or SIRAS signal.
The various restraints and model parametrizations allow customization
of Refmac to suit data quality. For instance, the use of secondary
structure restraint or local and global NCS restraints can greatly ben-
efit lower resolution data sets (Nicholls et al. 2012), whereas optional
refinement of anisotropic B-factors can give the fullest description of a
high resolution structure. The latter though is typically only used in the
final stage of model refinement and not during the model (re)building
stage.
The Crank (Ness et al. 2004) program is an attempt to streamline
and automate structure solution by experimental phasing methods and
there are plans to include MR in the near future. For its release in 2004,
Crank had already shown to effectively detect and phase anomalous
scatterers with only minimal user input and provide better quality solu-
tions over existing programs. Currently, Crank integrates programs in
substructure detection, refinement, phasing, DM and automated model
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building in a convenient and easy-to-use CCP4i graphical user interface
that sit on top of a powerful scriptable back-end, though a high-level de-
cision maker, for optimisation of pipeline selection and parameters to the
different plugins, as found in programs such as AutoRickshaw (Pan-
jikar et al. 2005) and Phenix is currently not implemented. Chapter 2
discusses the many enhancements incorporated since the first release of
Crank that have made the program more robust and have significantly





Recent advances in Crank
Abstract
For its first release in 2004, Crank was shown to effectively
detect and phase anomalous scatterers from SAD data. Since then,
Crank has significantly improved and many more structures can
be built automatically with single or multiple wavelength anoma-
lous diffraction or SIRAS data. Here, we discuss the new algo-
rithms we have developed that lead to the substantial improve-
ments and show Crank’s performance on over one hundred real
data sets. The latest version of Crank is freely available for down-
load at http://www.bfsc.leidenuniv.nl/software/crank/ and
from CCP4 (http://www.ccp4.ac.uk/).
The work in this chapter was published in N. S. Pannu, W.-J. Waterreus, P.
Skubák, I. Sikharulidze, J. P. Abrahams, and R. A. G. de Graaff (Apr. 2011).
“Recent advances in the CRANK software suite for experimental phasing.” In: Acta
Crystallographica, Section D: Biological Crystallography 67.Pt 4, pp. 331–7. doi:
10.1107/S0907444910052224
The author of this thesis implemented utilities for deployment of massive parallel
tests on openPBS; implemented a generic framework for parsing log files and au-
tomated analysis of extracted statistics; performed minor debugging of the Crank
program support scripts; evaluated, summarized and presented the results of parallel
tests.
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2.1 Introduction
Currently, many software packages are available to automatically solve
structures. The main aim of Crank (Ness et al. 2004) is to provide a
user friendly and automated system incorporating the latest computa-
tional developments in all stages of structure solution by experimental
phasing. Crank is not a monolithic system: users can define pipelines
from a choice of many different programs. Figure 2.1 shows the current
steps that Crank can perform and the programs that users can select
to perform the task. The externally developed programs that Crank
can interface with are SHELXC (Sheldrick 2008), SHELXD (Schneider
and Sheldrick 2002), SHELXE (Sheldrick 2002), dm (Cowtan 1994),
Parrot (Cowtan 2010), Pirate (Cowtan 2000), Buccaneer (Cow-
tan 2006), ARP/wARP (Langer et al. 2008) both of which iterate with
Refmac (Murshudov et al. 2011) and Resolve (Terwilliger 2000, 2002).
We are the main authors of the programs Afro (Pannu et al., in
preparation) for FA calculation, Crunch2 (de Graaff et al. 2001) for
substructure detection, Bp3 (Pannu and Read 2004) for substructure
phasing, Solomon (Abrahams and Leslie 1996) for density modifica-
tion, Multicomb (Skubák et al. 2010) for phase combination and co-
authors of the program Refmac. These programs use multivariate max-
imum likelihood methods that allow the observed diffraction data and
any current models to be considered simultaneously at any stage in the
structure solution process. Thus, the wealth of information contained
in the observed diffraction data can be used directly throughout the
structure solution process and not approximated or ignored as current
approaches do after constructing an initial electron density map.
Below, we provide a brief intuitive description of the novel methods
in various steps in experimental phasing that we have developed since
our first publication on Crank. We show the power of combining all
of these new methods on over one hundred real single- and multiple-
wavelength anomalous diffraction (SAD/MAD) and single isomorphous
replacement with anomalous scattering (SIRAS) data sets run automat-














Model building (& refinement)
Buccaneer (& Refmac),
ARP/wARP (& Refmac), Resolve
Output: model coordinates
Figure 2.1: The steps in the structure solution process from substructure
factor amplitude estimation to model building. The bottom half of each
node shows the programs that Crank can interface with in that step. In
the final phase the model can be refined by iterating either Buccaneer
or ARP/wARP with Refmac.
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The programs and methods we develop are not only available
in Crank, but also AutoRickshaw (Panjikar et al. 2005) and
ARP/wARP. Furthermore, the original methods we have developed
have also been re-written in mathematically identical forms in both
phenix.refine and phaser (Adams et al. 2010).
2.2 Recent developments in Crank
2.2.1 Substructure determination
After diffraction data has been indexed and merged, |FA| values are
calculated for input to substructure detection programs. |FA| values
are the amplitudes of structure factors corresponding to the heavy
atoms to be located. For single-wavelength anomalous diffraction (SAD)
data, most programs use the absolute value of Bijvoet differences,
∆F = ||F+|−|F−|| as an estimate for |FA|. Burla et al. (2002) proposed
employing multivariate joint probability distributions to obtain the ex-
pected value for |FA| in an equation that contains three integrals. In
order to obtain an analytical solution to the integrals, Burla et al. (2002)
assume the “Bijvoet phases” are equal. We have obtained an expression
requiring only one numerical integration without making this assump-
tion. This approach has been implemented in the program Afro and
performs satisfactorily. Details of the implementation and test results
will be shown elsewhere (Pannu et al., in preparation). The develop-
ment version of Afro containing the multivariate |FA| calculation is
available in the latest version of Crank and can be used as input for
either Crunch2 or SHELXD.
Within Crank, methods exist to validate whether a correct sub-
structure has been determined and to terminate the substructure detec-
tion step early. If a threshold value for a statistic used by the substruc-
ture detection program has been reached or if a significant deviation
exists between the best and worst score in different trials, the substruc-
ture detection program will successfully terminate before running all
trials. Crank also provides an alternate and independent assessment
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of whether a correct substructure solution has been located: an option
exists to run the substructure phasing program Bp3 quickly in “check”
mode and examine likelihood based statistics to determine whether a
correct and complete substructure has been found. The statistic that
Crank uses is a Luzzati (1952) parameter: if the average Luzzati param-
eter is greater than a threshold value (the default is 0.7), it is assumed
that the full substructure has been found and substructure detection is
terminated. Using likelihood methods to validate substructure detection
has been available in Crank for over three years (Pannu et al. 2007)
and this approach has been appreciated by phenix developers, who re-
cently adopted it in their own suite (Paul Adams, CCP4 bulletin board,
31 July 2010).
2.2.2 Substructure phasing
To incorporate anomalous phase information, heavy atom refinement
programs such as Sharp (Bricogne et al. 2003) or Mlphare (Collabora-
tive Computational Project Number 4 1994; Otwinowski et al. 1991) use
a Gaussian function on observed Bijvoet differences (∆F = |F+|−|F−|)
centered on the “calculated” Bijvoet difference that is determined from
an assumed value of the “true” structure factor and the heavy atom
structure factor (Matthews 1966; North 1965). Since, in general, the
“true” structure factor is not known for a SAD or multiple-wavelength
anomalous diffraction (MAD) experiment, Sharp integrates out the am-
plitude and phase of the true structure factor. Furthermore,the estimate
of measurement error for Bijvoet differences is determined by merging
the measurement errors for Friedel pairs (σ∆F =
√
σ2F+ + σ2F−), leading
to suboptimal use of experimental information.
To input the observed structure factors directly, it is necessary to
consider a joint probability of all observations given a current model.
We have previously shown that this method provides better results over
other approaches for the case of SAD (Ness et al. 2004; Pannu and Read
2004) as implemented in Bp3. We have recently shown that better
results may be obtained by deriving a multivariate function for SIRAS
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(Skubák et al. 2009) which will be released in the next version of Crank.
2.2.3 Density modification
In the density modification (DM) procedure, the density modified map
is iteratively combined with the initial map obtained from experimental
phasing. Current methods assume that these two maps are independent
and propagate the initial map’s phase information indirectly through
Hendrickson-Lattman coefficients (Hendrickson and Lattman 1970). We
have applied a multivariate analysis that considers the observed Friedel
pairs directly for a SAD experiment, accounts for the correlation between
the initial and density modified map and refines the errors that can occur
in a SAD experiment. Results on many test cases show a significant
improvement over the current state of the art (Skubák et al. 2010): the
maps produced by the multivariate phase combination algorithm lead
to many more structures being built automatically.
Despite the improvements in the quality of electron density maps,
figures of merit remained escalated after DM. To obtain more accu-
rate FOMs, we have recently developed and implemented a new cross-
validated scheme for accurate error parameter estimation in likelihood
based phase combination. The method leads to more reliable phase
probability statistics from DM and results in a further improvement in
subsequent model building. In addition, the more accurate FOMs en-
able a more reliable hand determination or identification of incorrect
non-crystallographic symmetry (NCS) operators used in DM (Skubák
and Pannu 2011). These developments have been implemented in a new
phase combination program called Multicomb and can be used in con-
junction with either Solomon or Parrot.
2.2.4 Automated model building and refinement
The incorporation of experimental phase information was previously
shown to improve refinement (Pannu et al. 1998). However, the
likelihood function developed, typically denoted maximum likelihood
Hendrickson-Lattman (MLHL), propagates the external phase informa-
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tion via Hendrickson-Lattman coefficients (Hendrickson and Lattman
1970). Thus, the MLHL function is dependent on the accuracy and reli-
ability of the coefficients that are input. Furthermore, in its derivation,
the MLHL function assumes that the experimental phase information
(represented by Hendrickson-Lattman coefficients) is independent from
the calculated structure factor. This assumption is questionable, as the
experimental phase information is used to build an initial model. To
overcome these issues, we considered and derived a multivariate likeli-
hood function for SAD (Skubák et al. 2005) and SIRAS (Skubák et al.
2009) experiments. The likelihood functions take as input the diffraction
data directly, the heavy atom coordinates and the calculated structure
factors and accounts for correlation between them. Compared to the
other likelihood functions in Refmac, more models are built automat-
ically in ARP/wARP with the multivariate functions. The SAD and
SIRAS functions in Refmac are available in Crank both in model
building with ARP/wARP and Buccaneer.
2.2.5 Integration of programs and steps
To support the integration of the different programs it interfaces with,
Crank has a plug-in architecture and communicates between plugins
via an XML file. At the moment, there are two methods available to
generate an XML file that Crank uses to run a pipeline: the program
gcx (Ness et al. 2004) and a CCP4i graphical user interface. Both inter-
faces to Crank can be run with only minimal input: an mtz file with the
relevant column labels specified, a sequence file and the name, expected
number and f’ and f" values for the heavy atoms. However, users can cus-
tomize settings for individual programs, define custom made pipelines
using any programs at each step and define the start and end step for a
particular pipeline.
The program gcx allows Crank to be run from command line with
a simple unix script: more information on it can be obtained from the
program’s documentation (http://www.ccp4.ac.uk/html/gcx.html).
The test cases described below were run with gcx. Most users are
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Figure 2.2: Screenshot of the CCP4i GUI for Crank showing the few
required fields and the possibility to customize pipelines for automatic
stucture solution.
likely to run Crank via the CCP4i GUI. The most convenient way to
view a Crank log file is via the baubles system that can be initiated
with the “View Annotated Logfile in a Web Browser” option in the
CCP4i GUI. Documentation for Crank can be found at the CCP4
wiki (http://www.ccp4wiki.org/) which includes information on how to





Here, we test the new methods described above on a wide range of real
SAD, MAD and SIRAS merged diffraction data sets. For our tests, only
the intensities or structure factor amplitudes, along with the sequence
for a protein monomer, the number of substructure atoms expected per
monomer and the f’ and f" values for the substructure atoms were input.
Crank performed substructure detection using Afro and Crunch2,
Bp3 for substructure phasing and Solomon with Multicomb was used
for DM. Three cycles of Buccaneer iterated with Refmac were used
for automated model building with iterative refinement. All options or
parameters were default in all programs. The defaults set by Crank
depend upon the particular experiment: for SAD data, Afro uses the
multivariate |FA| value calculation, Multicomb uses the multivariate
SAD function for phase combination in DM while Buccaneer uses
the SAD function implemented in Refmac. For SIRAS data, Afro
calculates |FA| from either the anomalous signal or using isomorphous
differences by determining which signal is greater. Bp3 uses the un-
correlated SIRAS function described previously (Pannu et al. 2003),
Solomon uses MLHL phase combination in Multicomb, while Buc-
caneer uses the multivariate SIRAS function in Refmac. Finally, for
MAD data, Afro chooses the wavelength with the greatest anoma-
lous signal and calculates multivariate FA values from it. Similar to
SIRAS data, Solomon uses MLHL phase combination in Multicomb
to perform DM and Buccaneer uses the MLHL likelihood function in
Refmac for model refinement.
In the test cases below, the previous version of Crank, 1.3, is tested
with the current version, 1.4 The main differences between the two ver-
sions is the development version of Afro that calculates multivariate
|FA| values given SAD data and the use of Multicomb for phase com-
bination in DM which are both introduced in version 1.4.
In total, we report results from 116 real data sets from several differ-
ent sources listed in Appendix A. The data sets provide a wide range of
resolution (from 0.94 to 3.29Å) and anomalous scatterers, including se-
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Figure 2.3: Improvement of Crank version 1.4 compared with Crank
version 1.3 in terms of the fraction of the model built for SAD, MAD
and SIRAS data sets. The fraction of the model built is defined as the
fraction of the coordinates that are within 1Å of the coordinates of the
structure deposited in the PDB.
lenium, sulfur, chloride, sulfate, manganese, bromide, calcium and zinc.
Of the 116 data sets, 63 are MAD data sets, 46 are SAD data sets, and
7 are SIRAS data sets.
2.4 Results and Discussion
Figure 2.3 shows the fraction of the backbone built within 1Å of the final
deposited structure for each of these data sets for the current version
of Crank (1.4) versus the previous version (1.3). In total, 77 out of
116 structures have greater than sixty percent of the structure built
correctly and of these 77 structures, 66 are built to over eighty percent
completeness.
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An example of an automatically built structure with a weak signal is
GerE (Ducros et al. 2001). The structure of GerE was originally solved
with a four wavelength seleno-methionine MAD data set collected at
2.7Å and a native data set diffracting to 2.1Å. Crank version 1.3
could build the structure from just the peak data set to a high degree,
but failed to build the structure with just the SAD inflection data set.
Crank version 1.4 can build the structure to a high degree using either
the peak or inflection data set. We are unaware of any other automated
package or collection of algorithms that can build GerE using either
the peak or inflection data set automatically. To give an indication of
the anomalous signal, Figure 2.4 plots the Bijvoet ratio (i.e. |∆F ||F | ) as a
function of resolution bin for the GerE peak and inflection wavelength
data: the overall Bijvoet ratios for the peak and inflection data are 0.167
and 0.139, respectively.
For the 77 structures that were built automatically, substructure
determination successfully terminated early in 69 of the cases. For 33 of
the 69 cases, the Luzzati parameter statistics in Bp3 allowed the early
termination, while the remaining 36 cases the complete substructure was
validated by an analysis of the Crunch2 statistics.
2.4.1 Analysis of data sets that were not automatically
built
39 of the 116 data sets could not be built automatically by Crank.
19 of the 39 data sets failed at substructure detection and could be
built automatically if the resolution cutoff in Crunch2 was changed or
SHELXC and SHELXD was used in substructure detection. It should
also be noted that the five cases that could not be built in version 1.4
but were successful in version 1.3 are all due to the changes in the
substructure detection algorithm. These tests will be used to further
debug and improve the development version of the multivariate |FA|
calculation in Afro.
For 5 of the 39 cases, Crank in conjunction with a new SIRAS
function for phasing leads to building when the current “uncorrelated”
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Figure 2.4: Plot of the Bijvoet ratios as a function of resolution for
the peak and inflection wavelength data of the GerE test case. The
peak and inflection wavelength are shown with a solid and dashed line,
respectively.
function in Bp3 had failed to produce an automatically traceable map.
The multivariate SIRAS function for phasing will be released in the next
version of Crank.
The remaining 15 cases could not be built automatically or manually
in Crank. For 7 of theses cases, Mueller-Dieckmann et al. (2007) had
also failed to built the structures. Similarly, 4 other cases consisted of
SAD experiments using derivative data sets from SIRAS experiments
also containing a very weak signal. It is very likely that no currently
available methods can build these structures and new methods need to
be developed to build structures from such weak data. The remaining
4 cases that could not be built are from the JCSG repository: these
structures can be built with currently available methods and the given
data. The reasons why Crank fails to build these data sets are yet to
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be determined.
2.5 Conclusions and future developments
Because of the new methods we have developed, Crank can build many
more structures automatically and can build structures where current
methods fail. Crank’s robustness is shown by the large number of data
sets we use in this test that require very minimal input.
Crank’s CCP4i GUI is easy to use, but does have some limitations.
Firstly, log files are only updated once a particular step in the pipeline
has finished. Secondly, users can not manually stop a current step and
proceed to a next step. Instead the pipeline can only be terminated and
the Crank run must be restarted from the beginning. Furthermore,
although, Crank has an interface to Coot (Emsley et al. 2010), it
cannot show real time updates of a model as a Crank run proceeds.
All of these shortcomings are being addressed and a new pyQt (http://
www.riverbankcomputing.co.uk/software/pyqt/intro) interface for
Crank is currently being developed in collaboration with CCP4.
Although having an easy to use and powerful interface is important,
the first priority for Crank will always be developing better methods
to solve data sets that elude current methods. For the case of MAD
data, current approaches in Crank and elsewhere use univariate, un-
correlated likelihood functions for FA calculation, substructure phasing
and the MLHL function for DM and automated model building and re-
finement. Obviously, a multivariate MAD function could address the
shortcomings in current approaches and could lead to structures where
current methods fail.
In the case of SAD data, the multivariate functions used in sub-
structure phasing, DM and model refinement only differ in the number
of input variables and the parametrization. Although current algorithms
separate these steps, the common mathematical framework suggests that
all the information could be used simultaneously and combined opti-
mally in a unified process using a single mathematical function, possibly




A new method for phase combination
Abstract
DM is a standard technique in macromolecular crystallogra-
phy that can significantly improve an initial electron density map.
To obtain optimal results, the initial and density modified map are
combined. Current methods assume these two maps are indepen-
dent and propagate the initial map information and its accuracy
indirectly through previously determined coefficients. We have
derived a multivariate equation that no longer assumes indepen-
dence between the initial and density modified map, considers the
observed diffraction data directly, and refines the errors that can
occur in a single wavelength anomalous diffraction experiment.
We have implemented and tested the equation on over one hun-
dred real data sets. Results are dramatic: the method provides
significantly improved maps over the current state of the art and
leads to many more structures built automatically.
The work in this chapter was published in P. Skubák, W.-J. Waterreus, and
N. S. Pannu (June 2010). “Multivariate phase combination improves automated
crystallographic model building”. In: Acta Crystallographica, Section D: Biological
Crystallography 66.7, pp. 783–788. doi: 10.1107/S0907444910014642 ∗ The first two
authors contributed equally.
The author of this thesis implemented utilities for deployment of massive parallel tests
on openPBS; implemented a generic framework for parsing log files and automated
analysis of extracted statistics; evaluated, summarized and presented the results of
parallel tests.
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3.1 Introduction
The single-wavelength anomalous diffraction (SAD) experiment is a
widely used technique to provide an estimate of the unknown structure
factor phases and thus experimentally solve a macromolecular structure.
To improve an electron density map obtained by SAD or another ex-
perimental method providing initial phase estimates, crystallographers
employ density modification (DM) techniques. DM relies on prior infor-
mation. For example, if the experimentally determined map is of suf-
ficient quality to distinguish between regions of ordered macromolecule
and disordered solvent, the electron density of the solvent region can be
flattened (Leslie 1987; Wang 1985). This density modified map is then
combined with the initial density map and the process is iterated as
illustrated in Figure 3.1.
“Phase combination” or combining the original and density modified
electron density map is important for the success of DM. Many currently
used density modification programs (e.g. dm (Cowtan 1994), Solomon
(Abrahams and Leslie 1996), SHELXE (Sheldrick 2002), CNS (Brünger
et al. 1998)) employ the σA (Lunin and Urzhumtsev 1984; Read 1986)
algorithm. In the σA algorithm, the original experimentally determined
phases, represented by Hendrickson-Lattman coefficients (Hendrickson
and Lattman 1970), are assumed to be independent from the density
modified structure factors and combined with them through a heuris-
tic weighting scheme (Read 1997). However, the density modified map
is obtained from the experimental map, invalidating this assumption
of independence. Methods have been developed to reduce the correla-
tion between the original and density modified structure factors such as
γ-correction (Abrahams 1997) or statistical density modification (Ter-
williger 2000). Yet, the correlation is not considered explicitly and still
remains.
Most density modification programs obtain prior phase information
in the form of Hendrickson-Lattman coefficients. When these coeffi-
cients are used, it is assumed that errors in structure factors can be















Figure 3.1: Flow chart of the different steps in density modification and
phase combination.
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Furthermore, any computer program that inputs Hendrickson-Lattman
coefficients assumes that the program that generated them can provide
a reliable and accurate estimate of the phase probability.
We have developed a multivariate probability distribution that no
longer assumes independence between the initial and combined elec-
tron density map, but considers the correlation between the observed
structure factor amplitudes, the density modified structure factor and a
heavy atom substructure for a single wavelength anomalous diffraction
experiment. The equation generates phase information directly from
the heavy atom substructure and the observed diffraction data and thus
does not require input of Hendrickson-Lattman coefficients. The equa-
tion also models and refines the errors in the density modified and heavy
atom structure factors to provide an advanced multivariate model for a
single wavelength anomalous diffraction experiment and phase combina-
tion. We have implemented this “SAD-DM” function in a new program
called Multicomb (Skubák et al. 2010). We were motivated to con-
sider these methods for phase combination since our previous work in
applying similar multivariate methods to experimental phasing (Pannu
and Read 2004) and in model building with iterative refinement (Skubák
et al. 2005) produced better results compared to previous approaches.
3.2 Methods
The multivariate SAD-DM function used for correlated DM phase com-
bination implemented in Multicomb is show in Equation 3.1. The
observed Bijvoet/Friedel pairs from a SAD experiment are denoted by
|F+| and |F−|. |FDM |, αDM and |FHA|, αHA are the amplitude and
phase for the density modified and heavy atom structure factors, re-
spectively. Σ is the covariance matrix with its elements denoted by aij
and Σ2 is the bottom right submatrix of Σ with its elements denoted by
cij . Equation 3.1 has previously been derived in Appendix A of (Pannu








+|2 − a22|F−|2 − (a33 − c33)|FDM |2)×
exp(−(a44 − c44)|FHA|2 − 2|FDM ||FHA|(a34 − c34) cos(αDM − αHA))×∫ 2π
0
exp(−2|F−||FDM |a23 cos(α− − αDM ))×
exp(−2|F−||FHA|a24 cos(α− − αHA))×
I0(2|F+|
√
(a12|F−| cos(α−) + a13|FDM | cos(αDM ) + a14|FHA| cos(αHA))2
+(a12|F−| sin(α−) + a13|FDM | sin(αDM ) + a14|FHA| sin(αHA))2)dα−
(3.1)
To compare Multicomb against the current SigmaA (Read 1986)
program, we used Solomon from CCP4 (Winn et al. 2011). The mod-
ular design of Solomon allowed an easy switch between Multicomb
and SigmaA for testing purposes.
For our tests, we started with merged diffraction data from a wide
range of real SAD data sets. Only the intensities or structure factor am-
plitudes, along with the sequence for a protein monomer, the number
of substructure atoms expected per monomer and the f’ and f" val-
ues for the substructure atoms were input into the Crank (Ness et al.
2004) structure solution suite. Crank performed substructure detec-
tion using either Afro (Pannu et al., in preparation) and Crunch2 (de
Graaff et al. 2001) or SHELXC (Sheldrick 2008), SHELXD (Schneider
and Sheldrick 2002) and SHELXE. Bp3 (Pannu and Read 2004) was
used for substructure phasing and twenty cycles of density modification
in Solomon were performed. Information about non-crystallographic
symmetry was not used in density modification. Either three cycles of
Buccaneer (Cowtan 2006) or ten cycles of ARP/wARP (Langer et al.
2008) both iterated with Refmac (Murshudov et al. 2011) (Murshudov
et al. 1997) using the SAD refinement target (Skubák et al. 2004) were
used for automated model building. A resolution cut-off or specifying
the number of disulphide bonds was needed for successful substructure
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determination for a few data sets. All other options or parameters were
default in all programs. In the results shown below, for any data set, the
changes shown were caused only by running either SigmaA or Multi-
comb with Solomon.
In total, we used 132 real data sets from several different sources
listed in Appendix A. The majority of these structures were originally
solved by multiple-wavelength anomalous diffraction (MAD), single iso-
morphous replacement with anomalous scattering (SIRAS) or molec-
ular replacement (MR). Data sets where we could not determine the
substructure or where a program within any pipeline terminated abnor-
mally were excluded from the statistics presented, resulting in 102 data
sets. In cases where multiple SAD data sets were available (i.e. collected
either at different wavelengths or processed with different redundancies),
the SAD data set corresponding to the highest f" value and to the high-
est data redundancy was used. The data sets provided a wide range
of resolution (from 0.94 to 3.29Å) and anomalous scatterers, including
selenium, sulphur, chloride, sulphate, manganese, bromide, calcium and
zinc.
3.3 Results
Figure 3.2 compares the quality of the electron density maps obtained
by density modification using the σA algorithm with the maps obtained
from the multivariate SAD-DM function for the 102 SAD data sets.
The quality of a map is measured by its correlation with the map con-
structed from the deposited model. In general, the graph can be divided
into three distinct regions. The first region is where the map correlation
for both algorithms is under 0.2. This region shows test cases where
the initial experimental phase information is too weak and results in an
uninterpretable electron density map. In the second region, with map
correlations over 0.8 after DM using both algorithms, all the points lie
very close to the diagonal line, indicating that both algorithms per-
formed similarly, producing high quality phases for these data sets. The
remaining region shows the greatest variation between the two methods:
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Map correlation after density modification
Figure 3.2: Map correlation after density modification compared to the
final deposited models using the multivariate SAD-DM function (X-axis)
and the σA algorithm (Y-axis).
in this region, there is a 21.4% increase in average map correlation for
the multivariate SAD-DM function. The overall increase in average map
correlation calculated from all data sets is 16.9% (from 0.539 to 0.630).
In Figure 3.3, the data sets are divided into two categories based on
the improvement of SAD-DM over σA maps and shown as a function
of data resolution and map correlation after experimental phasing. The
figure indicates that when the input map correlation is below 0.3, usually
neither method can significantly improve the map. Furthermore, when
the input map correlation is above 0.4 and the data set has a 2.0Å or
better resolution, both algorithms usually produce equally high quality
maps. A region where SAD-DM clearly outperforms σA are data sets
with a resolution lower than 2.1Å and an input map correlation higher
than 0.35.
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Figure 3.3: Map improvement of the SAD-DM algorithm over σA as a
function of resolution (X-axis) and map correlation after experimental
phasing (Y-axis). The data sets were divided into two groups based on
the difference between the SAD-DM and σA map correlations with the
deposited structure: the circles represent data sets where the SAD-DM
map correlation is better than σA by 3% or more, while a correlation
difference less than 3% is shown in squares.
Next, we examine the effect of the different phase combination al-
gorithms on automated model building with iterative model refinement
by using ARP/wARP (Perrakis et al. 1999) and Buccaneer (Cowtan
2006). Since ARP/wARP and Buccaneer use different protein trac-
ing algorithms, examining the behaviour of both programs (Figure 3.4)
provides a better comparison of the two different phase combination al-
gorithms. The graph again can be divided into three distinct regions:
the region where the fraction of the model correctly built is under 10%
indicating model building has failed for both phase combination algo-
rithms, the region where both phase combination algorithms lead to a
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Table 3.1: Average fraction of the model correctly built of all data sets
for Buccaneer and ARP/wARP. A residue is regarded as “correctly




model that is over 80% correctly built and the remaining region which
shows the greatest disparity between the two phase combination meth-
ods. This last region includes 36 data sets where maps produced by the
multivariate SAD-DM function result in a 59.6% increase in the average
fraction of the model built by ARP/wARP. The same region contains
50 data sets when using Buccaneer resulting in a 93.0% increase in
the fraction of the model built using multivariate methods over σA.
By comparing the quality of the electron density maps and the extent
to which model building programs could build a model, the performance
of the σA algorithm and SAD-DM function have been compared for 102
SAD data sets. The data summarized in Figures 3.2 to 3.4 and Table 3.1
are given in Table A.1 in Appendix A.
3.4 Discussion
The results clearly show that the multivariate SAD-DM function, in gen-
eral, significantly outperforms the existing phase combination method
in SigmaA. The improved map correlation provided by the multivari-
ate SAD-DM function led to 16.4% improvement of the overall average
fraction built using ARP/wARP and 36.7% improvement when using
Buccaneer, compared to the state of the art (Table 3.1). The differ-
ence in the degree of improvement between the model building programs
is mainly caused by the multivariate SAD refinement target used with
ARP/wARP which enables successful model building after σA for many
data sets that would otherwise fail: with the default Rice target, the
ARP/wARP improvement is similar to that of Buccaneer (44%).
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(a) Fraction built by Buccaneer
Figure 3.4: Performance of the multivariate SAD-DM function versus
the σA algorithm in terms of fraction correctly built for the model build-
ing programs (a) Buccaneer and (b) ARP/wARP. The X-axis and
Y-axis are the fraction of the model built after phase combination with
Multicomb and SigmaA, respectively. A residue is regarded as “cor-
rectly built” if it is within 1Å of the deposited model.
Although only SAD data was used in the above tests, the multivari-
ate framework laid out is by no means limited to only a SAD experiment.
Indeed, we have already implemented a multivariate SIRAS function for
phase combination and initial results are very promising (Skubák and
Pannu, in preparation). Furthermore, a multivariate MAD function is
currently being implemented.
The introduction of the multivariate function to phase combina-
tion has important consequences for automated structure solution and
manual structure solution at lower resolutions. The same multivariate
function described above is used in substructure phasing, density mod-
ification and model refinement. Thus, at any step in the process up
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(b) Fraction built by ARP/wARP
Figure 3.3: Continued
to or including substructure phasing, if a correct anomalous or even
non-anomalous portion of the structure is added, significantly improved
phases can be generated via simultaneously considering phasing, density
modification and model refinement together. In essence, the successful
implementation of multivariate methods to phase combination should
lead to a new paradigm where the crystallographer no longer considers
phasing, density modification, and model refinement as separate parts of
structure determination, but one process using one mathematical func-





Structural analysis of DNA binding
protein Sso10a2
Abstract
Archaeal chromatin proteins play an important role in func-
tionally organising the genomic DNA into a compact nucleoid.
Sulfolobus solfataricus expresses a small dimeric protein Sso10a,
that is thought to play an important role in chromatin organisa-
tion and dynamics. The dimer is constituted of a highly stable
coiled-coil and two winged helix DNA binding domains. The two
other Sso10a family members, Sso10a2 and Sso10a3, expressed
by S. solfataricus are highly similar yet their biological roles are
poorly understood. To gain insight into the molecular differences
between Sso10a and Sso10a2 we crystallized the Sso10a2 protein
and solved the crystal structure to 2Å resolution. Superposition
of the Sso10a and Sso10a2 crystal structures reveals significant
divergence in the winged helix DNA binding domains.
The author of this thesis performed the final purification of the Sso10a2 protein by gel
filtration; crystallisation of the Sso10a2 protein and diffraction analysis of its crystals
at the ESRF; solution, description and interpretation of the Sso10a2 structure.
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4.1 Introduction
The extreme conditions under which the hyperthermophilic Crenar-
chaeon Sulfolobus solfataricus and other extremophiles live pose unique
challenges to maintaining DNA duplex stability and genomic organisa-
tion. To this end crenarchaeal species express several highly abundant
small DNA binding proteins, which bend or wrap the DNA or bridge
duplexes to fold the DNA into a compact structure known as the nu-
cleoid (Driessen and Dame 2011). In addition confining the genome to
the cell volume, these DNA compacting proteins play important roles in
regulating essential cellular processes, such as DNA repair, replication
and transcription (Driessen and Dame 2013). In contrast to their eur-
yarchaeal counterparts who express true tetrameric histone homologues
that wrap DNA into structures reminiscent of eukaryotic nucleosomes
(Pereira et al. 1997), the small DNA organising proteins expressed by
Crenarchaea are more similar to those of bacteria (Driessen and Dame
2011). Throughout the domains of life the amino acid sequence simi-
larity between chromatin proteins is minimal. Despite this apparent
lack of homology, the architectural properties of chromatin proteins are
highly conserved (Luijsterburg et al. 2008). Knowledge of the structure
of these proteins may reveal the mechanisms of molecular recognition
that explain how bridgers engage in long range interactions to promote
higher-order genomic organisation and how wrappers and benders ex-
ert their effect on the DNA structure locally. Furthermore, molecular
models of bacterial DNA organising proteins, and in particular the dif-
ferences with their eukaryotic counterparts, may enable rational design
of new antibiotics that act by specifically disrupting bacterial DNA com-
paction.
S. solfataricus DNA binding proteins separate into three groups ac-
cording to their size (Dijk and Reinhardt 1986). The 7 kDa class that
includes the well studied Sso7d (Agback et al. 1998; Baumann et al.
1994; Choli et al. 1988; Edmondson and Shriver 2001; Knapp et al. 1996;
Lundbäck et al. 1998; Mai et al. 1998; Robinson et al. 1998; Shriver et
al. 2001), the recently discovered Sso7c4 (Hsu and Wang 2011) and the
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Cren7 protein (Guo et al. 2008); the 8 kDa class about which little is
known other than that is composed of the Sso8a and Sso8b species (Hsu
and Wang 2011; Teale et al. 2003); and lastly the 10 kDa group that con-
tains Sso10a, Sso10b and Sso10b2 (Dijk and Reinhardt 1986; Forterre
et al. 1999).
Insights into non-specific DNA binding in S. solfataricus is primar-
ily based on the protein–DNA complexes of Sso7d (Gao et al. 1998; Su
et al. 2000) and Cren7 (Feng et al. 2010). The Sso7d protein strongly
binds DNA in a sequence non-specific manner by docking into the mi-
nor groove. The residues involved in the interaction with the DNA are
located in a three stranded β-sheet. Binding is accompanied by inter-
calation of hydrophobic side chains, which cause a single sharp bend of
approximately 60° (Gao et al. 1998). The formation of the complex is
accomplished by several salt-bridges. However, non-electrostatic inter-
actions, primarily carried by hydrogen bonds, contribute significantly to
the free energy of binding (Gao et al. 1998). Interestingly, some of these
hydrogen bonds occur through bridging waters, which act as a filler to
accommodate different base pairs. This mechanism may in part explain
the sequence generality of DNA binding (Gao et al. 1998).
The Cren7 protein is a highly conserved crenarchaeal chromatin pro-
tein, that bends double-stranded DNA and constrains negative super-
coils (Driessen et al. 2013; Feng et al. 2010). Cren7 and Sso7d share many
functional characteristics and have a similar fold. Both compact DNA
molecules in a comparable manner and to approximately the same ex-
tent (Driessen et al. 2013). Like Sso7d, Cren7 has a DNA binding surface
composed of a three stranded β-sheet that contains positively charged,
as well as hydrophobic residues (Feng et al. 2010). The crystal structure
of the Cren7 protein in complex with double-stranded DNA shows that
intercalation of hydrophobic side chains induce a bend of approximately
60° (Feng et al. 2010), which is agreement molecular dynamics simu-
lations of the protein–DNA complex (Driessen et al. 2013). A notable
difference with Sso7d is the presence of the β3− β4 loop that interacts
strongly with the DNA, as evidenced by the observations that the loop
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becomes more rigid upon DNA binding in solution (Guo et al. 2008), and
that deletion of this loop gives a sixty fold reduction in DNA binding
affinity (Feng et al. 2010). Interestingly, several sites in this loop may be
methylated (Guo et al. 2008) and both methylated and unmethylated
forms of a lysine in this loop have been reported in vivo, suggesting that
DNA binding may be regulated by methylation (Feng et al. 2010).
Sso10b, also known as Alba (acetylation lowers binding affinity)
(Bell et al. 2002), is a well-characterized conserved archaeal protein that
tightly binds double-stranded DNA in a sequence non-specific manner.
The protein draws its name from the post-translational acetylation on
Lys16 by the acetyltransferase Pat that lowers the affinity for DNA
(Marsh et al. 2005). Conversely, a homologue of the eukaryotic his-
tone deacetylase Sir2 can deacetylate acetylation lowers binding affinity
(Alba) and mediate transcriptional repression in vitro (Bell et al. 2002).
The structure of Sso10b (Wardleworth et al. 2002) and its smaller iso-
form Sso10b2 (Chou et al. 2003) have been determined by X-ray crys-
tallography and models for the protein–DNA complex have been put
forward that suggest an important role in DNA binding for Lys16 and
Lys17 in Sso10b and the corresponding residues Lys12 and Lys14 in
Sso10b2. However, in the protein–DNA co-crystal structure of Ape10b2,
a Alba2 homologue from Aeropyrum pernix K1, the conserved Lys14 –
which corresponds to Lys17 and Lys14 in Sso10b and Sso10b2, respec-
tively – has been shown to have only an indirect role in coordination of
bound DNA and seems primarily involved in stabilizing the interaction
between individual Alba2 dimers (Tanaka et al. 2012). DNA binding by
Alba2 is effected by positively charged and polar residues located in the
monomer-monomer interface that pack into the opposite successive mi-
nor grooves of the DNA (Tanaka et al. 2012). Crystal contacts brought
about by hydrophobic interactions between the two α-helices between
Alba2 dimers suggest a possible mechanism for DNA compaction by
bridging of strands (Tanaka et al. 2012). This is in line with the single
molecule manipulation studies of Laurens et al. (2012) who, in addition
to DNA bridging, report stiffening of the DNA by cooperative side-by-
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side biding of Alba dimers.
Sso10a, the last member of the 10 kDa class, was identified by its ho-
mology to the Sac10a protein from Sulfolobus acidocaldarius. Electron
microscopy studies with reconstituted Sac10a–DNA complexes suggest
that Sac10a binds DNA in a sequence non-specific manner and can in-
troduce supercoiling (Lurz et al. 1986). The DNA binding properties
of Sso10a itself are poorly characterized, however, the 1.47Å crystal
structure of Sso10a dimer (Chen et al. 2004) contains two copies of the
winged helix fold which is observed in many DNA binding proteins. The
winged helix fold is a compact α/β structure consisting of a helix-turn-
helix DNA binding motif and two antiparallel β-strands that form the
wing (w1), arranged in order α1− β1− α2− α3− β2− w1− β3− w2.
In many winged helix proteins a second wing (w2) is formed by the C-
terminus of the DNA binding domain, however in the Sso10a dimer the
C-terminus of each chain is and extended α-helix. These helices interact
to form a very stable antiparallel left-handed coiled-coil. Based on ho-
mology with γδresolvase, Chen et al. (2004) suggest that Sso10a binding
of DNA is primarily mediated by insertion of α3 of the helix-turn-helix
DNA binding motif in the major groove of the DNA with only minor
roles in coordination of DNA binding by insertion of w1 and N-terminus
into the outer and inner minor groove, respectively. Nonetheless, the
winged helix fold is an extremely versatile motif with distinct DNA
binding modes (Gajiwala and Burley 2000), making predictions about
DNA binding highly speculative.
The Sso10a protein has two close homologues which, while showing
strong sequence conservation, have shown differential DNA binding be-
haviour in preliminary experiments. Here we describe the X-ray crystal
structure solution and compare the global structure of Sso10a2 with that
of the previously solved Sso10a (Chen et al. 2004; Kahsai et al. 2005) to
identify residues and structural elements that may be involved in DNA
binding.
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4.2 Methods
4.2.1 Cloning and overproduction
The sequence coding for the Sso10a2 protein was amplified from S. sol-
fataricus P2 strain genomic DNA by PCR with the forward primer 5’
ATA CAT ATG CAA CTT GAA CGG CGT AAA AGA GGA ACA
ATG G 3’ and reverse primer 5’ GGT GGA TCC TTA CTC ACT GTC
TGT TCT TAA AAG TTC ACT AAC 3’ and subsequently cloned
into the NdeI and BamHI sites of the pET11a cloning vector via a
classical restriction–ligation procedure. After sequence verification se-
lenomethionine substituted Sso10a2 was expressed in a methionine aux-
otrophic derivative of Escherichia coli BL21 as described by Sohi et
al. (2000). Briefly, E. coli were grown in minimal medium containing
50mgL−1 selenomethionine and 30mgL−1 ampicillin to an OD600 of
0.4 upon which Sso10a2 expression was induced by adding isopropyl β-D-
1-thiogalactopyranoside (IPTG) to a final concentration of 120mgL−1.
Cells were harvested after 2 h by centrifugation.
4.2.2 Purification
The cell pellet was resuspended in 20mL 50mm Tris (pH 8.0),
2mm MgCl2, 0.1% v/v Triton X-100, 3mm benzamidine, 10mm 2-
mercaptoethanol. After sonication to promote cell disruption and DNA
shearing, 1000 units of Omnicleave™ endonuclease (Epicentre) were
added per gram wet cell weight and the DNA was digested by incuba-
tion at 293K for 30min. By heating the sample to 343K for 40min non
thermostable proteins will denature and aggregate. Following cooling
down of the sample, EDTA and NaCl were added to a final concentra-
tion of 20mm and 100mm respectively. The soluble faction obtained by
ultracentrifugation of the cell lysate was filtered with a 0.45 µm filter
(Filtropur S, SARSTEDT) to remove residual aggregates.
The clarified lysate was loaded onto a 1ml RESOURCE S (GE
Healthcare, Little Chalfont, United Kingdom) cation-exchange column
equilibrated with 10mm K2HPO4/KH2PO4 (pH 7.0), 100mm NaCl,
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10% v/v glycerol and 5mm 2-mercaptoethanol and bound material was
eluted with a linear gradient of 0.1 m to 1 m NaCl. The pooled peak frac-
tions were dialysed against 10mm K2HPO4/KH2PO4 (pH 7.0), 100mm
NaCl and loaded onto a 1mL HiTrap Heparin HP column (GE Health-
care), equilibrated with the same buffer and eluted with the same gra-
dient.
The fractions containing Sso10a2, kindly provided by Dr. Nora
Goossen1, were pooled and the residual impurities removed by purifica-
tion on a Superdex 200 gel-filtration column (GE Healthcare). The col-
umn was equilibrated with 20mm Na2HPO4/NaH2PO4 pH 7.3, 150mm
NaCl and resolved at a flow rate 0.8mLmin−1.
At every stage in the purification the peak fractions were examined
on 17% tricine-SDS-PAGE gels stained with Coomassie Blue.
4.2.3 Crystallisation
Sso10a2 was concentrated to 10mgmL−1 with an 3 kDa molecular
weight cutoff centrifugal filter unit (Millipore). Sitting drop vapour
diffusion crystallisation trials were set up using the JCSG+ and PACT
screens purchased from Qiagen (Hilden, Germany). The reservoir solu-
tion (75 µL) was dispensed in MRC Crystallisation 2 drop plates (Molec-
ular Dimensions, Newmarket, United Kingdom)) using a Genesis RS200
liquid handling robot (Tecan, Männedorf, Switzerland)). Dispensing of
0.5 µL drops was performed with an Oryx robot (Douglas Instruments,
East Garston, United Kingdom). The protein to reservoir solution ra-
tio of the drops were 1:1 and 3:1, respectively. Over the course of 30
days, crystals appeared in several conditions. Those crystals confirmed
to contain protein by UV fluorescence microscopy using a U-MWU2 fil-
ter (Olympus, Tokyo, Japan) and were considered for X-ray diffraction
analysis.
1Faculty of Science, Leiden Institute of Chemistry, Molecular Genetics, Gorlaeus
Laboratories, Einsteinweg 55, 2333 CC Leiden
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4.2.4 X-ray diffraction analysis
Crystals were picked up in cryoloops and directly flash-cooled in liquid
nitrogen for those conditions containing known cryoprotectants. Crys-
tals from conditions without cryoprotectant were briefly soaked in a
solution composed of 10% v/v glycerol in mother liquor prior to flash-
cooling. X-ray diffraction experiments were conducted on ID 14-1 at
the European Synchrotron Radiation Facility (ESRF), Grenoble, France.
Crystals grown in PACT condition no. 71, consisting of 1 m succinic acid,
0.1 m HEPES pH 7.0 and 0.1% w/v PEG MME 2000 (final pH 7.0) in a
protein to reservoir solution ratio 3:1 showed strong diffraction. 378 im-
ages were collected at a wavelength of 0.933Å with an oscillation angle
of 0.95° and an exposure time of 7 s per frame at 100K. The diffrac-
tion images were processed with XDS (Kabsch 2010), excluding the
reflections around the 2.249Å ice-ring. Scaling and merging was done
with Aimless (Evans 2011) and the Crank (Ness et al. 2004) suite
was used to obtain an initial model with the following toolchain: Afro
(Pannu et al., in preparation), Crunch2 (de Graaff et al. 2001) and
Bp3 (Pannu and Read 2004) for substructure detection and refinement.
This was followed by density modification with Parrot (Cowtan 2010)
using the novel phase combination algorithm described in Chapter 3,
and Buccaneer (Cowtan 2006) in combination with Refmac (Mur-
shudov et al. 2011) for model building iterated with refinement. Manual
adjustments and completion of the model were performed in Coot (Em-
sley et al. 2010), also iterated with translation libration screw-motion
(TLS) and restrained refinement in Refmac with automatically gener-
ated TLS groups and non-crystallographic symmetry (NCS) restraints.
Both Parrot and all refinement cycles in Refmac were run with direct
phase restraints (Skubák et al. 2004, 2010). All programs except XDS
and Coot were run from the CCP4i graphical user interface. Data
reduction and refinement statistics are shown in Tables 4.1 and 4.2,
respectively. The atomic coordinates and structure factors have been
deposited in the RCSB Protein Data Bank under PDB identifier 4HW0.
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4.2.5 Analysis of the crystal structure
The Theseus (Theobald and Wuttke 2006) program was used for su-
perpositions and root-mean-square deviation calculations. Prior to
superposition with theseus the primary sequences were aligned with
ClustalW (Larkin et al. 2007), which was also used to align different
homologues of Sso10a2. Crystal packing and possible macromolecular
assemblies were examined using the PDBe PISA (Krissinel and Henrick
2007) web interface. The PyMOL (Schrödinger LLC 2010) package
was used to create views of Sso10a2 and superpositions with homolo-
gous structures.
4.3 Results and Discussion
4.3.1 Sequence analysis
The alignment of the Sso10a2 amino acid sequence (Figure 4.1) with
those of its paralogs Sso10a (Q97VX8), Sso10a3 (Q97UL8) and several
similar sequences from crenarchaeal species shows that the first twenty-
six residues are not present in any of the homologous proteins. Fur-
thermore, a BLAST (Altschul et al. 1990) search with these twenty-six
residues did not uncover any sequences with significant similarity and it
is unclear whether the full-length Sso10a2 protein or transcript exists.
A N-terminal α-helix predicted with the PSIPRED (Buchan and Ward
2010) server for secondary structure prediction server, is not essential
for DNA binding or protein stability, as we have found that the Sso10a2
protein truncated to Met27 to Glu130 is stable in solution and binds
DNA in both electrophoretic mobility shift assay (EMSA) and tethered
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Figure 4.1: ClustalW sequence alignment of Sso10a (Q97VX8) archaeal homologs, including Sso10a2 (Q97V10)
and Sso10a3 (Q97UL8) from Sulfolobus solfataricus; Sac10a (Q4JAD3) and a paralog (Q4J7Y2) from Sulfolobus
acidocaldarius; similar sequences from Metallosphaera sedula (A4YG75, A4YH26 and A4YG66), Sulfolobus toko-
daii (Q973Y2, Q973B3, F9VNH4, Q970P2 and Q974K1), and Sulfolobus islandicus (C3MSQ1, C3MV70, C3MUB9,
C3MSF1, C3MVN3 and C3MVP1). The secondary stucture of Sso10a2 is depicted in the first line. Violet and blue
shading denote a consensus of more than 80% and 50 to 80%, respectively. Residues that are chemically similar,
but not identical are shaded in magenta if the similarity exceeds 50%.73
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4.3.2 Structure solution
Initial attempts to solve the structure of Sso10a2 from a native data set
using Sso10a as search model molecular replacement (MR) were unsuc-
cessful. Interestingly a MR solution could not readily be obtained on
the selenomethionine data either using Phaser (McCoy et al. 2007) or
Molrep (Vagin and Teplyakov 1997) with one or both chains of Sso10a
as search model. Even with the A chain from the refined Sso10a2 model
a solution could not be found using the default setting for finding mul-
tiple copies of the search model in the asymmetric unit.
Table 4.1: Data collection statistics for Sso10a2 as reported by the
Scala (Evans 2006) program. The Rmerge factor was multiplicity
weighted (Diederichs and Karplus 1997; Weiss and Hilgenfeld 1997)
X-ray source ESRF ID14-1
X-ray detector ADSC Quantum 210
Wavelength (Å) 0.9334
Space group P2122
Unit-cell parameters a = 60.22, b = 69.54, c = 80.73,
α = β = γ = 90.00
Matthews coefficient (Å3 Da−1) 2.31
Solvent content (%) 46.73
Resolution (Å) 40.36 – 2.00 (2.11 – 2.00)
Wilson plot B factor (Å2) 32.24
Rmerge (%) 3.9 (48.2)
Rrim (%) 5.2 (54.1)
Rpim (%) 1.4 (16.8)
Mean I/σ(I) 39.6 (4.4)
Completeness (%) 93.3 (95.2)
Multiplicity 13.5 (9.6)
Anomalous completeness (%) 92.9 (94.0)
Anomalous multiplicity 7.2 (5.0)
Total No. of observations 296078
No. of unique reflections 21998
No. of reflections in Rfree set 1118
Given that both the completeness and multiplicity were higher in
the selenomethionine data set compared to the native data set, we built
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and refined the structure using the anomalous data. The data collec-
tion statistics shown in Table 4.1 are consistent with those of a good
quality data set (Evans 2006), with high completeness, redundancy and
a strong anomalous signal. Unfortunately, even though the crystal was
soaked in 10% v/v glycerol prior to flash freezing, the diffraction data
showed strong ice-rings. Weak reflections close to ice-rings are usually
treated properly by the data processing programs. Nonetheless during
refinement it was observed that around the 2.249Å ice-ring the R factors
increase sharply, with a respective mean R and Rfree factor of 40.5% and
46.5% in the 2.27 to 2.21Å resolution bin, as opposed to a mean overall
R of 25.6% and Rfree of 21.4%. The large difference between the over-
all R factors and the R factors of reflections between 2.27 and 2.21Å
suggests that the reflections near the ice-rings carry little information.
Moreover, the concomitant rise in the mean R factors, as compared to
the situation where the reflections near the ice-rings are removed, is such
that these values are no longer a reflection of the quality of the refined
model. Excluding the reflections around 2.249Å only slightly affected
the (anomalous) completeness without noticeably decreasing the quality
of the electron-density map.
The initial model output by the automatic structure solution suite
Crank was very complete. The R and Rfree were 28.9% and 34.6%,
respectively. The RMSD of the Cα-backbone with respect to the final
refined model was just 0.44Å. After manual model building in Coot
Chain A was most complete with residue 7 to 104 out of 104 residues se-
quenced correctly. While some features of the first six N-terminal amino
acids could be distinguished the electron-density map was to poor in this
region to place the residues unambiguously. The same was true for the
first seven residues of the B and C chains and portions of the C-termini
of these chains. After placement of waters and several rounds of man-
ual model building, iterated with restrained refinement in Refmac with
TLS and loose NCS restraints the Rfree decreased to 24.5% (Table 4.2).
With the exception of both termini the quality of the electron-density
map for chain A was excellent. In contrast, the electron-density map for
75
4. Structural analysis of DNA binding protein Sso10a2
Table 4.2: Refinement statistics for Sso10a2.
Resolution (Å) 40.36 – 2.00
No. of reflections 20862













Bond lengths (Å) 0.0167
Bond angles (°) 1.7139
No. of TLS bodies 3
Ramachandran favoured (%) 98.57
Ramachandran outliers (%) 0
Rotamer outliers (%) 2.34
the B and C chains was poor around Lys57 to Lys63. Overall the quality
of the map around chain B was almost equal to that of chain A, whereas
it was noticeably worse for chain C, of which several residues have poorly
resolved side-chains. The decline in quality of the electron-density map
is clearly illustrated by Figure 4.2 which shows the electron-density map
contoured at 1.5σ around the Lys57 to Lys63 region for each of the
chains. This is also consistent with the rise in the mean temperature
factors (Table 4.2), which suggest increasing disorder going from chain
A to chain C. Because of the absence of any striking differences between
the chains and the notable better quality of the chain A model it seems
reasonable to discuss the structure of Sso10a2 with reference to chain A
only.
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4.3.3 Global structure
The structure of Sso10a2 has been determined to 2Å resolution and
contains three molecules in the ASU. The average interchain RMSD after
a least-squares superposition in Coot was 0.341Å (0.302 and 0.391Å
for chain A with respect to chain B and C and 0.331Å between chain B
and chain C), which indicates that the overall structure of each of the
chains is very similar.
Analogous to Sso10a the Sso10a2 monomer’s winged helix domain is
arranged in a α1−β1−α2−α3−β2−β3 topology. The protein is com-
posed of mostly α-helices (69.7%) and approximately 14.1% β-sheets.
The first α-helix (α1, 2.5 turns, Thr10 to Asn20) is preceded by a short
negatively charged stretch that becomes increasingly disordered toward
the distal end of the N-terminus. The first α-helix is directly followed
by Cys21, which forms a sulphur bridge with Cys25, the only other cys-
teine in the monomer. The aforementioned residues are connected by
a short loop that ends with Pro23 in the cis configuration, followed by
a short β-strand. Together with α1, a second short helix (α2, 2 turns,
Ile27 to Ala34) is packed against a third slightly longer α-helix (α3,
3.5 turns, Tyr38 to Val51) to form the hydrophobic core, stabilised by
the sulphur bridge formed between the two cysteines. Finally, the wing
of the winged helix domain is a β-hairpin composed of two six residue
β-strands (β2, Leu54 to Glu59 and β3, Arg62 to Ile67). The second
domain in Sso10a2 is a 30 residue C-terminal α-helix (8 turns, Glu69
to Leu98) that forms an antiparallel coiled-coil in the dimer. Similar to
the N-terminus the last six C-terminal residues appear to be part of a
flexible region in the protein.
4.3.4 Comparison of Sso10a and Sso10a2
Like the Sso10a dimer, the Sso10a2 dimer is defined by the coiled-coil
interaction which closely follows the typical “knobs-into-holes” packing
(Crick 1953). The presence of the non-hydrophobic Asp69 and Lys86∗
pair in Sso10a disrupts the heptad repeat pattern (Chen et al. 2004).
However, the atypical salt bridge between these residues is not formed
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between the corresponding residues His77 –Lys94∗ in Sso10a2. At phys-
iological pH histidine carries little charge and no strong interaction will
occur with the positively charged lysine. Indeed the distance of 4.2Å
between the primary amine NZ of the lysine and tertiary amine NE2
of the histidine precludes a hydrogen bond. Furthermore the conforma-
tional freedom of the Lys94 side chain does not appear to be constrained
by strong interactions as is clear from the low contrast of the side chain
electron density.
Roughly two-thirds of the coiled-coil is solvent exposed with the
majority of the solvent exposed residues being hydrophilic and con-
versely the inward facing residues hydrophobic. A noteworthy excep-
tion is Leu82 that is found in a position where one would expect a hy-
drophilic residue according to the heptad repeat. Together with Leu74
and Leu78 from H1 and Phe15 and Leu18 in H4 this residue partakes
in the hydrophobic interface between both helices to form a contiguous
hydrophobic core between the N-terminal end of the coiled-coil. The
interface is further stabilized by hydrogen bonds between Glu12 –Arg85
and Glu22 –Arg75, similar to the Gln11 –Asn74 and Glu15 –Arg71 hy-
drogen bonded pairs in Sso10a. The coiled-coil and winged helix DNA
binding domains are more closely associated in Sso10a2 compared to
Sso10a, which causes the globular head to be tilted approximately 5°
toward the H4 helical axis with respect to the orientation in Sso10a, as
shown in Figure 4.3. Consequently, the DNA binding domains in the
Sso10a2 dimer are closer together than in Sso10a. For example, within
the dimer the distance between the Cαatoms of the highly conserved ty-
rosine at position 34 in Sso10a and 38 in Sso10a2 is 61.1Å for Sso10a and
56.2Å for Sso10a2. The conserved tyrosine is found in the N-terminal
end of the α3 helix that has previously been speculated to be involved
in DNA binding (Chen et al. 2004). Presumably the different orienta-
tion of the DNA binding domains and the α3 helices in particular has
consequences for DNA binding by Sso10a2.
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4.3.5 Concluding remarks
Sso10a2 is a member of three highly similar proteins in S. solfataricus,
yet to some extent the protein sequences have diverged. In the case of
Sso10a and Sso10a2 this leads to significant biochemical and structural
differences, which may have consequences for the biological function,
most importantly DNA binding. As of yet the exact mechanism of
DNA binding remain unclear and predictions regarding the effects of
single amino acid substitutions or the observed global shift of secondary
structure elements remain highly speculative.
The similarity between the “knob-and-hole” pattern between Sso10a
and Sso10a2 may allow formation of heterodimers. This intriguing possi-
bility, potentially offers further means for fine tuning DNA organisation
by Sso10a family members. The existence and relative distribution of the
different putative Sso10a dimer species is therefore an interesting avenue
for investigation. Additionally, in vivo studies at protein level should
also conclusively demonstrate whether truncation of Sso10a2 based on
the sequence similarity with Sso10a and Sso10a3 was indeed justified.
The structures of Sso10a and Sso10a2 have opened up the possibil-
ity of further comparative analyses by for instance molecular dynamics
simulations of DNA binding and multimerisation, as well as, enabling
rational design of point mutants to identify residues that influence the
stability of the coiled-coil or higher order assemblies, as well as DNA
interacting residues. However, the precise coordination of DNA binding
requires co-crystallisation of Sso10a2 with a suitable DNA substrate.
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(a) Chain A
(b) Chain B (c) Chain C
Figure 4.2: The electron-density map contoured at 1.5σ around the
Lys57 to Lys63 loop representative for each of the NCS related chains
in Sso10a2
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(a) Front
(b) Back
Figure 4.3: Theseus maximum likelihood superpositioning of the




Crystallisation of human recombinant C1
inhibitor
Abstract
C1 inhibitor (C1INH), a member of the serpin superfamily of
protease inhibitors, is an important down-regulator of inflamma-
tory processes in the blood by preventing spontaneous activation
of the complement system. In addition C1INH acts on the co-
agulation contact activation pathway by inhibition of kallikrein,
activated factor XI, and activated factor XII. Genetic C1INH de-
ficiency results in hereditary angioedema (HAE), a serious illness
associated with recurring swelling in the upper airways that may
be life threatening. Ruconest® is a recombinant human C1 in-
hibitor (rhC1INH) that was recently approved for replacement
therapy in HAE. Here we present extensive crystallisation screen-
ing of rhC1INH, as well as two low molecular weight variants that
both retain their inhibitory activity in vitro. Crystals were formed
in several conditions and a number of high quality crystals were
selected for analysis at the European Synchrotron Radiation Facil-
ity. These crystals are believed to contain rhC1INH in the active
form, whose conformation is unknown for this serpin.
The author of this thesis designed and evaluated high-throughput crystallisation stud-
ies of the full length rhC1INH protein and its two low molecular weight species.
83
5. Crystallisation of human recombinant C1 inhibitor
5.1 Introduction
C1INH is an acute phase plasma protein essential for down-regulation of
inflammation that acts through inhibiting activation of the complement
system, as well as, the coagulation contact (kallikrein-kinin) activation
pathway. As part of the innate immune system, the complement system
“complements” the ability of phagocytic cells and antibodies to defend
the host against pathogens and altered host cells. Its activation occurs
through three distinct routes: the classical complement pathway, the
alternative complement pathway, and the lectin pathway. C1INH is the
only known inhibitor that down-regulates early components in the com-
plement system activation cascade by inhibiting both C1r and C1s serine
proteases of the classical complement pathway (Cooper 1985; Schapira
et al. 1985; Sim et al. 1979), as well as, the highly similar MASP-1
and MASP-2 proteins of the lectin pathway (Matsushita et al. 2000).
In addition to its role in the complement system, C1INH also targets
activated factor XI (fXIa), activated factor XII (fXIIa) and kallikrein
of the contact activation system (Chan et al. 1977; Pixley et al. 1985;
Schapira et al. 1982; van der Graaf et al. 1983; Wuillemin et al. 1995).
C1INH has several other anti-inflammatory functions, including sup-
pression of gram negative sepsis and endotoxin shock (Liu et al. 2003,
2004; Nuijens et al. 1989), as well as direct and indirect interactions that
influence leukocyte behaviour (Cai and Davis 2003; Cai et al. 2005). Fi-
nally C1INH treatment has show to improve the clinical outcome in a
number of inflammation related conditions, including sepsis and other
bacterial infections, ischaemia-reperfusion injury and acute transplant
rejection as reviewed by Davis et al. (2010).
The physiological importance of C1INH is perhaps best illustrated
by its absence in HAE, a genetic C1INH deficiency that is responsible
for localized increases in vascular permeability. The resulting episodic
bouts of tissue swelling may be life-threatening when occurring in the
upper airways. This essential role of C1INH in the pathology of HAE
was established with the discovery by Donaldson and Evans (1963), who
showed that patients with HAE have low blood plasma levels of C1INH.
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The disease is known to be autosomal dominantly inherited, in fact the
hereditary nature of HAE has been firmly established for well over a
century (Osler 1888). To date, a variety of mutations, deletions and
translocations have been identified that lead to the disease (Bock et al.
1986; Bowen et al. 2001). On this genetic basis two variants of HAE
can be distinguished. The type 1 form of HAE affects roughly 85% of
the patients, in which expression of C1INH from one of the alleles is
abolished altogether. In the less common type 2 form patients have a
mutation leading to dysfunctional protein (Bos et al. 2003). Both types
of the disease cause a decrease in the level of functional C1INH, a trait
HAE has in common with acquired angioedema, a disease with a similar
clinical presentation, but caused by aberrant antibody activity against
C1INH that effectively blocks its activity, rather than a genetic C1INH
deficiency.
While it is clear that C1INH is a key player in HAE, the exact bio-
chemical mechanism explaining the recurrent acute localised increases
in vascular permeability remains somewhat unclear. Davis et al. (2010)
reviewed the various biological functions of C1INH also in relation to
HAE. One theory suggests involvement of factors derived from comple-
ment activation (da Silva 1967; Donaldson et al. 1969, 1977; Klemperer
et al. 1968; Strang et al. 1986, 1988). However this theory has been aban-
doned, at least in part, in favour of an explanation that suggests a role
for the contact activation pathway in the pathogenesis of HAE. Hall-
marks of contact system activation, such as decrease of pre-kallikrein
and high-molecular-weight kinogen (HMWK) plasma levels (Schapira
et al. 1983), cleavage of HMWK (Berrettini et al. 1986; Lämmle et al.
1988), and presence of bradykinin in plasma (Nussberger et al. 1998),
have been observed during HAE attacks. Additionally several stud-
ies show that bradykinin is released during in vitro incubation of HAE
plasma (Curd et al. 1982; Fields et al. 1983) and that this activity de-
pends on the presence of pre-kallikrein, HMWK, and factor XII (fXII)
(Shoemaker et al. 1994). Furthermore HAE does not occur in cases if
the mutation in C1INH only affects inhibition of C1r and C1s, but not
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fXIIa and plasma kallikrein, ruling out disruption of the complement
system as the sole cause for HAE (Wisnieski et al. 1994; Zahedi et al.
1995, 1997). Finally, increased vascular permeability observed in C1INH
knockout mice can be reversed by administering C1INH, but also with
a kallikrein inhibitor or a bradykinin type 2 receptor (Bk2R) antago-
nist. Interestingly C1INH/Bk2R double knockout mice did not develop
increased vascular permeability. In summary it would seem that disrup-
tion of the contact system activation is responsible for the angioedema
attacks in HAE and that bradykinin is it principle mediator.
Like all other members of the serine protease inhibitor superfamily,
C1INH can exist in two states, a metastable conformation in which the
flexible reactive center loop (RCL) is exposed and acts as a bait to trap
one of C1INH’s target proteases. Cleavage of the peptide bond by the
targeted protease triggers the trap and results in a large conformational
change in the serpin-domain that distorts the active site of the protease
and locks the covalently linked protease in a C1INH-protease complex
(Huntington et al. 2000). During this architectural transition the RCL
is inserted in the A β-sheet of the serpin domain forming an additional
β-strand. Spontaneous insertion of the RCL into β-sheet A transforms
the serpin in latent conformation and is accompanied by the loss in
inhibitory activity as the RCL is no longer exposed to bind its target
protease.
C1INH has an unusual architecture, with a C-terminal serpin domain
and a heavily glycosylated N-terminal domain that it not found in other
serpins (Bock et al. 1986). The structure of the latent form of C1INH,
solved by Beinrohr et al. (2007), is similar to that of other serpins.
The exception is the complete insertion of the RCL into the β-sheet
A, which represents a novel conformation comprised of seven parallel
β-strands. The other unique feature is the unusual arrangement of the
six C-terminal residues. In particular, the C-terminal proline, which is
found in a different position from almost all other serpins. Beinrohr
et al. (2007) speculate that the C-terminus may act as a barrier to RCL
insertion as it needs to move considerably with respect to its presumed
86
5.1. Introduction
location in active C1INH.
Heparin and other glycosaminoglycans have an distinct effect on
C1INH activity (Caldwell et al. 1999; Caughman et al. 1982), though the
precise mechanism of C1INH potentiation remains unclear (Bos et al.
2002). Beinrohr et al. (2007) put forward a mechanism for C1INH poten-
tiation whereby polyanions are “sandwiched” between C1INH and the
target protease, neutralising the positive charge surrounding the RCL
and the active site of the protease.
While the effect of frameshifts, introduced stop codons and large
deletions in HAE can be readily explained, knowledge of the active,
as well as the latent form of C1INH is needed to provide a structural
explanation for the effect of certain point mutations. In particular, mu-
tations that only partly affect the inhibitory activity of C1INH are of
interest, for example the Ala443Val mutation that significantly impairs
binding with C1r, but is able to complex with Cls, kallikrein, and fXIIa
(Zahedi et al. 1995). Additionally, insight in C1INH structure and its
intermediate states may also offer means to prevent spontaneous active
to latent transition and stabilize therapeutic formulations of (recombi-
nant) C1INH. Finally, as the inhibitory activity of C1INH on several of
its targets is modulated by glycosaminoglycans such as heparin, it may
be possible to design therapeutic glycosaminoglycan mimics that po-
tentiate C1INH towards specific protease targets or speed up formation
of transition state complexes thereby effectively boosting C1INH’s spe-
cific activity. This could improve clinical outcomes in situations where
(endogenous) levels of functional C1INH are low, such as HAE. Determi-
nation of the structure of active C1INH is the first step in this process.
Infusion of C1INH isolated from human plasma has been used in
Europe for over four decades to successfully treat HAE attacks (Waytes
et al. 1996). Recently the safety and efficacy of rhC1INH (Ruconest®)
for the treatment of angioedema attacks in patients with HAE have
been demonstrated (Plosker 2012; Varga and Farkas 2011; Zuraw et
al. 2010). rhC1INH is commercially produced in high quantities from
the milk of transgenic rabbits by the Dutch company Pharming. A
87
5. Crystallisation of human recombinant C1 inhibitor
small fraction of the expressed rhC1INH protein lack either the first
84 or the first 96 N-terminal residues. An unwanted impurity from
a pharmacological perspective, however, as both retain their inhibitory
activity (van Veen et al. 2012), these truncated forms present interesting
targets for structure determination. Here, we describe the crystallisation
of both truncated fully glycosylated active forms of rhC1INH and report
the outcome of extensive crystallization trials with full-length rhC1INH.
5.2 Methods
5.2.1 Protein expression and purification
Expression and purification of rhC1INH was as described before by van
Veen et al. (2012). In brief, rhC1INH was secreted into the milk of trans-
genic New Zealand White rabbits. The transgenic rabbit milk was defat-
ted by centrifugation and applied to a SP Sepharose column (GE Health-
care, Uppsala, Sweden), followed by a Q Sepharose column (GE Health-
care, Uppsala, Sweden) to separate rhC1INH from rabbit milk proteins
including trace amounts of endogenous C1INH and to remove chemi-
cals added during purification. Residual rabbit protein impurities were
removed in a chromatographic step consisting of a zinc-charged chelat-
ing Sepharose column (GE Healthcare, Uppsala, Sweden). The puri-
fied rhC1INH was filtered over Planova™15N hollow fibers (Asahi Ka-
sei Bioprocess, Tokyo, Japan) and formulated in 20mm sodium citrate,
6.5% w/v sucrose of pH 6.8 by ultrafiltration using Biomax-10 mem-
branes (Millipore, Billerica, MA). Analytical size-exclusion chromatog-
raphy of purified rhC1INH revealed a purity of 99%. Beside multimeric
rhC1INH species, the 1% impurities contained two N-terminal cleaved
C1INH species starting at amino acid 85 (LMW1) and 97 (LMW2),
respectively. The LMW species were isolated from purified rhC1INH
by a purification procedure that will be described elsewhere. All puri-
fied rhC1INH species were buffer exchanged using Vivaspin filter units
(10 kDa MWCO; Sartorius, Goettingen, Germany) to a solution com-




The inhibitory effect of intact rhC1INH on the target proteases C1s,
Factor XIIa, kallikrein and Factor XIa has been shown previously, as
has inhibition of C1s by both truncated forms of rhC1INH (van Veen
et al. 2012). All three purified C1INH species were kindly provided by
Pharming Technologies B.V. (Leiden, The Netherlands). Initial sit-
ting drop vapour diffusion crystallisation trials were set up using the
JCSG+ and PACT screens purchased from Qiagen (Hilden, Germany)
in Corning® 3550 96 well protein crystallisation plates (Sigma-Aldrich,
St. Louis, MO). A comprehensive screen was performed varying the pro-
tein to precipitant ratio between 10 to 90% v/v with a 10% v/v step
and a drop size of 0.8 µL using three different concentrations (17, 50 and
100mgmL−1) of full-length rhC1INH protein. Additionally, crystallisa-
tion trials were set up with 50mgmL−1 full-length rhC1INH pretreated
with 1 U PNGase F per 100 µg protein for 24h at 37 ◦C to partially
remove the N-glycans and enhance the propensity of rhC1INH to crys-
tallise.
Considerably less material was available for setting up trials with
the truncated rhC1INH species and the initial screens were set up in
Corning® 3550 plates using a fraction containing a mixture of LMW1
and LMW2. Three drops of 0.66 µL were dispensed composed of 30, 50
and 70% v/v protein solution with concentration of 13.4mgmL−1.
Optimisation of initial hits with the rhC1INH truncated species were
set up in MRC Crystallisation 2 drop plates (Molecular Dimensions,
Newmarket, United Kingdom). These grid screens were formulated from
stock solutions using the Rock Maker software package (Formulatrix,
Waltham, MA) by varying the polyethylene glycol (PEG) 3350 and KF
concentration from 10 to 30% w/v and from 100 to 300mm, respectively.
The concentration of LMW1 and LMW2 was approximately 10mgmL−1
and the drop size 1 µL with a protein content in each of the drops of 60
and 70% v/v, respectively.
Where required the protein was concentrated with an 15 kDa molec-
ular weight cut-off centrifugal filter unit (Millipore, Billerica, MA). The
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reservoir solution (75 µL) was dispensed with a Genesis RS200 liquid
handling platform (Tecan, Männedorf, Switzerland) and an Oryx robot
(Douglas Instruments, East Garston, United Kingdom) was used to set
the crystallisation drops. Over the course of 27 days crystals appeared
in several conditions, which were verified to contain protein by UV fluo-
rescence microscopy using a U-MWU2 filter (Olympus, Tokyo, Japan).
5.3 Results and discussion
5.3.1 Crystallisation screening
rhC1INH remains soluble to at least 180mgmL−1 in PBS without loss
in activity (Van Veen 2012, personal communication). This exceptional
solubility was confirmed by the results of the crystallisation experiments
with the full-length protein. While some of drops remained clear, even
at a concentration of 100mgmL−1 protein and 90% v/v precipitant,
the drops went from completely clear to full precipitate for the vast
majority of the 192 tested conditions, indicating adequate sampling of
the crystallisation space. No crystals could be detected in any of the
drops, though phase separation and skin formation on the drops was
observed for a number of conditions. Glycosylation has been shown
to both stabilize and promote protein solubility (Solá and Griebenow
2009), which may explain the high solubility of the full-length rhC1INH
whos N-terminus is extensively N- and O-glycosylated (Bock et al. 1986).
Nevertheless no difference in crystallisation behaviour of the PNGase
F treated protein compared to non-deglycosylated rhC1INH was ob-
served. It should be noted though that the deglycosylation of the native
rhC1INH was not monitored and it is generally accepted that the effi-
ciency of PNGase F under non-denaturing conditions is limited.
The crystallisation experiments with a mixture of the N-terminally
truncated forms of rhC1INH produced several hits. In the JCSG+ screen
crystals were found in conditions with a drop composition of 70% v/v
10% w/v PEG 1000, 10% w/v PEG 8000 and 30% v/v 0.1 m imidazole
(pH 8), 10% w/v PEG 8000 (JCSG+ conditions No. 36 and 60), as well
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as JCSG+ conditions No. 81 and 82 containing 30% w/v polyethylene
glycol monomethyl ether (PEG MME) 2000 and 0.1 m KSCN or 0.15 m
KBr. In the latter two conditions the crystals were found in drops con-
taining 30 to 50% v/v and 50 to 70% v/v protein solution, respectively.
In the PACT screen all crystals suitable for diffraction analysis were
found in drops composed of 70% v/v well solution in PACT conditions
No. 3 to 6, 18, 29, 30, 39, 40, 42, and 49. These conditions contained
25% w/v PEG 1500 in all but one case, where the well solution was com-
posed of 0.2 m NaF and 20% w/v PEG 3350. The nine remaining drops
that produced suitable crystals were buffered with 0.1 m SPG (succinic
acid, sodium dihydrogen phosphate and glycine) at pH 6, 7, 8, and 9;
MIB (succinic acid, sodium dihydrogen phosphate and glycine) at pH 9;
PCB (sodium propionate, sodium cacodylate and Bis-tris propane) at
pH 8 and 9; and MMT (DL-malic acid, MES and Tris base) at pH 6, 7,
and 9.
Varying the PEG 3350 and KF concentration resulted in crystallisa-
tion in both drops for almost all conditions with the truncated forms of
rhC1INH. Though crystals suitable for diffraction analysis were predom-
inantly found in the grid rectangle defined by well E8 (22.7% w/v PEG
3350, 214mm KF) to F11 (28.2% w/v PEG 3350, 243mm KF) and very
few of such crystals were found in conditions with a PEG concentration
below 17.3% w/v or a KF concentration below 157mm.
5.3.2 Diffraction targets
Crystals of appropriate size for X-ray diffraction all showed strong flu-
orescence under UV illumination, making it very likely that they con-
tain protein. The morphology typical of the crystals selected for X-ray
diffraction analysis (Figure 5.1) includes highly regular crystals com-
posed of a single crystal domain (Figure 5.1c) or with minor packing
defects (Figure 5.1d). In both cases the smallest dimension of the crys-
tals ranged from approximately 50 to 250 µm. It is generally accepted
that single crystals offer the best chances for obtaining good quality
diffraction. Nonetheless, several crystals with irregular packing such as
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those shown in Figures 5.1a and 5.1b were also selected for diffraction
analysis. While the diffraction pattern of these macroscopically twinned
crystals will likely be uninterpretable, it will definitively show whether
the crystal contains protein and whether the protein is ordered in the
individual crystal domains. Further optimisation of the crystallization
conditions possibly in combination with micro-seeding may improve the
quality of these crystals. Additionally, the crystal clusters were dis-
sected into individual crystals yielding fragments of 20 to 50 µm along
the shortest edge, that may yet provide good quality diffraction.
5.3.3 Concluding remarks
We have reported conditions to successfully crystallise two active forms
of rhC1INH lacking the first 84 and 96 N-terminal residues, respectively.
As both truncations have previously been shown to inhibit their target
proteases (van Veen et al. 2012) in vitro, it is possible that the crystals
contain rhC1INH in an active form. In contrast to the structure of la-
tent C1INH previously reported by Beinrohr et al. (2007) both truncated
forms were not deglycosylated prior to crystallisation possibly providing
additional structural information. While the planned diffraction exper-
iments may not yet provide a high resolution model, their outcome can
certainly be used to guide future crystallisation experiments by optimis-
ing only those conditions that produce diffracting crystals.
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(a) (b)
(c) (d)
Figure 5.1: Crystals of truncated forms of rhC1INH representative of
those selected for X-ray diffraction analysis at the European Synchrotron
Radiation Facility (ESRF). (a) a 170×700 µm sized crystal composed of
parallelly arranged rod-like crystal domains with an approximate mean
width of 30 µm (b) crystal roughly 80×470 µm composed of stacked
plates with roughly 50 µm in both directions of the plate plane (c) highly-
regular crystal measuring approximately 250×350 µm (d) rod-like crys-




Data sets used for testing
For testing of the new algorithms presented in Chapters 2 and 3 a total of
134 data sets were used. A majority of 78 data sets was provided by the
Joint Center for Structural Genomics (JCSG, http://www.jcsg.org/):
1vjn, 1vjr, 1vjz, 1vk4, 1vkm, 1vlm, 1vqr, 1z82, 1zy9, 1zyb, 2a2m, 2a2o,
2a3n, 2a6b, 2aml, 2avn, 2b8m, 2etd, 2etj, 2ets, 2etv, 2evr, 2f4p, 2fea,
2ffj, 2fg0, 2fg9, 2fna, 2fqp, 2fur, 2fzt, 2g0t, 2g42, 2gc9, 2nlv, 2nuj, 2nwv,
2o08, 2o1q, 2o2x, 2o2z, 2o3l, 2o62, 2o7t, 2o8q, 2obp, 2oc5, 2od5, 2od6,
2oh3, 2okc, 2okf, 2ooj, 2opk, 2osd, 2otm, 2ozg, 2ozj, 2p10, 2p4o, 2p7h,
2p7i, 2p97, 2pg3, 2pg4, 2pgc, 2pim, 2pn1, 2pnk, 2ppv, 2pr7, 2prr, 2prv,
2prx, 2pv4, 2pw4, 2b78, 2b79; 23 data sets from Mueller-Dieckmann
et al. (2007): 2g4h, 2g4i, 2g4j, 2g4k, 2g4p, 2g4q, 2g4l, 2g4n, 2g4o, 2g4r,
2g4s, 2g4t, 2g4u, 2g4v, 2g4w, 2g4x, 2g4y, 2g4z, 2ill, 2g51, 2g52, 2g54,
2g55; and 33 from various other individual data set contributors: 1e42
(Owen, Vallis, et al. 2000), 1e6i (Owen, Ornaghi, et al. 2000), 1hf8 (Ford
et al. 2001), 2ahy (Shi et al. 2006), 2hba, 2o0h (Sun et al. 2007), 2rkk
(Xiao et al. 2008), 3bpj, 2fdn (Dauter et al. 1997), 1of3 (Boraston et
al. 2003), 1i4u (Gordon et al. 2001), 1dw9 (Walsh et al. 2000), 2v0o
(Henne et al. 2007), 1fse (Ducros et al. 2001), 1xib (Carrell et al. 1989),
1fj2 (Devedjiev et al. 2000), 1h29 (Matias et al. 2002), 1c8u (Li et al.
2000), 1lvy (Schiltz et al. 1997), 1lz8 (Dauter et al. 1999), 1e3m (Lamers
et al. 2000), 1ga1 (Dauter et al. 2001), 1djl (White et al. 2000), 1dtx
(Skarzyński 1992), 1dpx (Weiss 2001), 1mso (Smith et al. 2003), 1ocy
(Thomassen et al. 2003), 1rju (Calderone 2004), 1rgg & 2sar (Sevcik et
al. 1996, 1991), 1m32 (Chen et al. 2002). Finally, two data sets that were
used have not been deposited in the PDB: a subtilisin savinase (sav3,
Betzel et al. 1988; Dauter et al. 2002) and glucose isomerase (gilu, Dauter










Table A.1: The raw data summarized in Chapter 3. The PDB code is given by the first column. For data sets
SAD data is taken from peak wavelength MAD data (※) or the inflection wavelength (†) or were phased on a partial
heavy atom substructure or substructure from another data set (b). data sets not deposited in the PDB are shown
in italics. The maximum resolution is denoted by R, followed by the fraction of the substructure that was detected
and the map correlation after experimental phasing as S and MPh, respectively. MσA and MSAD-DM denote the map
correlation with the map generated from the deposited model phases with the map after density modification and
phase combination with the σA and the SAD-DM algorithm, respectively. The difference between the two is given
by ∆M . Similarly the fraction built with Buccaneer and ARP/wARP are denoted by B and A, respectively.
PDB ID R (Å) S MPh MσA MSAD-DM ∆M BSAD-DM BσA ASAD-DM AσA
1vjn 3 0.38 0.08 0.03 0.03 0 0.02 0.02 0 0
1vjr 2.4 1 0.41 0.8 0.6 0.2 0.87 0.54 0.89 0.93
1vjz 2.5 1 0.41 0.72 0.55 0.17 0.81 0.37 0.3 0.08
1vk4 2 1 0.58 0.85 0.78 0.07 0.92 0.93 0.85 0.83
1vkm 2.6 0.98 0.51 0.76 0.61 0.15 0.96 0.64 0.77 0.62
1vlm 2.8 1 0.34 0 0 0 0.01 0 0 0
1vqr 2.77 0.86 0.4 0.6 0.41 0.19 0.58 0.11 0.15 0.05
1z82 2.05 0.85 0.4 0.47 0.43 0.04 0.09 0.06 0.06 0.06
1zyb 2.1 1 0.34 0.53 0.4 0.14 0.39 0.16 0.38 0.11
2a3n 1.23 1 0.58 0.84 0.8 0.05 0.98 0.98 0.97 0.96
2a6b 2.1 1 0.3 0.58 0.4 0.18 0.86 0.08 0.85 0.6
2aml 1.5 0.75 0.52 0.71 0.62 0.1 0.96 0.62 0.94 0.93
2avn 2.35 0.9 0.42 0.83 0.73 0.1 0.98 0.96 0.87 0.92
2etd 2.3 1 0.28 0.17 0.16 0.01 0.05 0.02 0.03 0.02
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PDB ID R (Å) S MPh MσA MSAD-DM ∆M BSAD-DM BσA ASAD-DM AσA
2etj 1.74 1 0.36 0.5 0.4 0.1 0.06 0.09 0.44 0.22
2ets 2.25 1 0.39 0.81 0.68 0.13 0.97 0.93 0.93 0.93
2evr 1.6 1 0.48 0.91 0.91 0 0.91 0.92 0.96 0.96
2f4p 1.9 1 0.3 0.39 0.35 0.04 0.02 0.03 0.06 0.06
2fea 2 1 0.49 0.84 0.72 0.12 0.81 0.94 0.92 0.92
2fg0 1.79 1 0.41 0.86 0.74 0.12 0.97 0.94 0.94 0.93
2fg9 2.2 1 0.5 0.83 0.65 0.18 0.9 0.74 0.77 0.69
2fna 2 0.89 0.33 0.34 0.31 0.03 0.05 0.02 0.04 0.02
2fqp 1.8 1 0.47 0.6 0.56 0.03 0.17 0.03 0.45 0.37
2fur 1.9 1 0.41 0.51 0.48 0.03 0.1 0.04 0.24 0.19
2gc9 1.7 1 0.44 0.64 0.6 0.04 0.78 0.59 0.89 0.89
2nlv 1.33 0.53 0.43 0.68 0.64 0.04 0.56 0.68 0.94 0.89
2nuj 2 1 0.45 0.89 0.88 0.02 0.98 0.96 0.88 0.87
2nwv 1.85 1 0.3 0.66 0.42 0.24 0.52 0.02 0.88 0.11
2o08 2.5 1 0.4 0.72 0.49 0.23 0.79 0.23 0.67 0.1
2o1q 2 0.89 0.46 0.51 0.5 0 0.03 0.07 0.39 0.31
2o2x 1.5 1 0.55 0.71 0.67 0.04 0.87 0.89 0.92 0.92
2o2z 2.6 1 0.46 0.81 0.78 0.03 0.97 0.96 0.88 0.91
2o3l 2.05 0.92 0.48 0.84 0.74 0.1 0.87 0.95 0.87 0.85
2o62 1.75 1 0.41 0.76 0.57 0.2 0.88 0.31 0.92 0.91
2o7t 2.1 1 0.35 0.3 0.3 0 0.06 0.05 0.02 0.02
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PDB ID R (Å) S MPh MσA MSAD-DM ∆M BSAD-DM BσA ASAD-DM AσA
2obp 1.7 1 0.52 0.89 0.89 0 0.98 0.98 0.94 0.93
2oc5 1.68 1 0.56 0.92 0.92 0 1 1 0.97 0.94
2od5 1.98 1 0.33 0.86 0.68 0.18 0.97 0.88 0.85 0.81
2od6 1.9 0.95 0.46 0.72 0.61 0.12 0.9 0.39 0.91 0.83
2oh3 2 0.8 0.47 0.82 0.76 0.06 0.95 0.93 0.89 0.9
2okc 2.2 1 0.47 0.69 0.57 0.12 0.71 0.3 0.28 0.15
2okf 1.6 1 0.44 0.82 0.75 0.06 0.92 0.87 0.78 0.78
2ooj 1.84 0.92 0.42 0.72 0.56 0.16 0.7 0.25 0.93 0.71
2opk 2.1 1 0.4 0.82 0.6 0.22 0.96 0.26 0.93 0.65
2osd 2.3 0.57 0.19 0.14 0.14 0 0.04 0.03 0.01 0
2otm 1.9 0.83 0.41 0.85 0.67 0.18 0.97 0.81 0.95 0.94
2ozg 2.05 1 0.4 0.57 0.5 0.08 0.31 0.19 0.32 0.13
2ozj 1.6 0.67 0.44 0.7 0.67 0.03 0.32 0.26 0.78 0.77
2p4o 1.95 1 0.34 0.39 0.36 0.04 0.05 0.05 0.03 0.05
2p7h 1.85 1 0.37 0.81 0.57 0.24 0.95 0.26 0.79 0.81
2p7i 1.84 1 0.45 0.84 0.67 0.16 0.95 0.85 0.89 0.89
2p97 1.6 1 0.41 0.82 0.81 0.01 0.98 0.94 0.93 0.93
2pg3 2.4 0.75 0.44 0.75 0.62 0.13 0.83 0.49 0.69 0.25
2pg4 2.2 0.33 0.31 0.33 0.29 0.04 0.13 0.11 0.05 0.04
2pim 2.2 0.8 0.4 0.62 0.52 0.1 0.81 0.26 0.72 0.38
2pn1 2 1 0.39 0.41 0.39 0.02 0.02 0.01 0.06 0.04
2pr7 1.55 1 0.39 0.7 0.6 0.1 0.96 0.88 0.95 0.89
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PDB ID R (Å) S MPh MσA MSAD-DM ∆M BSAD-DM BσA ASAD-DM AσA
2prv 1.3 1 0.31 0.4 0.38 0.01 0.04 0.02 0.75 0.63
2pv4 1.95 1 0.49 0.84 0.71 0.13 0.98 0.9 0.91 0.86
2pw4 1.45 1 0.48 0.83 0.79 0.04 0.93 0.95 0.96 0.95
1e42 2.2 0.5 0.06 0.02 0.02 0 0.02 0 0.01 0.01
1e6i 1.87 0.83 0.36 0.62 0.43 0.19 0.87 0.08 0.93 0.86
1hf8 2 0.5 0.31 0.65 0.39 0.26 0.79 0.09 0.65 0.09
2b78 1.94 1 0.27 0.41 0.31 0.1 0 0.01 0.09 0.05
2b79 2.35 1 0.32 0.58 0.45 0.13 0.26 0.09 0.06 0.04
2hba 2.28 0.75 0.36 0.48 0.39 0.09 0.39 0.07 0.07 0.22
2o0h 3.29 0.64 0.28 0 0 0.02 0.03 0.02 0.01 0
2rkk 2.99 1 0.44 0.64 0.55 0.09 0.82 0.46 0.19 0.09
3bpj 2.28 0.78 0.39 0.63 0.55 0.08 0.79 0.81 0.71 0.58
2ill 2.2 1 0.29 0.65 0.43 0.21 0.29 0.11 0.56 0.15
2g4h 2 1 0.52 0.88 0.89 0 0.98 0.98 0.94 0.93
1of3 2 0.75 0.37 0.89 0.84 0.06 0.94 0.87 0.95 0.95
1i4u 2.6 0.5 0.31 0.25 0.24 0.01 0.01 0.01 0.02 0.01
1dw9※ 2.4 0.97 0.58 0.86 0.79 0.08 0.92 0.92 0.95 0.97
2v0o 3.1 1 0.09 0.07 0.07 0 0.01 0.02 0 0
1fse† 2.73 0.83 0.34 0.48 0.35 0.13 0.27 0.11 0.02 0.02
1fse※ 2.73 1 0.41 0.71 0.5 0.21 0.93 0.58 0.67 0.34
gilu 1.5 1 0.43 0.91 0.9 0.01 0.97 0.97 0.95 0.95
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PDB ID R (Å) S MPh MσA MSAD-DM ∆M BSAD-DM BσA ASAD-DM AσA
2g4k 1.82 0.95 0.39 0.53 0.45 0.08 0.14 0.14 0.6 0.2
1h29※ 2.81 0.91 0.41 0.5 0.42 0.09 0.1 0.06 0.04 0.03
2g4m 1.8 1 0.56 0.91 0.91 0 0.92 0.86 0.9 0.88
1c8u† 2.5 1 0.44 0.78 0.62 0.16 0.91 0.52 0.91 0.83
1c8u※ 2.5 1 0.52 0.83 0.72 0.11 0.96 0.89 0.95 0.93
1lvy 1.87 1 0 0.01 0 0.02 0 0.01 0 0
1lz8 1.53 0.94 0.58 0.77 0.68 0.1 0.71 0.61 0.98 0.95
2g4q 1.84 0.8 0.5 0.7 0.58 0.12 0.73 0.43 0.98 0.95
1e3m※ 3 0.98 0.51 0.79 0.72 0.07 0.9 0.78 0.69 0.66
2g4s 2.2 0.75 0.24 0.59 0.36 0.23 0.49 0.15 0.67 0.12
2g4u on Cab 1.84 1 0.46 0.66 0.5 0.16 0.42 0.01 0.93 0.65
2g4u on Nab 2.15 1 0.49 0.71 0.55 0.16 0.85 0.25 0.96 0.54
2g4v 2.14 0.93 0.47 0.63 0.53 0.1 0.48 0.33 0.9 0.32
1ga1※ 1.8 1 0.3 0.61 0.61 0 0.9 0.94 0.92 0.91
1rgg & 2sarb 2.53 0.57 0.33 0.42 0.34 0.07 0.1 0.05 0.03 0.01
sav3 1.75 1 0.48 0.71 0.61 0.1 0.7 0.7 0.93 0.94
1djl 2.48 0.94 0.45 0.82 0.62 0.21 0.98 0.61 0.95 0.93
2g4z 1.98 0.54 0.46 0.8 0.62 0.18 0.93 0.65 0.96 0.94
2g51 1.84 0.29 0.1 0.06 0.09 0 0.03 0.01 0 0
2g55 1.82 0.83 0.52 0.75 0.6 0.15 0.79 0.52 0.97 0.96
1dpx 1.64 0.75 0.55 0.71 0.61 0.1 0.81 0.22 0.95 0.94
1ocy 2.74 1 0.37 0.5 0.45 0.06 0.19 0.15 0.3 0.28
100
Bibliography
Abrahams, J. P. (July 1997). “Bias reduction in phase refinement by modified
interference functions: introducing the gamma correction.” In: Acta Crys-
tallographica, Section D: Biological Crystallography 53.Pt 4, pp. 371–6. doi:
10.1107/S0907444996015272 (cit. on pp. 30, 52).
Abrahams, J. P. and A. G. W. Leslie (Jan. 1996). “Methods used in the struc-
ture determination of bovine mitochondrial F1 ATPase.” In: Acta Crystal-
lographica, Section D: Biological Crystallography 52.Pt 1, pp. 30–42. doi:
10.1107/S0907444995008754 (cit. on pp. 30, 38, 52).
Adams, P. D., P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols,
J. J. Headd, W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy,
N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson,
T. C. Terwilliger, and P. H. Zwart (Feb. 2010). “PHENIX: a comprehen-
sive Python-based system for macromolecular structure solution.” In: Acta
Crystallographica, Section D: Biological Crystallography 66.Pt 2, pp. 213–
21. doi: 10.1107/S0907444909052925 (cit. on pp. 24, 40).
Agback, P., H. Baumann, S. Knapp, R. Ladenstein, and T. Härd (July 1998).
“Architecture of nonspecific protein-DNA interactions in the Sso7d-DNA
complex.” In: Nature structural biology 5.7, pp. 579–84. doi: 10.1038/836
(cit. on p. 64).
Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman (Oct.
1990). “Basic local alignment search tool.” In: Journal of molecular biology
215.3, pp. 403–10. doi: 10.1016/S0022-2836(05)80360-2 (cit. on p. 71).
Barton, W. A., D. Tzvetkova-Robev, H. Erdjument-Bromage, P. Tempst, and
D. B. Nikolov (Aug. 2006). “Highly efficient selenomethionine labeling of
recombinant proteins produced in mammalian cells”. In: Protein science :
a publication of the Protein Society 15.8, pp. 2008–2013. doi: 10.1110/
ps.062244206 (cit. on pp. 19, 22).
Baumann, H., S. Knapp, T. Lundbäck, R. Ladenstein, and T. Härd (Nov.
1994). “Solution structure and DNA-binding properties of a thermostable
protein from the archaeon Sulfolobus solfataricus”. In: Nature structural
biology 1.11, pp. 808–819. doi: 10.1038/nsb1194-808 (cit. on p. 64).
Beinrohr, L., V. Harmat, J. Dobó, Z. Lörincz, P. Gál, and P. Závodszky (July
2007). “C1 inhibitor serpin domain structure reveals the likely mechanism
of heparin potentiation and conformational disease.” In: The Journal of
101
biological chemistry 282.29, pp. 21100–9. doi: 10.1074/jbc.M700841200
(cit. on pp. 7, 86, 87, 92).
Bell, S. D., C. H. Botting, B. N. Wardleworth, S. P. Jackson, and M. F. White
(Apr. 2002). “The interaction of Alba, a conserved archaeal chromatin pro-
tein, with Sir2 and its regulation by acetylation.” In: Science 296.5565,
pp. 148–51. doi: 10.1126/science.1070506 (cit. on p. 66).
Berrettini, M., B. Lämmle, T. White, M. J. Heeb, H. P. Schwarz, B. L. Zu-
raw, J. G. Curd, and J. H. Griffin (Aug. 1986). “Detection of in vitro and
in vivo cleavage of high molecular weight kininogen in human plasma by
immunoblotting with monoclonal antibodies.” In: Blood 68.2, pp. 455–62
(cit. on p. 85).
Betzel, C., Z. Dauter, M. Dauter, M. Ingelman, G. Papendorf, K. S. Wil-
son, and S. Branner (Dec. 1988). “Crystallization and preliminary X-ray
diffraction studies of an alkaline protease from Bacillus lentus.” In: Journal
of molecular biology 204.3, pp. 803–4 (cit. on p. 95).
Blow, D. M. and F. H. C. Crick (Oct. 1959). “The treatment of errors in
the isomorphous replacement method”. In: Acta crystallographica 12.10,
pp. 794–802. doi: 10.1107/S0365110X59002274 (cit. on pp. 20, 21, 26).
Bock, S. C., K. Skriver, E. Nielsen, H. C. Thøgersen, B. Wiman, V. H. Donald-
son, R. L. Eddy, J. Marrinan, E. Radziejewska, and R. Huber (July 1986).
“Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal
localization.” In: Biochemistry 25.15, pp. 4292–301 (cit. on pp. 85, 86, 90).
Boraston, A. B., T. J. Revett, C. M. Boraston, D. Nurizzo, and G. J. Davies
(June 2003). “Structural and thermodynamic dissection of specific mannan
recognition by a carbohydrate binding module, TmCBM27.” In: Structure
(London, England : 1993) 11.6, pp. 665–75 (cit. on p. 95).
Bos, I. G. A., C. E. Hack, and J. P. Abrahams (Nov. 2002). “Structural and
Functional Aspects of C1-Inhibitor”. In: Immunobiology 205.4-5, pp. 518–
533. doi: 10.1078/0171-2985-00151 (cit. on p. 87).
Bos, I. G. A., Y. T. P. Lubbers, D. Roem, J. P. Abrahams, C. E. Hack, and
E. Eldering (Aug. 2003). “The functional integrity of the serpin domain
of C1-inhibitor depends on the unique N-terminal domain, as revealed by
a pathological mutant.” In: The Journal of biological chemistry 278.32,
pp. 29463–70. doi: 10.1074/jbc.M302977200 (cit. on p. 85).
Bourenkov, G. P. and A. N. Popov (Jan. 2006). “A quantitative ap-
proach to data-collection strategies.” en. In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 62.Pt 1, pp. 58–64. doi: 10 . 1107 /
S0907444905033998 (cit. on p. 18).
Bowen, B., J. J. Hawk, S. Sibunka, S. Hovick, and J. M. Weiler (Feb. 2001).
“A review of the reported defects in the human C1 esterase inhibitor gene
producing hereditary angioedema including four new mutations.” In: Clin-
ical immunology (Orlando, Fla.) 98.2, pp. 157–63. doi: 10.1006/clim.
2000.4947 (cit. on p. 85).
Bragg, W. L. (1913). “The Diffraction of Short Electromagnetic Waves by
a Crystal”. In: Proceedings Of The Cambridge Philosophical Society 17,
pp. 43–57 (cit. on p. 8).
102
Bricogne, G., C. Vonrhein, C. Flensburg, M. Schiltz, and W. Paciorek (Oct.
2003). “Generation, representation and flow of phase information in struc-
ture determination: recent developments in and around SHARP 2.0”.
In: Acta Crystallographica, Section D: Biological Crystallography 59.11,
pp. 2023–2030. doi: 10.1107/S0907444903017694 (cit. on pp. 26, 41).
Brünger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W.
Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J.
Read, L. M. Rice, T. Simonson, and G. L. Warren (Sept. 1998). “Crys-
tallography & NMR System: A New Software Suite for Macromolecular
Structure Determination”. In: Acta Crystallographica, Section D: Biologi-
cal Crystallography 54.5, pp. 905–921. doi: 10.1107/S0907444998003254
(cit. on p. 52).
Buchan, D. W. A. and S. M. Ward (July 2010). “Protein annotation and mod-
elling servers at University College London”. In: Nucleic acids research
38.Web Server issue, W563–8. doi: 10.1093/nar/gkq427 (cit. on p. 71).
Burla, M. C., R. Caliandro, M. Camalli, B. Carrozzini, G. L. Cascarano, C.
Giacovazzo, M. Mallamo, A. Mazzone, G. Polidori, and R. Spagna (Feb.
2012). “SIR2011 : a new package for crystal structure determination and
refinement”. In: Journal of applied crystallography 45.2, pp. 357–361. doi:
10.1107/S0021889812001124 (cit. on p. 26).
Burla, M. C., B. Carrozzini, G. L. Cascarano, C. Giacovazzo, G. Polidori, and
D. Siliqi (June 2002). “MAD phasing: probabilistic estimate of [F (oa)].”
In: Acta Crystallographica, Section D: Biological Crystallography 58.Pt 6
Pt 2, pp. 928–35 (cit. on p. 40).
Cai, S. and A. E. Davis (Nov. 2003). “Complement regulatory protein C1 in-
hibitor binds to selectins and interferes with endothelial-leukocyte adhe-
sion.” In: Journal of immunology (Baltimore, Md. : 1950) 171.9, pp. 4786–
91 (cit. on p. 84).
Cai, S., V. S. Dole, W. Bergmeier, J. Scafidi, H. Feng, D. D. Wagner, and
A. E. Davis (May 2005). “A direct role for C1 inhibitor in regulation of
leukocyte adhesion.” In: Journal of immunology (Baltimore, Md. : 1950)
174.10, pp. 6462–6 (cit. on p. 84).
Calderone, V. (Dec. 2004). “Practical aspects of the integration of different
software in protein structure solution.” In: Acta Crystallographica, Section
D: Biological Crystallography 60.Pt 12 Pt 1, pp. 2150–5. doi: 10.1107/
S0907444904019055 (cit. on p. 95).
Caldwell, E. E., A. M. Andreasen, M. A. Blietz, J. N. Serrahn, V. VanderNoot,
Y. Park, G. Yu, R. J. Linhardt, and J. M. Weiler (Jan. 1999). “Heparin
binding and augmentation of C1 inhibitor activity.” In: Archives of bio-
chemistry and biophysics 361.2, pp. 215–22. doi: 10.1006/abbi.1998.
0996 (cit. on p. 87).
Carrell, H. L., J. P. Glusker, V. Burger, F. Manfre, D. Tritsch, and J. F.
Biellmann (June 1989). “X-ray analysis of D-xylose isomerase at 1.9 A:
native enzyme in complex with substrate and with a mechanism-designed
inactivator.” In: Proceedings of the National Academy of Sciences of the
United States of America 86.12, pp. 4440–4 (cit. on p. 95).
103
Caughman, G. B., R. J. Boackle, and J. Vesely (Feb. 1982). “A postulated
mechanism for heparin’s potentiation of C1 inhibitor function.” In: Molec-
ular immunology 19.2, pp. 287–95 (cit. on p. 87).
Champoux, J. J. (Jan. 2001). “DNA topoisomerases: structure, function, and
mechanism.” en. In: Annual review of biochemistry 70, pp. 369–413. doi:
10.1146/annurev.biochem.70.1.369 (cit. on p. 4).
Chan, J. Y., C. E. Burrowes, F. M. Habal, and H. Z. Movat (Jan. 1977).
“The inhibition of activated factor XII (Hageman factor) by antithrombin
III: the effect of other plasma proteinase inhibitors.” In: Biochemical and
biophysical research communications 74.1, pp. 150–8 (cit. on p. 84).
Chen, C. C. H., H. Zhang, A. D. Kim, A. Howard, G. M. Sheldrick, D. Mariano-
Dunaway, and O. Herzberg (Nov. 2002). “Degradation pathway of the phos-
phonate ciliatine: crystal structure of 2-aminoethylphosphonate transami-
nase.” In: Biochemistry 41.44, pp. 13162–9 (cit. on p. 95).
Chen, L., r. Chen, X. E. Zhou, Y. Wang, M. A. Kahsai, A. T. Clark, S. P.
Edmondson, Z.-j. Liu, J. P. Rose, c. Wang, E. J. Meehan, and J. W. Shriver
(July 2004). “The hyperthermophile protein Sso10a is a dimer of winged
helix DNA-binding domains linked by an antiparallel coiled coil rod.” In:
Journal of molecular biology 341.1, pp. 73–91. doi: 10.1016/j.jmb.2004.
05.044 (cit. on pp. 67, 77, 78).
Choli, T., P. Henning, B. Wittmann-Liebold, and R. Reinhardt (July 1988).
“Isolation, characterization and microsequence analysis of a small basic
methylated DNA-binding protein from the Archaebacterium, Sulfolobus
solfataricus.” In: Biochimica et biophysica acta 950.2, pp. 193–203 (cit. on
p. 64).
Chou, C.-C., T.-W. Lin, C.-Y. Chen, and A. H.-J. Wang (July 2003). “Crys-
tal Structure of the Hyperthermophilic Archaeal DNA-Binding Protein
Sso10b2 at a Resolution of 1.85 Angstroms”. In: Journal of bacteriology
185.14, pp. 4066–4073. doi: 10.1128/JB.185.14.4066-4073.2003 (cit.
on p. 66).
Collaborative Computational Project Number 4 (Sept. 1994). “The CCP4 suite:
programs for protein crystallography.” In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 50.Pt 5, pp. 760–3. doi: 10 . 1107 /
S0907444994003112 (cit. on pp. 26, 41).
Cooper, N. R. (Jan. 1985). “The classical complement pathway: activation and
regulation of the first complement component.” In: Advances in immunol-
ogy 37, pp. 151–216 (cit. on p. 84).
Cowtan, K. D. (1994). “’dm’: An Automated Procedure for Phase Improvement
by Density Modification”. In: Joint CCP4 AND ESF-EACBM Newslet-
ter on Protein Crystallography Number 31 32. Ed. by S. ( L. Bailey and
K. ( c. D. Wilson, pp. 34–38 (cit. on pp. 38, 52).
— (Sept. 1999). “Error estimation and bias correction in phase-improvement
calculations”. In: Acta Crystallographica, Section D: Biological Crystallog-
raphy 55.9, pp. 1555–1567. doi: 10 . 1107 / S0907444999007416 (cit. on
p. 30).
104
— (Dec. 2000). “General quadratic functions in real and reciprocal space and
their application to likelihood phasing.” In: Acta Crystallographica, Section
D: Biological Crystallography 56.Pt 12, pp. 1612–21 (cit. on pp. 30, 38).
— (Sept. 2006). “The Buccaneer software for automated model building. 1.
Tracing protein chains.” In: Acta Crystallographica, Section D: Biological
Crystallography 62.Pt 9, pp. 1002–11. doi: 10.1107/S0907444906022116
(cit. on pp. 32, 33, 38, 55, 58, 70).
— (Apr. 2010). “Recent developments in classical density modification.” In:
Acta Crystallographica, Section D: Biological Crystallography 66.Pt 4,
pp. 470–8. doi: 10.1107/S090744490903947X (cit. on pp. 29, 30, 38, 70).
Cowtan, K. D. and P. Main (Jan. 1996). “Phase combination and cross vali-
dation in iterated density-modification calculations.” In: Acta Crystallo-
graphica, Section D: Biological Crystallography 52.Pt 1, pp. 43–8. doi:
10.1107/S090744499500761X (cit. on p. 30).
Crick, F. H. C. (Sept. 1953). “The packing of α-helices: simple coiled-
coils”. en. In: Acta crystallographica 6.8, pp. 689–697. doi: 10 . 1107 /
S0365110X53001964 (cit. on p. 77).
Crick, F. H. C. and B. S. Magdoff (Nov. 1956). “The theory of the method
of isomorphous replacement for protein crystals. I”. en. In: Acta crystal-
lographica 9.11, pp. 901–908. doi: 10.1107/S0365110X56002552 (cit. on
pp. 15, 16).
Crowther, R. A. (1972). “The Molecular Replacement Method”. In: New York:
Gordon and Breach. Ed. by M. G. Rossmann, pp. 173–178 (cit. on p. 14).
Curd, J. G., M. Yelvington, N. Burridge, N. P. Stimler, C. Gerard, L. J. Pro-
grais, C. G. Cochrane, and H. J. Müller-Eberhard (1982). “Generation of
bradykinin during incubation of hereditary angioedema plasma”. In:Molec-
ular immunology 19.11, p. 1365 (cit. on p. 85).
Da Silva, W. D. (May 1967). “Complement as a mediator of inflammation: II.
Biological properties of anaphylatoxin prepared with purified components
of human complement”. In: The Journal of experimental medicine 125.5,
pp. 921–946. doi: 10.1084/jem.125.5.921 (cit. on p. 85).
Dauter, Z. (Apr. 2010). “Carrying out an optimal experiment.” en. In: Acta
Crystallographica, Section D: Biological Crystallography 66.Pt 4, pp. 389–
92. doi: 10.1107/S0907444909038578 (cit. on p. 18).
Dauter, Z., M. Dauter, E. de La Fortelle, G. Bricogne, and G. M. Sheldrick
(May 1999). “Can anomalous signal of sulfur become a tool for solving
protein crystal structures?” In: Journal of molecular biology 289.1, pp. 83–
92. doi: 10.1006/jmbi.1999.2743 (cit. on p. 95).
Dauter, Z., M. Dauter, and E. J. Dodson (Feb. 2002). “Jolly SAD”. In: Acta
Crystallographica, Section D: Biological Crystallography 58.3, pp. 494–506.
doi: 10.1107/S090744490200118X (cit. on p. 95).
Dauter, Z., M. Li, and A. Wlodawer (Mar. 2001). “Practical experience with
the use of halides for phasing macromolecular structures: a powerful tool
for structural genomics.” In: Acta Crystallographica, Section D: Biological
Crystallography 57.Pt 2, pp. 239–49 (cit. on p. 95).
105
Dauter, Z., K. S. Wilson, L. C. Sieker, J. Meyer, and J. M. Moulis (Dec. 1997).
“Atomic resolution (0.94 A) structure of Clostridium acidurici ferredoxin.
Detailed geometry of [4Fe-4S] clusters in a protein.” In: Biochemistry 36.51,
pp. 16065–73. doi: 10.1021/bi972155y (cit. on p. 95).
Davis, A. E., F. Lu, and P. Mejia (Nov. 2010). “C1 inhibitor, a multi-functional
serine protease inhibitor.” In: Thrombosis and haemostasis 104.5, pp. 886–
93. doi: 10.1160/TH10-01-0073 (cit. on pp. 84, 85).
Debaerdemaeker, T. and M. M. Woolfson (Mar. 1983). “On the application of
phase relationships to complex structures. XXII. Techniques for random
phase refinement”. In: Acta Crystallographica, Section A: Foundations of
Crystallography 39.2, pp. 193–196. doi: 10.1107/S0108767383000434 (cit.
on p. 25).
De Graaff, R. A. G., M. Hilge, J. L. van der Plas, and J. P. Abrahams
(Nov. 2001). “Matrix methods for solving protein substructures of chlo-
rine and sulfur from anomalous data”. In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 57.12, pp. 1857–1862. doi: 10.1107/
S0907444901016535 (cit. on pp. 26, 38, 55, 70).
Devedjiev, Y., Z. Dauter, S. R. Kuznetsov, T. L. Jones, and Z. S. Derewenda
(Nov. 2000). “Crystal structure of the human acyl protein thioesterase I
from a single X-ray data set to 1.5 A.” In: Structure (London, England :
1993) 8.11, pp. 1137–46 (cit. on p. 95).
Diederichs, K. and P. A. Karplus (Apr. 1997). “Improved R-factors for diffrac-
tion data analysis in macromolecular crystallography”. In: Nature struc-
tural biology 4.4, pp. 269–275. doi: 10.1038/nsb0497-269 (cit. on p. 74).
Dijk, J. and R. Reinhardt (1986). Bacterial chromatin. Ed. by C. O. Gualerzi
and C. L. Pon. Proceedings in life sciences. Berlin: Springer-Verlag, pp. 185–
218 (cit. on pp. 64, 65).
Dill, K. A. (Aug. 1990). “Dominant forces in protein folding”. In: Biochemistry
29.31, pp. 7133–7155. doi: 10.1021/bi00483a001 (cit. on p. 6).
Donaldson, V. H. and R. R. Evans (July 1963). A biochemical abnormality in
hereditary angioneurotic edema: Absence of serum inhibitor of C’1-esterase
(cit. on p. 84).
Donaldson, V. H., O. D. Ratnoff, W. Dias Da Silva, and F. S. Rosen
(1969). “Permeability-increasing activity in hereditary angioneurotic edema
plasma. II. Mechanism of formation and partial characterization.” In: The
Journal of clinical investigation 48.4, pp. 642–653 (cit. on p. 85).
Donaldson, V. H., F. S. Rosen, and D. H. Bing (Jan. 1977). “Role of the
second component of complement (C2) and plasmin in kinin release in
hereditary angioneurotic edema (H.A.N.E.) plasma.” In: Transactions of
the Association of American Physicians 90, pp. 174–83 (cit. on p. 85).
Doutch, J., M. A. Hough, S. S. Hasnain, and R. W. Strange (Jan. 2012). “Chal-
lenges of sulfur SAD phasing as a routine method in macromolecular crys-
tallography.” In: Journal of synchrotron radiation 19.Pt 1, pp. 19–29. doi:
10.1107/S0909049511049004 (cit. on pp. 18, 19).
106
Driessen, R. P. C. and R. T. Dame (Jan. 2011). “Nucleoid-associated proteins in
Crenarchaea.” In: Biochemical Society transactions 39.1, pp. 116–21. doi:
10.1042/BST0390116 (cit. on p. 64).
— (Feb. 2013). “Structure and dynamics of the crenarchaeal nucleoid.”
In: Biochemical Society transactions 41.1, pp. 321–5. doi: 10 . 1042 /
BST20120336 (cit. on p. 64).
Driessen, R. P. C., H. Meng, G. Suresh, R. Shahapure, G. Lanzani, U. D.
Priyakumar, M. F. White, H. Schiessel, J. van Noort, and R. T. Dame
(Jan. 2013). “Crenarchaeal chromatin proteins Cren7 and Sul7 compact
DNA by inducing rigid bends.” In: Nucleic acids research 41.1, pp. 196–
205. doi: 10.1093/nar/gks1053 (cit. on p. 65).
Duboule, D., F. Grosveld, E. Soutoglou, and T. Misteli (2007). “Mobility and
immobility of chromatin in transcription and genome stability”. In: Current
Opinion in Genetics & Development 17.5, pp. 435–442 (cit. on p. 5).
Ducros, V. M., R. J. Lewis, C. S. Verma, E. J. Dodson, G. Leonard, J. P.
Turkenburg, G. N. Murshudov, A. J. Wilkinson, and J. A. Brannigan (Mar.
2001). “Crystal structure of GerE, the ultimate transcriptional regulator
of spore formation in Bacillus subtilis.” In: Journal of molecular biology
306.4, pp. 759–71. doi: 10.1006/jmbi.2001.4443 (cit. on pp. 47, 95).
Edmondson, S. P. and J. W. Shriver (2001). “DNA-binding proteins Sac7d
and Sso7d from Sulfolobus”. In: Hyperthermophilic Enzymes, Part C. Ed.
by R. M. K. Michael W. W. Adams. Vol. 334. Methods in Enzymology.
Academic Press, pp. 129–145. doi: http://dx.doi.org/10.1016/S0076-
6879(01)34463-4 (cit. on p. 64).
Emsley, P., B. Lohkamp, W. G. Scott, and K. D. Cowtan (Apr. 2010). “Features
and development of Coot.” In: Acta Crystallographica, Section D: Biological
Crystallography 66.Pt 4, pp. 486–501. doi: 10.1107/S0907444910007493
(cit. on pp. 49, 70).
Eriksson, a. E., W. a. Baase, X. J. Zhang, D. W. Heinz, M. Blaber, E. P.
Baldwin, and B. W. Matthews (Jan. 1992). “Response of a protein structure
to cavity-creating mutations and its relation to the hydrophobic effect.” In:
Science 255.5041, pp. 178–83 (cit. on p. 6).
Evans, P. R. (Jan. 2006). “Scaling and assessment of data quality.” In: Acta
Crystallographica, Section D: Biological Crystallography 62.Pt 1, pp. 72–
82. doi: 10.1107/S0907444905036693 (cit. on pp. 74, 75).
— (Apr. 2011). “An introduction to data reduction: space-group determi-
nation, scaling and intensity statistics.” In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 67.Pt 4, pp. 282–92. doi: 10 . 1107 /
S090744491003982X (cit. on p. 70).
Fan, H.-F., Q. Hao, Y.-X. Gu, J.-Z. Qian, C.-D. Zheng, and H.-M. Ke
(Nov. 1990). “Combining direct methods with isomorphous replacement
or anomalous scattering data. VII. Ab initio phasing of one-wavelength
anomalous scattering data from a small protein”. en. In: Acta Crystallo-
graphica, Section A: Foundations of Crystallography 46.11, pp. 935–939.
doi: 10.1107/S0108767390008030 (cit. on p. 20).
107
Feng, Y., H. Yao, and J. Wang (June 2010). “Crystal structure of the cre-
narchaeal conserved chromatin protein Cren7 and double-stranded DNA
complex.” In: Protein science : a publication of the Protein Society 19.6,
pp. 1253–7. doi: 10.1002/pro.385 (cit. on pp. 65, 66).
Fields, T., B. Ghebrehiwet, and A. P. Kaplan (July 1983). “Kinin formation in
hereditary angioedema plasma: evidence against kinin derivation from C2
and in support of "spontaneous" formation of bradykinin.” In: The Journal
of allergy and clinical immunology 72.1, pp. 54–60 (cit. on p. 85).
Ford, M. G., B. M. Pearse, M. K. Higgins, Y. Vallis, D. J. Owen, A. Gibson,
C. R. Hopkins, P. R. Evans, and H. T. McMahon (Feb. 2001). “Simulta-
neous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation
of clathrin lattices on membranes.” In: Science 291.5506, pp. 1051–5. doi:
10.1126/science.291.5506.1051 (cit. on p. 95).
Forterre, P., F. Confalonieri, and S. Knapp (May 1999). “Identification of the
gene encoding archeal-specific DNA-binding proteins of the Sac10b family.”
In: Molecular microbiology 32.3, pp. 669–70 (cit. on p. 65).
Franklin, R. E. and R. G. Gosling (Apr. 1953). “Molecular Configuration in
Sodium Thymonucleate”. In: Nature 171.4356, pp. 740–741. doi: 10.1038/
171740a0 (cit. on p. 3).
Gajiwala, K. S. and S. K. Burley (Feb. 2000). “Winged helix proteins.” In:
Current opinion in structural biology 10.1, pp. 110–6 (cit. on p. 67).
Gao, Y. G., S. Y. Su, H. Robinson, S. Padmanabhan, L. Lim, B. S. McCrary,
S. P. Edmondson, J. W. Shriver, and A. H.-J. Wang (Sept. 1998). “The crys-
tal structure of the hyperthermophile chromosomal protein Sso7d bound
to DNA.” In: Nature structural biology 5.9, pp. 782–6. doi: 10.1038/1822
(cit. on p. 65).
Giacovazzo, C. (Oct. 2008). “Direct methods”. In: International Tables
for Crystallography Volume B: Reciprocal space. Ed. by U. Shmueli.
3rd ed. Vol. B. International Tables for Crystallography. Dordrecht,
The Netherlands: Springer. Chap. 2.2, pp. 215–235. doi: 10 . 1107 /
97809553602060000102 (cit. on p. 12).
Giorgetti, A., D. Raimondo, A. E. Miele, and A. Tramontano (Sept. 2005).
“Evaluating the usefulness of protein structure models for molecular re-
placement.” In: Bioinformatics (Oxford, England) 21 Suppl 2, pp. ii72–6.
doi: 10.1093/bioinformatics/bti1112 (cit. on p. 13).
Gordon, E. J., G. A. Leonard, S. McSweeney, and P. F. Zagalsky (Sept. 2001).
“The C1 subunit of alpha-crustacyanin: the de novo phasing of the crystal
structure of a 40 kDa homodimeric protein using the anomalous scattering
from S atoms combined with direct methods.” In: Acta Crystallographica,
Section D: Biological Crystallography 57.Pt 9, pp. 1230–7 (cit. on p. 95).
Grosse-Kunstleve, R. W. and P. D. Adams (Oct. 2003). “Substructure search
procedures for macromolecular structures”. In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 59.11, pp. 1966–1973. doi: 10.1107/
S0907444903018043 (cit. on p. 26).
108
Groth, A., W. Rocha, A. Verreault, and G. Almouzni (2007). “Chromatin Chal-
lenges during DNA Replication and Repair”. In: Cell 128.4, pp. 721–733
(cit. on p. 5).
Guo, L., Y. Feng, Z. Zhang, H. Yao, Y. Luo, J. Wang, and L. Huang (Mar.
2008). “Biochemical and structural characterization of Cren7, a novel chro-
matin protein conserved among Crenarchaea.” In: Nucleic acids research
36.4, pp. 1129–37. doi: 10.1093/nar/gkm1128 (cit. on pp. 65, 66).
Hauptmann, H. A. (May 1982). “On integrating the techniques of direct meth-
ods and isomorphous replacement. I. The theoretical basis”. en. In: Acta
Crystallographica, Section A: Foundations of Crystallography 38.3, pp. 289–
294. doi: 10.1107/S0567739482000631 (cit. on p. 20).
— (May 1996). “The SAS Maximal Principle: a New Approach to the Phase
Problem”. en. In: Acta Crystallographica, Section A: Foundations of Crys-
tallography 52.3, pp. 490–496. doi: 10.1107/S0108767396001237 (cit. on
p. 20).
Hauptmann, H. A. and J. Karle (1953). Solution of the Phase Problem: 1. The
Centrosymmetric Crystal. Acta monograph v. 1. Pittsburgh, PA: American
Crystallographic Association (cit. on p. 25).
Hendrickson, W. A. and E. E. Lattman (Feb. 1970). “Representation of
phase probability distributions for simplified combination of independent
phase information”. In: Acta Crystallographica, Section B: Structural Crys-
tallography and Crystal Chemistry 26.2, pp. 136–143. doi: 10 . 1107 /
S0567740870002078 (cit. on pp. 29, 42, 43, 52).
Hendrickson, W. A. and C. M. Ogata (1997). “Phase determination from
multiwavelength anomalous diffraction measurements”. In:Macromolecular
Crystallography Part A. Ed. by J. Charles W. Carter. Vol. 276. Methods
in Enzymology. Academic Press. Chap. 28, pp. 494–523. doi: 10.1016/
S0076-6879(97)76074-9 (cit. on p. 19).
Hendrickson, W. A. and M. M. Teeter (Mar. 1981). “Structure of the hydropho-
bic protein crambin determined directly from the anomalous scattering of
sulphur”. In: Nature 290.5802, pp. 107–113. doi: 10.1038/290107a0 (cit.
on pp. 18, 20).
Henne, W. M., H. M. Kent, M. G. J. Ford, B. G. Hegde, O. Daumke, P. J. G.
Butler, R. Mittal, R. Langen, P. R. Evans, and H. T. McMahon (July
2007). “Structure and analysis of FCHo2 F-BAR domain: a dimerizing
and membrane recruitment module that effects membrane curvature.” In:
Structure (London, England : 1993) 15.7, pp. 839–52. doi: 10.1016/j.
str.2007.05.002 (cit. on p. 95).
Hsu, C.-H. and A. H.-J. Wang (Aug. 2011). “The DNA-recognition fold of
Sso7c4 suggests a new member of SpoVT-AbrB superfamily from archaea.”
In: Nucleic acids research 39.15, pp. 6764–74. doi: 10.1093/nar/gkr283
(cit. on pp. 64, 65).
Huntington, J. A., R. J. Read, and R. W. Carrell (2000). “Structure of a serpin-
protease complex shows inhibition by deformation.” In: Nature 407.6806,
pp. 923–6. doi: 10.1038/35038119 (cit. on p. 86).
109
Ingram, V. M. (June 1958). “Abnormal human haemoglobins. I. The com-
parison of normal human and sickle-cell haemoglobins by fingerprinting.”
In: Biochimica et biophysica acta 28.3, pp. 539–45. doi: 10.1016/0006-
3002(58)90516-X (cit. on p. 6).
Kabsch, W. (Feb. 2010). “XDS.” In: Acta Crystallographica, Section D: Biologi-
cal Crystallography 66.Pt 2, pp. 125–32. doi: 10.1107/S0907444909047337
(cit. on p. 70).
Kahsai, M. A., B. Vogler, A. T. Clark, S. P. Edmondson, and J. W. Shriver
(Mar. 2005). “Solution structure, stability, and flexibility of Sso10a: a hy-
perthermophile coiled-coil DNA-binding protein.” In: Biochemistry 44.8,
pp. 2822–32. doi: 10.1021/bi047669t (cit. on p. 67).
Karle, J. and H. A. Hauptmann (Aug. 1956). “A theory of phase determination
for the four types of non-centrosymmetric space groups 1 P 222, 2 P 22, 3
P 1 2, 3 P 2 2”. In: Acta crystallographica 9.8, pp. 635–651. doi: 10.1107/
S0365110X56001741 (cit. on p. 26).
Kendrew, J. C., G. Bodo, H. M. Dintzis, R. G. Parrish, H. Wyckoff, and
D. C. Phillips (Mar. 1958). “A Three-Dimensional Model of the Myoglobin
Molecule Obtained by X-Ray Analysis”. In: Nature 181.4610, pp. 662–666.
doi: 10.1038/181662a0 (cit. on pp. 3, 14).
Klemperer, M. R., V. H. Donaldson, and F. S. Rosen (1968). “Effect of C’1 es-
terase on vascular permeability in man: studies in normal and complement-
deficient individuals and in patients with hereditary angioneurotic edema”.
In: The Journal of clinical investigation 47.3, pp. 604–611 (cit. on p. 85).
Knapp, S., A. Karshikoff, K. D. Berndt, P. Christova, B. Atanasov, and R.
Ladenstein (Dec. 1996). “Thermal unfolding of the DNA-binding protein
Sso7d from the hyperthermophile Sulfolobus solfataricus.” In: Journal of
molecular biology 264.5, pp. 1132–44. doi: 10.1006/jmbi.1996.0701 (cit.
on p. 64).
Krissinel, E. and K. Henrick (Sept. 2007). “Inference of macromolecular as-
semblies from crystalline state.” In: Journal of molecular biology 372.3,
pp. 774–97. doi: 10.1016/j.jmb.2007.05.022 (cit. on p. 71).
Lamers, M. H., A. Perrakis, J. H. Enzlin, H. H. Winterwerp, N. de Wind, and
T. K. Sixma (Oct. 2000). “The crystal structure of DNA mismatch repair
protein MutS binding to a G x T mismatch.” In: Nature 407.6805, pp. 711–
7. doi: 10.1038/35037523 (cit. on p. 95).
Lämmle, B., B. L. Zuraw, M. J. Heeb, H. P. Schwarz, M. Berrettini, J. G. Curd,
and J. H. Griffin (Apr. 1988). “Detection and quantitation of cleaved and
uncleaved high molecular weight kininogen in plasma by ligand blotting
with radiolabeled plasma prekallikrein or factor XI.” In: Thrombosis and
haemostasis 59.2, pp. 151–61 (cit. on p. 85).
Lander, E. S. et al. (Feb. 2001). “Initial sequencing and analysis of the human
genome.” In: Nature 409.6822, pp. 860–921. doi: 10.1038/35057062 (cit.
on p. 4).
Langer, G., S. X. Cohen, V. S. Lamzin, and A. Perrakis (Jan. 2008). “Au-
tomated macromolecular model building for X-ray crystallography using
110
ARP/wARP version 7.” In: Nature protocols 3.7, pp. 1171–9. doi: 10 .
1038/nprot.2008.91 (cit. on pp. 32, 38, 55).
Larkin, M. A., G. Blackshields, N. P. Brown, R. Chenna, P. A. McGettigan, H.
McWilliam, F. Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thomp-
son, T. J. Gibson, and D. G. Higgins (Nov. 2007). “Clustal W and Clustal
X version 2.0.” In: Bioinformatics (Oxford, England) 23.21, pp. 2947–8.
doi: 10.1093/bioinformatics/btm404 (cit. on p. 71).
Laurens, N., R. P. C. Driessen, I. Heller, D. Vorselen, M. C. Noom, F. J. H. Hol,
M. F. White, R. T. Dame, and G. J. L. Wuite (Jan. 2012). “Alba shapes
the archaeal genome using a delicate balance of bridging and stiffening the
DNA.” In: Nature communications 3, p. 1328. doi: 10.1038/ncomms2330
(cit. on p. 66).
Leslie, A. G. W. (Jan. 1987). “A reciprocal-space method for calculating a
molecular envelope using the algorithm of B.C. Wang”. In: Acta Crystal-
lographica, Section A: Foundations of Crystallography 43.1, pp. 134–136.
doi: 10.1107/S0108767387099720 (cit. on pp. 27, 52).
Li, G., M. Levitus, C. Bustamante, and J. Widom (Jan. 2005). “Rapid sponta-
neous accessibility of nucleosomal DNA.” In: Nature structural & molecular
biology 12.1, pp. 46–53. doi: 10.1038/nsmb869 (cit. on p. 5).
Li, J., U. Derewenda, Z. Dauter, S. Smith, and Z. S. Derewenda (July 2000).
“Crystal structure of the Escherichia coli thioesterase II, a homolog of the
human Nef binding enzyme.” In: Nature structural biology 7.7, pp. 555–9.
doi: 10.1038/76776 (cit. on p. 95).
Liu, D., S. Cai, X. Gu, J. Scafidi, X. Wu, and A. E. Davis (Sept. 2003).
“C1 inhibitor prevents endotoxin shock via a direct interaction with
lipopolysaccharide.” In: Journal of immunology (Baltimore, Md. : 1950)
171.5, pp. 2594–601 (cit. on p. 84).
Liu, D., X. Gu, J. Scafidi, and A. E. Davis (Apr. 2004). “N-linked glycosylation
is required for c1 inhibitor-mediated protection from endotoxin shock in
mice.” In: Infection and immunity 72.4, pp. 1946–55 (cit. on p. 84).
Liu, Z., F. Galli, W.-J. Waterreus, E. M. Meulenbroek, R. I. Koning, G. E. M.
Lamers, R. C. L. Olsthoorn, N. S. Pannu, T. H. Oosterkamp, A. J. Koster,
R. T. Dame, and J. P. Abrahams (Apr. 2012). “Single-walled carbon nan-
otubes as scaffolds to concentrate DNA for the study of DNA-protein in-
teractions.” In: Chemphyschem : a European journal of chemical physics
and physical chemistry 13.6, pp. 1569–75. doi: 10.1002/cphc.201100896.
Lodish, H. F., A. Berk, S. L. Zipursky, P. Matsudaira, D. Baltimore, and J.
Darnell (2000). Molecular Cell Biology. 4th ed. New York: W. H. Freeman
and Company (cit. on p. 4).
Luijsterburg, M. S., M. F. White, R. van Driel, and R. T. Dame (2008). “The
major architects of chromatin: architectural proteins in bacteria, archaea
and eukaryotes.” In: Critical reviews in biochemistry and molecular biology
43.6, pp. 393–418. doi: 10.1080/10409230802528488 (cit. on pp. 5, 64).
Lundbäck, T., H. Hansson, S. Knapp, R. Ladenstein, and T. Härd (Mar. 1998).
“Thermodynamic characterization of non-sequence-specific DNA-binding
111
by the Sso7d protein from Sulfolobus solfataricus.” In: Journal of molecular
biology 276.4, pp. 775–86. doi: 10.1006/jmbi.1997.1558 (cit. on p. 64).
Lunin, V. Y. and A. G. Urzhumtsev (May 1984). “Improvement of protein
phases by coarse model modification”. In: Acta Crystallographica, Sec-
tion A: Foundations of Crystallography 40.3, pp. 269–277. doi: 10.1107/
S0108767384000544 (cit. on pp. 29, 52).
Lurz, R., M. Grote, J. Dijk, R. Reinhardt, and B. Dobrinski (Dec. 1986).
“Electron microscopic study of DNA complexes with proteins from the
Archaebacterium Sulfolobus acidocaldarius.” In: The EMBO journal 5.13,
pp. 3715–21 (cit. on p. 67).
Luzzati, V. (Nov. 1952). “Traitement statistique des erreurs dans la determina-
tion des structures cristallines”. In: Acta crystallographica 5.6, pp. 802–810.
doi: 10.1107/S0365110X52002161 (cit. on p. 41).
Mai, V. Q., X. Chen, R. Hong, and L. Huang (May 1998). “Small abundant
DNA binding proteins from the thermoacidophilic archaeon Sulfolobus shi-
batae constrain negative DNA supercoils.” In: Journal of bacteriology 180.9,
pp. 2560–3 (cit. on p. 64).
Marsh, V. L., S. Y. Peak-Chew, and S. D. Bell (June 2005). “Sir2 and the
acetyltransferase, Pat, regulate the archaeal chromatin protein, Alba.” In:
The Journal of biological chemistry 280.22, pp. 21122–8. doi: 10.1074/
jbc.M501280200 (cit. on p. 66).
Matias, P. M., A. V. Coelho, F. M. A. Valente, D. Plácido, J. LeGall, A. V.
Xavier, I. A. C. Pereira, and M. A. Carrondo (Dec. 2002). “Sulfate respi-
ration in Desulfovibrio vulgaris Hildenborough. Structure of the 16-heme
cytochrome c HmcA AT 2.5-A resolution and a view of its role in transmem-
brane electron transfer.” In: The Journal of biological chemistry 277.49,
pp. 47907–16. doi: 10.1074/jbc.M207465200 (cit. on p. 95).
Matsushita, M., S. Thiel, J. C. Jensenius, I. Terai, and T. Fujita (Sept. 2000).
“Proteolytic activities of two types of mannose-binding lectin-associated
serine protease.” In: Journal of immunology (Baltimore, Md. : 1950) 165.5,
pp. 2637–42 (cit. on p. 84).
Matthews, B. W. (Jan. 1966). “The extension of the isomorphous replacement
method to include anomalous scattering measurements”. In: Acta crystal-
lographica 20.1, pp. 82–86. doi: 10 . 1107 / S0365110X6600015X (cit. on
p. 41).
McCoy, A. J., R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C.
Storoni, and R. J. Read (Aug. 2007). “Phaser crystallographic software.”
In: Journal of applied crystallography 40.Pt 4, pp. 658–674. doi: 10.1107/
S0021889807021206 (cit. on p. 74).
Miller, R., G. T. DeTitta, R. Jones, D. A. Langs, C. M. Weeks, and H. A.
Hauptmann (Mar. 1993). “On the application of the minimal principle to
solve unknown structures.” In: Science 259.5100, pp. 1430–3 (cit. on p. 25).
Miller, W. H. (1839). A Treatise on Crystallography. Cambridge: J. & J. J.
Deighton (cit. on p. 8).
Misteli, T. and E. Soutoglou (Apr. 2009). “The emerging role of nuclear ar-
chitecture in DNA repair and genome maintenance.” In: Nature reviews.
112
Molecular cell biology 10.4, pp. 243–54. doi: 10.1038/nrm2651 (cit. on
p. 5).
Morris, R. J. and G. Bricogne (Feb. 2003). “Sheldrick’s 1.2 Årule and be-
yond”. In: Acta Crystallographica, Section D: Biological Crystallography
59.3, pp. 615–617. doi: 10.1107/S090744490300163X (cit. on p. 13).
Morris, R. J., A. Perrakis, and V. S. Lamzin (May 2002). “ARP / wARP ’s
model-building algorithms. I. The main chain”. In: Acta Crystallographica,
Section D: Biological Crystallography 58.6, pp. 968–975. doi: 10.1107/
S0907444902005462 (cit. on p. 32).
Morris, R. J., P. H. Zwart, S. X. Cohen, F. J. Fernandez, M. Kakaris, O. Kir-
illova, C. Vonrhein, A. Perrakis, and V. S. Lamzin (Nov. 2003). “Breaking
good resolutions with ARP/wARP”. In: Journal of synchrotron radiation
11.1, pp. 56–59. doi: 10.1107/S090904950302394X (cit. on p. 32).
Mueller-Dieckmann, C., S. Panjikar, A. Schmidt, S. Mueller, J. Kuper, A.
Geerlof, M. Wilmanns, R. K. Singh, P. A. Tucker, and M. S. Weiss (Mar.
2007). “On the routine use of soft X-rays in macromolecular crystallog-
raphy. Part IV. Efficient determination of anomalous substructures in
biomacromolecules using longer X-ray wavelengths.” en. In: Acta Crystal-
lographica, Section D: Biological Crystallography 63.Pt 3, pp. 366–80. doi:
10.1107/S0907444906055624 (cit. on pp. 48, 95).
Muirhead, H., J. M. Cox, L. Mazzarella, and M. F. Perutz (1967). “Structure
and function of haemoglobin: III. A three-dimensional fourier synthesis
of human deoxyhaemoglbin at 5·5 Åresolution”. In: Journal of molecular
biology 28.1, pp. 117–150. doi: http://dx.doi.org/10.1016/S0022-
2836(67)80082-2 (cit. on pp. 27, 28).
Murshudov, G. N., P. Skubák, A. A. Lebedev, N. S. Pannu, R. A. Steiner, R. A.
Nicholls, M. D. Winn, F. Long, and A. A. Vagin (Apr. 2011). “REFMAC5
for the refinement of macromolecular crystal structures.” In: Acta Crystal-
lographica, Section D: Biological Crystallography 67.Pt 4, pp. 355–67. doi:
10.1107/S0907444911001314 (cit. on pp. 33, 38, 55, 70).
Murshudov, G. N., A. A. Vagin, and E. J. Dodson (May 1997). “Refinement of
macromolecular structures by the maximum-likelihood method.” In: Acta
Crystallographica, Section D: Biological Crystallography 53.Pt 3, pp. 240–
55. doi: 10.1107/S0907444996012255 (cit. on p. 55).
Näsvall, J., L. Sun, J. R. Roth, and D. I. Andersson (Oct. 2012). “Real-time
evolution of new genes by innovation, amplification, and divergence.” In:
Science 338.6105, pp. 384–7. doi: 10.1126/science.1226521 (cit. on p. 5).
Neel, J. V. (July 1949). “The Inheritance of Sickle Cell Anemia.” In: Science
110.2846, pp. 64–6. doi: 10.1126/science.110.2846.64 (cit. on p. 6).
Ness, S. R., R. A. G. de Graaff, J. P. Abrahams, and N. S. Pannu (Oct. 2004).
“CRANK: new methods for automated macromolecular crystal structure
solution.” In: Structure (London, England : 1993) 12.10, pp. 1753–61. doi:
10.1016/j.str.2004.07.018 (cit. on pp. 33, 38, 41, 43, 55, 70).
Nicholls, R. A., F. Long, and G. N. Murshudov (Apr. 2012). “Low-resolution
refinement tools in REFMAC5.” In: Acta Crystallographica, Section
113
D: Biological Crystallography 68.Pt 4, pp. 404–17. doi: 10 . 1107 /
S090744491105606X (cit. on p. 33).
North, A. C. T. (Feb. 1965). “The combination of isomorphous replacement and
anomalous scattering data in phase determination of non-centrosymmetric
reflexions”. In: Acta crystallographica 18.2, pp. 212–216. doi: 10.1107/
S0365110X65000488 (cit. on p. 41).
Nuijens, J. H., A. J. Eerenberg-Belmer, C. C. Huijbregts, W. O. Schreuder,
R. J. Felt-Bersma, J. J. Abbink, L. G. Thijs, and C. E. Hack (Aug. 1989).
“Proteolytic inactivation of plasma C1- inhibitor in sepsis.” In: The Journal
of clinical investigation 84.2, pp. 443–50. doi: 10.1172/JCI114185 (cit. on
p. 84).
Nussberger, J., M. Cugno, C. Amstutz, M. Cicardi, A. Pellacani, and A.
Agostoni (June 1998). “Plasma bradykinin in angio-oedema.” In: Lancet
351.9117, pp. 1693–7. doi: 10.1016/S0140- 6736(97)09137- X (cit. on
p. 85).
Oberdoerffer, P. and D. A. Sinclair (Sept. 2007). “The role of nuclear architec-
ture in genomic instability and ageing.” In: Nature reviews. Molecular cell
biology 8.9, pp. 692–702. doi: 10.1038/nrm2238 (cit. on p. 5).
Ohno, S. (1970). Evolution by gene duplication. London: George Alien & Unwin
Ltd. Berlin, Heidelberg and New York: Springer-Verlag. (cit. on p. 5).
Osler, W. (1888). “Hereditary Angio-Neurotic Oedema”. In: The American
journal of the medical sciences 95.4 (cit. on p. 85).
Otwinowski, Z., W. Wolf, P. R. Evans, and A. G. W. Leslie (1991). “Isomor-
phous replacement and anomalous scattering”. In: Proceedings of the CCP4
Study Weekend, 25-26 Jan 1991. Ed. by W. ( L. Wolf, P. R. ( C. Evans,
and A. G. W. ( C. Leslie. Vol. None, pp. 80–86 (cit. on pp. 26, 41).
Owen, D. J., P. Ornaghi, J. C. Yang, N. Lowe, P. R. Evans, P. Ballario, D.
Neuhaus, P. Filetici, and A. A. Travers (Nov. 2000). “The structural basis
for the recognition of acetylated histone H4 by the bromodomain of histone
acetyltransferase gcn5p.” In: The EMBO journal 19.22, pp. 6141–9. doi:
10.1093/emboj/19.22.6141 (cit. on p. 95).
Owen, D. J., Y. Vallis, B. M. Pearse, H. T. McMahon, and P. R. Evans (Aug.
2000). “The structure and function of the beta 2-adaptin appendage do-
main.” In: The EMBO journal 19.16, pp. 4216–27. doi: 10.1093/emboj/
19.16.4216 (cit. on p. 95).
Palade, G. E. (Aug. 1964). “The organization of living matter”. In: Proceedings
of the National Academy of Sciences of the United States of America 52.5,
pp. 613–34 (cit. on p. 4).
Panjikar, S., V. Parthasarathy, V. S. Lamzin, M. S. Weiss, and P. A. Tucker
(Apr. 2005). “Auto-rickshaw: an automated crystal structure determina-
tion platform as an efficient tool for the validation of an X-ray diffraction
experiment.” In: Acta Crystallographica, Section D: Biological Crystallog-
raphy 61.Pt 4, pp. 449–57. doi: 10 . 1107 / S0907444905001307 (cit. on
pp. 34, 40).
Pannu, N. S., A. J. McCoy, and R. J. Read (Sept. 2003). “Application of
the complex multivariate normal distribution to crystallographic methods
114
with insights into multiple isomorphous replacement phasing”. In: Acta
Crystallographica, Section D: Biological Crystallography 59.10, pp. 1801–
1808. doi: 10.1107/S090744490301936X (cit. on p. 45).
Pannu, N. S., G. N. Murshudov, E. J. Dodson, and R. J. Read (Nov. 1998). “In-
corporation of Prior Phase Information Strengthens Maximum-Likelihood
Structure Refinement”. In: Acta Crystallographica, Section D: Biological
Crystallography 54.6, pp. 1285–1294. doi: 10.1107/S0907444998004119
(cit. on pp. 30, 42).
Pannu, N. S. and R. J. Read (Dec. 2004). “The application of multivariate sta-
tistical techniques improves single-wavelength anomalous diffraction phas-
ing”. In: Acta Crystallographica, Section D: Biological Crystallography 60.1,
pp. 22–27. doi: 10.1107/S0907444903020808 (cit. on pp. 27, 38, 41, 54,
55, 70).
Pannu, N. S., P. Skubák, I. Sikharulidze, J. P. Abrahams, and R. A. G. de
Graaff (Aug. 2007). “Recent advances in the CRANK automated struc-
ture solution suite”. In: Acta Crystallographica, Section A: Foundations of
Crystallography 63.a1, s116. doi: 10.1107/S0108767307097516 (cit. on
p. 41).
Pannu, N. S., W.-J. Waterreus, P. Skubák, I. Sikharulidze, J. P. Abrahams,
and R. A. G. de Graaff (Apr. 2011). “Recent advances in the CRANK
software suite for experimental phasing.” In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 67.Pt 4, pp. 331–7. doi: 10 . 1107 /
S0907444910052224 (cit. on p. 37).
Pereira, S. L., R. A. Grayling, R. Lurz, and J. N. Reeve (Nov. 1997). “Archaeal
nucleosomes”. In: Proceedings of the National Academy of Sciences of the
United States of America 94.23, pp. 12633–7 (cit. on p. 64).
Perrakis, A., R. J. Morris, and V. S. Lamzin (May 1999). “Automated protein
model building combined with iterative structure refinement.” In: Nature
structural biology 6.5, pp. 458–63. doi: 10.1038/8263 (cit. on pp. 32, 58).
Perutz, M. F. (Nov. 1956). “Isomorphous replacement and phase determination
in non-centrosymmetric space groups”. en. In: Acta crystallographica 9.11,
pp. 867–873. doi: 10.1107/S0365110X56002485 (cit. on p. 15).
Pixley, R. A., M. Schapira, and R. W. Colman (Feb. 1985). “The regulation
of human factor XIIa by plasma proteinase inhibitors.” In: The Journal of
biological chemistry 260.3, pp. 1723–9 (cit. on p. 84).
Plosker, G. L. (Oct. 2012). “Recombinant human c1 inhibitor (conestat alfa):
in the treatment of angioedema attacks in hereditary angioedema.” In: Bio-
Drugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
26.5, pp. 315–23. doi: 10.2165/11206880-000000000-00000 (cit. on pp. 7,
87).
Ramagopal, U. A., M. Dauter, and Z. Dauter (May 2003). “Phasing on anoma-
lous signal of sulfurs: what is the limit?” In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 59.6, pp. 1020–1027. doi: 10 . 1107 /
S0907444903007467 (cit. on p. 18).
Rappleye, J., M. Innus, C. M. Weeks, and R. Miller (May 2002). “SnB version
2.2: an example of crystallographic multiprocessing”. In: Journal of applied
115
crystallography 35.3, pp. 374–376. doi: 10.1107/S0021889802005782 (cit.
on p. 13).
Read, R. J. (May 1986). “Improved Fourier coefficients for maps using phases
from partial structures with errors”. In: Acta Crystallographica, Section
A: Foundations of Crystallography 42.3, pp. 140–149. doi: 10 . 1107 /
S0108767386099622 (cit. on pp. 29, 52, 55).
— (1997). “Model phases: Probabilities and bias”. In: Macromolecular Crys-
tallography Part B. Ed. by R. M. S. Charles W. Carter Jr. Vol. 277. Meth-
ods in Enzymology. Academic Press. Chap. 7, pp. 110–128. doi: 10.1016/
S0076-6879(97)77009-5 (cit. on pp. 29, 52).
Robinson, H., Y. G. Gao, B. S. McCrary, S. P. Edmondson, J. W. Shriver, and
A. H.-J. Wang (Mar. 1998). “The hyperthermophile chromosomal protein
Sac7d sharply kinks DNA.” In: Nature 392.6672, pp. 202–5. doi: 10.1038/
32455 (cit. on p. 64).
Rossmann, M. G. (Feb. 1990). “The molecular replacement method”. en. In:
Acta Crystallographica, Section A: Foundations of Crystallography 46.2,
pp. 73–82. doi: 10.1107/S0108767389009815 (cit. on p. 14).
Rould, M. A. (1997). “Screening for heavy-atom derivatives and obtaining accu-
rate isomorphous differences”. In: Macromolecular Crystallography Part A.
Ed. by J. Charles W. Carter. Vol. 276. Methods in Enzymology. Academic
Press. Chap. 26, pp. 461–472. doi: 10.1016/S0076- 6879(97)76072- 5
(cit. on p. 15).
Ruhaak, L. R., C. Huhn, W.-J. Waterreus, A. R. de Boer, C. Neusüss, C. H.
Hokke, A. M. Deelder, and M. Wuhrer (Aug. 2008). “Hydrophilic interac-
tion chromatography-based high-throughput sample preparation method
for N-glycan analysis from total human plasma glycoproteins.” In: Analyt-
ical chemistry 80.15, pp. 6119–26. doi: 10.1021/ac800630x.
Schaefer, C. and B. Rost (Jan. 2012). “Predict impact of single amino acid
change upon protein structure.” In: BMC genomics 13 Suppl 4, S4. doi:
10.1186/1471-2164-13-S4-S4 (cit. on p. 6).
Schapira, M., A. de Agostini, J. A. Schifferli, and R. W. Colman (Jan. 1985).
“Biochemistry and pathophysiology of human C1 inhibitor: current issues.”
In: Complement (Basel, Switzerland) 2.2-3, pp. 111–26 (cit. on p. 84).
Schapira, M., C. F. Scott, and R. W. Colman (Feb. 1982). “Contribution of
plasma protease inhibitors to the inactivation of kallikrein in plasma.” In:
The Journal of clinical investigation 69.2, pp. 462–8 (cit. on p. 84).
Schapira, M., L. D. Silver, C. F. Scott, A. H. Schmaier, L. J. Prograis,
J. G. Curd, and R. W. Colman (1983). “Prekallikrein activation and high-
molecular-weight kininogen consumption in hereditary angioedema.” In:
The New England journal of medicine 308.18, pp. 1050–1053 (cit. on p. 85).
Schiltz, M., W. Shepard, R. Fourme, T. Prangé, E. de La Fortelle, and G.
Bricogne (Jan. 1997). “High-pressure krypton gas and statistical heavy-
atom refinement: a successful combination of tools for macromolecular
structure determination.” In: Acta Crystallographica, Section D: Biologi-
cal Crystallography 53.Pt 1, pp. 78–92. doi: 10.1107/S0907444996009705
(cit. on p. 95).
116
Schneider, T. R. and G. M. Sheldrick (Sept. 2002). “Substructure solution
with SHELXD”. In: Acta Crystallographica, Section D: Biological Crystal-
lography 58.10, pp. 1772–1779. doi: 10.1107/S0907444902011678 (cit. on
pp. 13, 38, 55).
Schrödinger LLC (Aug. 2010). “The PyMOL Molecular Graphics System, Ver-
sion 1.5.0.3” (cit. on p. 71).
Sevcik, J., Z. Dauter, V. S. Lamzin, and K. S. Wilson (Mar. 1996). “Ribonucle-
ase from Streptomyces aureofaciens at atomic resolution.” In: Acta Crys-
tallographica, Section D: Biological Crystallography 52.Pt 2, pp. 327–44.
doi: 10.1107/S0907444995007669 (cit. on p. 95).
Sevcik, J., E. J. Dodson, and G. G. Dodson (Apr. 1991). “Determination and
restrained least-squares refinement of the structures of ribonuclease Sa and
its complex with 3’-guanylic acid at 1.8 Åresolution”. In: Acta Crystallo-
graphica, Section B: Structural Science 47.2, pp. 240–253. doi: 10.1107/
S0108768190009569 (cit. on p. 95).
Sharp, K. A. (Apr. 1991). “The hydrophobic effect”. In: Current opinion in
structural biology 1.2, pp. 171–174. doi: 10.1016/0959-440X(91)90057-Z
(cit. on p. 6).
Sheldrick, G. M. (1990). “Phase annealing in SHELX-90: direct methods for
larger structures”. In: Acta Crystallographica, Section A: Foundations of
Crystallography 46.6, pp. 467–473. doi: 10.1107/S0108767390000277 (cit.
on p. 12).
— (Dec. 2002). “Macromolecular phasing with SHELXE”. In: Zeitschrift für
Kristallographie 217.12-2002, pp. 644–650. doi: 10.1524/zkri.217.12.
644.20662 (cit. on pp. 32, 38, 52).
— (Jan. 2008). “A short history of SHELX.” In: Acta Crystallographica, Sec-
tion A: Foundations of Crystallography 64.Pt 1, pp. 112–22. doi: 10.1107/
S0108767307043930 (cit. on pp. 38, 55).
Shi, N., S. Ye, A. Alam, L. Chen, and Y. Jiang (Mar. 2006). “Atomic structure
of a Na+- and K+-conducting channel.” In: Nature 440.7083, pp. 570–4.
doi: 10.1038/nature04508 (cit. on p. 95).
Shoemaker, L. R., S. J. Schurman, V. H. Donaldson, and A. E. Davis (1994).
“Hereditary angioneurotic oedema: characterization of plasma kinin and
vascular permeability-enhancing activities.” In: Clinical and experimental
immunology 95.1, pp. 22–28 (cit. on p. 85).
Shriver, J. W., W. B. Peters, N. Szary, A. T. Clark, and S. P. Edmondson
(2001). “Calorimetric analyses of hyperthermophile proteins”. In: Hyper-
thermophilic Enzymes, Part C. Ed. by R. M. K. Michael W. W. Adams.
Vol. 334. Methods in Enzymology. Academic Press, pp. 389–422. doi: http:
//dx.doi.org/10.1016/S0076-6879(01)34483-X (cit. on p. 64).
Sim, R. B., A. Reboul, G. J. Arlaud, C. L. Villiers, and M. G. Colomb (Jan.
1979). “Interaction of 125I-labelled complement subcomponents C-1r and
C-1s with protease inhibitors in plasma.” In: FEBS letters 97.1, pp. 111–5
(cit. on p. 84).
Skarzyński, T. (Apr. 1992). “Crystal structure of alpha-dendrotoxin from the
green mamba venom and its comparison with the structure of bovine pan-
117
creatic trypsin inhibitor.” In: Journal of molecular biology 224.3, pp. 671–
83 (cit. on p. 95).
Skubák, P., G. N. Murshudov, and N. S. Pannu (Dec. 2004). “Direct incorpo-
ration of experimental phase information in model refinement.” In: Acta
Crystallographica, Section D: Biological Crystallography 60.Pt 12 Pt 1,
pp. 2196–201. doi: 10.1107/S0907444904019079 (cit. on pp. 54, 55, 70).
— (Oct. 2009). “A multivariate likelihood SIRAS function for phasing and
model refinement.” In: Acta Crystallographica, Section D: Biological Crys-
tallography 65.Pt 10, pp. 1051–61. doi: 10.1107/S0907444909028078 (cit.
on pp. 42, 43).
Skubák, P., S. R. Ness, and N. S. Pannu (Dec. 2005). “Extending the resolu-
tion and phase-quality limits in automated model building with iterative
refinement.” In: Acta Crystallographica, Section D: Biological Crystallog-
raphy 61.Pt 12, pp. 1626–35. doi: 10.1107/S0907444905032233 (cit. on
pp. 43, 54).
Skubák, P. and N. S. Pannu (Mar. 2011). “Reduction of density-modification
bias by β correction”. In: Acta Crystallographica, Section D: Biological
Crystallography 67.4, pp. 345–354. doi: 10.1107/S0907444911002083 (cit.
on pp. 30, 42).
Skubák, P., W.-J. Waterreus, and N. S. Pannu (June 2010). “Multivariate
phase combination improves automated crystallographic model building”.
In: Acta Crystallographica, Section D: Biological Crystallography 66.7,
pp. 783–788. doi: 10.1107/S0907444910014642 (cit. on pp. 38, 42, 51,
54, 70).
Smith, G. D., W. A. Pangborn, and R. H. Blessing (Mar. 2003). “The struc-
ture of T6 human insulin at 1.0 A resolution.” In: Acta Crystallographica,
Section D: Biological Crystallography 59.Pt 3, pp. 474–82 (cit. on p. 95).
Sohi, M., A. Alexandrovich, G. F. Moolenaar, R. Visse, N. Goosen, X. Vernede,
J. C. Fontecilla-Camps, J. Champness, and M. R. Sanderson (Jan. 2000).
“Crystal structure of Escherichia coli UvrB C-terminal domain, and a
model for UvrB-uvrC interaction.” In: FEBS letters 465.2-3, pp. 161–4
(cit. on p. 68).
Solá, R. J. and K. Griebenow (Apr. 2009). “Effects of glycosylation on the sta-
bility of protein pharmaceuticals.” In: Journal of pharmaceutical sciences
98.4, pp. 1223–45. doi: 10.1002/jps.21504 (cit. on p. 90).
Soria, G., S. E. Polo, and G. Almouzni (2012). “Prime, Repair, Restore: The
Active Role of Chromatin in the DNA Damage Response”. In: Molecular
cell 46.6, pp. 722–734 (cit. on p. 5).
Stefl, S., H. Nishi, M. Petukh, A. R. Panchenko, and E. Alexov (July 2013).
“Molecular Mechanisms of Disease-Causing Missense Mutations.” In: Jour-
nal of molecular biology. doi: 10.1016/j.jmb.2013.07.014 (cit. on p. 6).
Strang, C. J., H. S. Auerbach, and F. S. Rosen (1986). “C1s-induced vascular
permeability in C2-deficient guinea pigs.” In: The Journal of Immunology
137.2, pp. 631–635 (cit. on p. 85).
Strang, C. J., S. Cholin, J. Spragg, A. E. Davis, E. E. Schneeberger, V. H. Don-
aldson, and F. S. Rosen (Nov. 1988). “Angioedema induced by a peptide
118
derived from complement component C2.” In: The Journal of experimental
medicine 168.5, pp. 1685–98 (cit. on p. 85).
Strub, M. P., F. Hoh, J. F. Sanchez, J. M. Strub, A. Böck, A. Aumelas, and C.
Dumas (Nov. 2003). “Selenomethionine and selenocysteine double labeling
strategy for crystallographic phasing.” In: Structure (London, England :
1993) 11.11, pp. 1359–67 (cit. on p. 19).
Sun, S., K. Kondabagil, P. M. Gentz, M. G. Rossmann, and V. B. Rao (Mar.
2007). “The structure of the ATPase that powers DNA packaging into
bacteriophage T4 procapsids.” In: Molecular cell 25.6, pp. 943–9. doi: 10.
1016/j.molcel.2007.02.013 (cit. on p. 95).
Su, S., Y. G. Gao, H. Robinson, Y. C. Liaw, S. P. Edmondson, J. W. Shriver,
and A. H.-J. Wang (Oct. 2000). “Crystal structures of the chromosomal
proteins Sso7d/Sac7d bound to DNA containing T-G mismatched base-
pairs.” In: Journal of molecular biology 303.3, pp. 395–403. doi: 10.1006/
jmbi.2000.4112 (cit. on p. 65).
Tanaka, T., S. Padavattan, and T. Kumarevel (Mar. 2012). “Crystal structure
of archaeal chromatin protein Alba2-double-stranded DNA complex from
Aeropyrum pernix K1.” In: The Journal of biological chemistry 287.13,
pp. 10394–402. doi: 10.1074/jbc.M112.343210 (cit. on p. 66).
Taylor, G. L. (Apr. 2010). “Introduction to phasing.” In: Acta Crystallograph-
ica, Section D: Biological Crystallography 66.Pt 4, pp. 325–38. doi: 10.
1107/S0907444910006694 (cit. on pp. 13, 15).
Teale, M. J., M. Kahsai, S. K. Singh, S. P. Edmondson, R. Gupta, J. W.
Shriver, and E. J. Meehan (June 2003). “Cloning, expression, crystallization
and preliminary X-ray analysis of the DNA-binding protein Sso10a from
Sulfolobus solfataricus”. In: Acta Crystallographica, Section D: Biological
Crystallography 59.7, pp. 1320–1322. doi: 10.1107/S090744490301062X
(cit. on p. 65).
Terwilliger, T. C. (Aug. 2000). “Maximum-likelihood density modification.”
In: Acta Crystallographica, Section D: Biological Crystallography 56.Pt 8,
pp. 965–72. doi: 10.1107/S0907444900005072 (cit. on pp. 32, 33, 38, 52).
— (Dec. 2002). “Automated main-chain model building by template match-
ing and iterative fragment extension”. In: Acta Crystallographica, Sec-
tion D: Biological Crystallography 59.1, pp. 38–44. doi: 10 . 1107 /
S0907444902018036 (cit. on pp. 32, 33, 38).
— (Dec. 2004). “Using prime-and-switch phasing to reduce model bias
in molecular replacement.” In: Acta Crystallographica, Section D: Bi-
ological Crystallography 60.Pt 12 Pt 1, pp. 2144–9. doi: 10 . 1107 /
S0907444904019535 (cit. on p. 30).
Terwilliger, T. C. and J. Berendzen (Apr. 1999). “Automated MAD and MIR
structure solution”. In: Acta Crystallographica, Section D: Biological Crys-
tallography 55.4, pp. 849–861. doi: 10.1107/S0907444999000839 (cit. on
pp. 24, 30).
Theobald, D. L. and D. S. Wuttke (Sept. 2006). “THESEUS: maximum
likelihood superpositioning and analysis of macromolecular structures.”
119
In: Bioinformatics (Oxford, England) 22.17, pp. 2171–2. doi: 10.1093/
bioinformatics/btl332 (cit. on p. 71).
Thomassen, E., G. Gielen, M. Schütz, G. Schoehn, J. P. Abrahams, S. Miller,
and M. J. van Raaij (Aug. 2003). “The structure of the receptor-binding
domain of the bacteriophage T4 short tail fibre reveals a knitted trimeric
metal-binding fold.” In: Journal of molecular biology 331.2, pp. 361–73 (cit.
on p. 95).
Usón, I. and G. M. Sheldrick (Oct. 1999). “Advances in direct methods for pro-
tein crystallography.” In: Current opinion in structural biology 9.5, pp. 643–
8 (cit. on pp. 13, 26).
Vagin, A. A. and A. Teplyakov (Dec. 1997). “MOLREP : an Automated Pro-
gram for Molecular Replacement”. In: Journal of applied crystallography
30.6, pp. 1022–1025. doi: 10.1107/S0021889897006766 (cit. on p. 74).
Van der Graaf, F., J. A. Koedam, and B. N. Bouma (Jan. 1983). “Inactivation
of kallikrein in human plasma.” In: The Journal of clinical investigation
71.1, pp. 149–58 (cit. on p. 84).
Van der Plas, J. L., R. A. G. de Graaff, and H. Schenk (May 1998). “Karle–
Hauptman Matrices and Eigenvalues: a Practical Approach”. In: Acta Crys-
tallographica, Section A: Foundations of Crystallography 54.3, pp. 267–272.
doi: 10.1107/S0108767397013603 (cit. on p. 26).
Van Veen, H. (Nov. 2012). Personal communication. E-mail correspondence
of November 6th 2012: ”a concentration of 178mgmL−1 can be reached
without loss in activity.” (cit. on p. 90).
Van Veen, H. A., J. Koiter, C. J. M. Vogelezang, N. van Wessel, T. van Dam, I.
Velterop, K. van Houdt, L. Kupers, D. Horbach, M. Salaheddine, J. H. Nui-
jens, and M. L. M. Mannesse (Dec. 2012). “Characterization of recombinant
human C1 inhibitor secreted in milk of transgenic rabbits.” In: Journal of
biotechnology 162.2-3, pp. 319–26. doi: 10.1016/j.jbiotec.2012.09.005
(cit. on pp. 88, 89, 92).
Varga, L. and H. Farkas (Mar. 2011). “rhC1INH: a new drug for the treatment
of attacks in hereditary angioedema caused by C1-inhibitor deficiency.” In:
Expert review of clinical immunology 7.2, pp. 143–53. doi: 10.1586/eci.
11.5 (cit. on pp. 7, 87).
Walsh, M. A., Z. Otwinowski, A. Perrakis, P. M. Anderson, and A. Joachimiak
(May 2000). “Structure of cyanase reveals that a novel dimeric and de-
cameric arrangement of subunits is required for formation of the enzyme
active site.” In: Structure (London, England : 1993) 8.5, pp. 505–14 (cit. on
p. 95).
Wang, C. (1985). “Resolution of phase ambiguity in macromolecular crystal-
lography”. In: Diffraction Methods for Biological Macromolecules Part B.
Ed. by S. N. T. Harold W. Wyckoff C. H. W. Hirs. Vol. 115. Methods in
Enzymology. Academic Press, pp. 90–112. doi: http://dx.doi.org/10.
1016/0076-6879(85)15009-3 (cit. on pp. 20, 27, 52).
Wang, Z. and J. Moult (Apr. 2001). “SNPs, protein structure, and disease.” In:
Human mutation 17.4, pp. 263–70. doi: 10.1002/humu.22 (cit. on p. 6).
120
Wardleworth, B. N., R. J. M. Russell, S. D. Bell, G. L. Taylor, and M. F. White
(Sept. 2002). “Structure of Alba: an archaeal chromatin protein modulated
by acetylation.” In: The EMBO journal 21.17, pp. 4654–62 (cit. on p. 66).
Watson, J. D. and F. H. C. Crick (Apr. 1953). “Molecular structure of nu-
cleic acids; a structure for deoxyribose nucleic acid.” In: Nature 171.4356,
pp. 737–8 (cit. on pp. 3, 4).
Waytes, A. T., F. S. Rosen, and M. M. Frank (June 1996). “Treatment of
hereditary angioedema with a vapor-heated C1 inhibitor concentrate.” In:
The New England journal of medicine 334.25, pp. 1630–4. doi: 10.1056/
NEJM199606203342503 (cit. on p. 87).
Weeks, C. M. and R. Miller (Feb. 1999). “Optimizing Shake-and-Bake for pro-
teins.” In: Acta Crystallographica, Section D: Biological Crystallography
55.Pt 2, pp. 492–500 (cit. on p. 13).
Weiss, M. S. (Apr. 2001). “Global indicators of X-ray data quality”. In:
Journal of applied crystallography 34.2, pp. 130–135. doi: 10 . 1107 /
S0021889800018227 (cit. on p. 95).
Weiss, M. S. and R. Hilgenfeld (Apr. 1997). “On the use of the merging R factor
as a quality indicator for X-ray data”. In: Journal of applied crystallography
30.2, pp. 203–205. doi: 10.1107/S0021889897003907 (cit. on p. 74).
White, S. A., S. J. Peake, S. McSweeney, G. Leonard, N. P. Cotton, and
J. B. Jackson (Jan. 2000). “The high-resolution structure of the NADP(H)-
binding component (dIII) of proton-translocating transhydrogenase from
human heart mitochondria.” In: Structure (London, England : 1993) 8.1,
pp. 1–12 (cit. on p. 95).
Winn, M. D., C. C. Ballard, K. D. Cowtan, E. J. Dodson, P. Emsley, P. R.
Evans, R. M. Keegan, E. B. Krissinel, A. G. W. Leslie, S. J. McNicholas,
G. N. Murshudov, N. S. Pannu, E. A. Potterton, H. R. Powell, R. J. Read,
A. Vagin, and K. S. Wilson (Apr. 2011). “Overview of the CCP4 suite and
current developments.” In: Acta Crystallographica, Section D: Biological
Crystallography 67.Pt 4, pp. 235–42. doi: 10.1107/S0907444910045749
(cit. on pp. 23, 55).
Wisnieski, J. J., T. C. Knauss, I. Yike, D. G. Dearborn, R. L. Narvy, and G. B.
Naff (Mar. 1994). “Unique C1 inhibitor dysfunction in a kindred without
angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.” In:
Journal of immunology (Baltimore, Md. : 1950) 152.6, pp. 3199–209 (cit.
on p. 86).
Wuillemin, W. A., M. Minnema, J. C. Meijers, D. Roem, A. J. Eerenberg, J. H.
Nuijens, H. ten Cate, and C. E. Hack (Mar. 1995). “Inactivation of factor
XIa in human plasma assessed by measuring factor XIa-protease inhibitor
complexes: major role for C1-inhibitor.” In: Blood 85.6, pp. 1517–26 (cit. on
p. 84).
Xiao, J., H. Xia, J. Zhou, I. F. Azmi, B. A. Davies, D. J. Katzmann, and Z. Xu
(Jan. 2008). “Structural basis of Vta1 function in the multivesicular body
sorting pathway.” In: Developmental cell 14.1, pp. 37–49. doi: 10.1016/
j.devcel.2007.10.013 (cit. on p. 95).
121
Yue, P., Z. Li, and J. Moult (Oct. 2005). “Loss of protein structure stability as
a major causative factor in monogenic disease.” In: Journal of molecular
biology 353.2, pp. 459–73. doi: 10.1016/j.jmb.2005.08.020 (cit. on p. 6).
Zahedi, R., J. J. Bissler, A. E. Davis, C. Andreadis, and J. J. Wisnieski (Mar.
1995). “Unique C1 inhibitor dysfunction in a kindred without angioedema.
II. Identification of an Ala443–>Val substitution and functional analysis of
the recombinant mutant protein.” In: The Journal of clinical investigation
95.3, pp. 1299–305. doi: 10.1172/JCI117780 (cit. on pp. 86, 87).
Zahedi, R., J. J. Wisnieski, and A. E. Davis (July 1997). “Role of the P2 residue
of complement 1 inhibitor (Ala443) in determination of target protease
specificity: inhibition of complement and contact system proteases.” In:
Journal of immunology (Baltimore, Md. : 1950) 159.2, pp. 983–8 (cit. on
p. 86).
Zhang, K. Y. J., K. D. Cowtan, and P. Main (1997). “Combining constraints for
electron-density modification”. In:Macromolecular Crystallography Part B.
Ed. by R. M. S. Charles W. Carter Jr. Vol. 277. Methods in Enzymology.
Academic Press. Chap. 4, pp. 53–64. doi: http://dx.doi.org/10.1016/
S0076-6879(97)77006-X (cit. on pp. 27, 28).
Zuraw, B. L., M. Cicardi, R. J. Levy, J. H. Nuijens, A. Relan, S. Visscher,
G. Haase, L. Kaufman, and C. E. Hack (Oct. 2010). “Recombinant human
C1-inhibitor for the treatment of acute angioedema attacks in patients with
hereditary angioedema.” In: The Journal of allergy and clinical immunology
126.4, 821–827.e14. doi: 10.1016/j.jaci.2010.07.021 (cit. on pp. 7,
87).
Nederlandse samenvatting
Eiwitten zijn de moleculaire raderen van het leven en spelen een cen-
trale rol in vrijwel alle cellulaire processen. De vergisting van wort tot
bier, fotosynthese in planten, de vermeerdering van erfelijk materiaal,
de doorgave van stimuli in zenuwcellen en de verdediging tegen ziek-
teverwekkers zijn slechts enkele van de processen waarbij verschillende
eiwitten tezamen een bijdrage leveren in zeer complexe, doch goed ge-
organiseerde systemen.
De rol van een enkel eiwit in zo’n systeem kan vaak begrepen wor-
den vanuit de driedimensionale structuur. Deze kan inzicht geven in
het verloop van de chemische reacties en moleculaire interacties waar-
aan het eiwit zijn functie ontleent. Daarbij kan de globale vouwing
van het eiwit van belang zijn, maar ook de plek en reactiviteit van de
individuele aminozuren, de bouwstenen waaruit eiwitten bestaan. Ver-
reweg de meerderheid van de eiwitstructuren wordt bepaald middels
röntgendiffractie. Hierbij wordt een kristal met een zeer smalle mono-
chromatische röntgenbundel vanuit verschillende hoeken bestraald. Uit
de resulterende verstrooiingspatronen kan middels fouriertransformatie
de elektronendichtheid in het kristal verkregen worden, waaruit vervol-
gens de molecuulstructuur, ook wel kristalstructuur genoemd, afgeleid
kan worden. Behalve fundamenteel inzicht in de werking en de ont-
staansgeschiedenis van het leven, kan kennis van de kristalstructuur van
een eiwit dat betrokken is bij een ziekteproces bijdragen tot ontwik-
keling van nieuwe medicijnen. Kennis en gerichte aanpassing van de
structuur van eiwitten die gebruikt worden in industriële toepassingen
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kunnen kostenbesparingen en nieuwe producten opleveren.
De organisatie van chromatine is essentieel in alle organismen. Niet
alleen vanwege haar rol in het efficiënt verpakken van het DNA zodat het
in de cel of celkern past, maar ook door de betrokkenheid van chroma-
tineorganisatie bij allerlei cellulaire processen. Door bijvoorbeeld lokaal
het DNA toegankelijker of juist meer compact te maken kan de ex-
pressie van een gen beïnvloed worden. Chromatine-eiwitten kunnen het
DNA samentrekken door het DNA te buigen of door een DNA streng
op twee verschillende plekken te binden en zo lussen te vormen. Andere
chromatine-eiwitten maken het DNA meer compact door als een spoel
met DNA omwikkeld te worden. Hoofdstuk 4 beschrijft de structuur van
het Sso10a2 eiwit uit de Archaeon Sulfolobus solfataricus. Tezamen met
de homologe eiwitten Sso10a en Sso10a3 speelt Sso10a2 mogelijk een rol
in chromatinedynamiek en -organisatie in S. solfataricus. Sso10a2 vormt
een uitermate stabiele dimeer waarbij de lange C-terminale α-helix een
belangrijke rol speelt. Daarnaast bevat de Sso10a2 monomeer een DNA-
bindend domein dat ook in andere chromatine-eiwitten is geïdentificeerd.
Ten opzichte van de Sso10a structuur zijn een aantal van de secundaire
structuurelementen in het DNA-bindende domein van de Sso10a2 mo-
nomeer verschoven, wat mogelijk van invloed is op de binding van DNA.
Ruconest® is een recombinant C1INH eiwit dat recentelijk is goed-
gekeurd voor behandeling van patiënten met hereditair angio-oedeem.
C1INH behoort tot de familie van serpineproteaseremmers en reguleert
ontstekingsprocessen in het bloed door het voorkomen van spontane acti-
vatie van het complementsysteem. Genetische C1INH deficiëntie veroor-
zaakt hereditair angio-oedeem. Deze ziekte gaat gepaard met zwellingen
die levensbedreigend kunnen zijn wanneer ze voorkomen in de bovenste
luchtwegen. Hoofdstuk 5 beschrijft de succesvolle kristallisatie van twee
varianten van het recombinante C1INH eiwit. Van beiden is aangetoond
dat ze hun remmende activiteit in vitro behouden. In tegenstelling tot
de eerder opgeloste latente structuur van C1INH zijn beide varianten
gekristalliseerd met de glycosilering intact. Mogelijkerwijs verschaft de
structuur meer inzicht in de actief–latent transitie welke voor deze ser-
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pine nog niet volledig is opgehelderd.
Om de kristalstructuur middels fouriertransformatie uit de diffrac-
tiepatronen te berekenen zijn zowel de intensiteit van de verstrooide
röntgenbundels als hun onderlinge fases nodig. De intensiteit is gemak-
kelijk te meten met behulp van een röntgendiffractometer, echter de
faserelatie kan niet direct experimenteel bepaald worden. Dit probleem
is in de kristallografie bekend als het faseprobleem. Hoofdstuk 1 geeft
een overzicht van de verschillende methoden die in de loop der jaren
ontwikkeld zijn om het faseprobleem op te lossen. Hierbij zijn grofweg
twee verschillende benaderingen te onderscheiden. Een techniek die de
afgelopen jaren erg populair is geworden, maakt gebruik van een gelij-
kende reeds bekende eiwitstructuur om een eerste schatting van de fases
van de onbekende structuur te verkrijgen. De tweede groep methoden
maakt gebruik van informatie uit het diffractie-experiment om een deel
van de molecuulstructuur en vervolgens de fase-informatie voor het ge-
hele molecuul te achterhalen. Het verkrijgen van de fase-informatie op
deze manier wordt ook wel experimentele fasebepaling genoemd.
Om de structuurbepaling te vereenvoudigen en sneller te maken zijn
veel van de taken in de structuuranalyse geautomatiseerd. Het pro-
gramma Crank koppelt verschillende programma’s die elk afzonderlijk
een enkele taak uitvoeren in de structuuroplossing middels experimen-
tele fasebepaling. Hierdoor is het mogelijk voor een eiwit van gemid-
delde grootte met verstrooiingspatronen van goede kwaliteit binnen en-
kele uren een vrijwel volledig model te genereren. In hoofdstuk 2 komen
de vele verbeteringen in Crank aan bod die bij tests met meer dan
honderd verschillende datasets tot structuren leidden die aanmerkelijk
meer volledig zijn dan bij een vorige versie van Crank. Daarnaast zijn
enkele structuren opgelost met de nieuwe versie die voorheen nog niet
automatisch opgelost konden worden.
Veel van de verbeteringen in Crank hebben hun oorsprong in nieuwe
geavanceerde waarschijnlijkheidsfuncties waarmee meerdere bronnen
van (experimentele) informatie tegelijkertijd beschouwd kunnen wor-
den en welke de correlaties tussen verschillende bronnen van informatie
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in acht nemen. Daarnaast kan ook de experimentele foutmarge beter
worden gemodelleerd met dit type functies. Hoofdstuk 3 beschrijft de
toepassing van de nieuwe SAD-DM waarschijnlijkheidsfunctie die fase-
informatie na experimentele fasebepaling combineert met fases verkre-
gen vanuit empirisch verbeterde elektronendichtheid.
Vaak is de elektronendichtheid in eerste instantie van onvoldoende
kwaliteit om een model van de eiwitstructuur in te bouwen. Door ge-
bruik te maken van kennis over de typische verdeling van de elektronen-
dichtheid in een kristal kan deze verbeterd worden. Zo varieert de elek-
tronendichtheid bijvoorbeeld sterk op plaatsen waar eiwit zit en is deze
uniform in de tussenruimte tussen verschillende eiwitmoleculen in het
kristal. De verbeterde fases worden verkregen door inverse fouriertrans-
formatie van de verbeterde elektronendichtheid en gecombineerd met de
oorspronkelijke experimenteel bepaalde fases. Dit proces wordt herhaald
totdat de elektronendichtheid niet langer noemenswaardig verbetert. De
nieuwe SAD-DM functie voor fasecombinatie is een aanmerkelijke voor-
uitgang in vergelijking met het meest gebruikte algoritme σA. Dit komt
onder andere doordat de SAD-DM functie in tegenstelling tot σA er bij
de fasecombinatie niet vanuit gaat dat de oorspronkelijke en verbeterde
fases onafhankelijk van elkaar zijn.
Het verkrijgen van een goed verstrooiend eiwitkristal is een proces
dat maanden tot jaren in beslag kan nemen. Echter een goed verstrooi-
end kristal is geen garantie dat de structuur opgelost kan worden. In veel
gevallen bevatten de diffractiepatronen hiertoe niet genoeg informatie.
Dankzij de geavanceerde waarschijnlijkheidsfuncties zoals beschreven in
hoofdstuk 2 en 3 kan de beschikbare data beter gebruikt worden. Zo
kunnen structuren opgelost worden die met bestaande software niet of
moeilijk op te lossen zijn.
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